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Streptomyces are multicellular, Gram-positive bacteria in the phylum of actino-
bacteria which produce a high amount of bioactive natural products of which the 
expression is tightly coordinated with the lifecycle. During growth of Streptomyces, 
cell growth and division are two separate processes. Exponential growth of vegeta-
tive hyphae is achieved by apical growth and mycelial branching, driven by DivIVA 
(Flärdh, 2010). Cell division does not physically separate cells at this stage, instead 
long hyphae are formed which are separated by occasional cross-walls (Jakimowicz 
& van Wezel, 2012, Celler et al., 2016). Canonical division occurs during sporulation, 
which requires all components of the divisome. At this stage, the long aerial hyphae 
are separated by up to a hundred septa and spores are formed by a highly coordi-
nated process of cell division and DNA segregation (Zhang et al., 2016a). One of the 
most renowned properties of streptomycetes is that they can growth without cell di-
vision, thus uniquely enabling the deletion of the cell division gene ftsZ (McCormick 
et al., 1994). These remarkable properties make streptomycetes a unique model for 
the study of growth and cell division (McCormick, 2009).
 Streptomyces are well-known for the production of a wide arrange of antibiotics, 
immune suppressants and anti-cancer compounds (Berdy, 2012, Hopwood, 2007, 
Barka et al., 2016). The production of this high amount of specialized metabolites 
is commonly attributed to the lifecycle of these bacteria, consisting of growth of an 
intricate hyphal network, development of reproductive spores and an event of pro-
grammed cell death where old mycelia are broken down and become available in 
the direct environment (Figure 1). The production of secondary metabolites occurs 
at the onset of morphological differentiation from vegetative to reproductive growth 
(van der Heul et al., 2018, van Wezel & McDowall, 2011).The hunt for novel an-
timicrobial compounds has led to the isolation of huge numbers of actinobacteria 
from soil and aquatic environments, leading to the discovery of more than 600 type 
strains of streptomycetes (Labeda et al., 2017, Hopwood, 2007). These were then 
screened for the production of novel bioactive molecules, resulting in many different 
medicines from actinobacterial sources. This strategy was very successful and sup-
ported the discovery of a large amount of secondary metabolites in the past, but the 
amount of novel antibiotics found by this same process has decreased to a rate that 
this is no longer feasible (Kolter & van Wezel, 2016). A breakthrough in the field oc-
curred when the first Streptomyces genomes were sequenced: it became clear that 
Streptomyces are capable of producing ten times more secondary metabolites than 
previously discovered (Ikeda et al., 2003, Bentley et al., 2002). This sparked interest 
in novel approaches, such as ‘awakening’ silent gene clusters (Rutledge & Challis, 
2015, Zhu et al., 2014a, Bentley et al., 2002). Research to find novel antimicrobials 
is mostly driven with the natural environment and life cycle as a starting point. Scien-
tists do not just ask ‘what’ is being produced, but also ‘why’ and ‘when’. Having the 
biology in mind, researchers have several different approaches: Firstly, competition 
between bacteria can be mimicked by co-cultivation. For example, when the fila-
mentous fungus Aspergillus niger and the filamentous bacteria Streptomyces coe-
licolor are cultured together, the combination of strains produce metabolites neither 
organism would produce when grown solitary (Wu et al., 2015). This suggests that 
secondary metabolites can be produced as a signal to predation or to a social cue 
(van der Meij et al., 2017). Secondly, when strains are grown on different media they 
behave in a different manner, which is one of the reasons that growth on 7 different 
media is an essential part of Streptomyces taxonomy (Shirling & Gottlieb, 1966). 
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Rich or poor growth conditions, or the presence of specific eliciting compounds such 
N-acetyl glucosamine, can make all the difference in terms of antibiotic production 
(Swiatek et al., 2012, Zhu et al., 2014b, Rigali et al., 2008). Thirdly, novel bacteria 
are increasingly isolated from underexplored and extreme habitats are used in order 
to look for more novel species with the potential to produce novel secondary metab-
olites (Bull et al., 2016). This approach has led to the isolation of the new family of 
Salinispora sp. and a large amount of novel secondary metabolites (Ahmed et al., 
2013, Ziemert et al., 2014, Maldonado et al., 2005). 
Figure 1. Schematic representation of the Streptomyces life cycle. Germination of spores 
is controlled by the cAMP receptor protein CRP and supported by RPF like proteins and mu-
ramidases. Vegetative hyphae then grow by tip growth, driven by DivIVA and eventually form 
a complex multicellular vegetative mycelium. When nutrients are exhausted, an event of PCD 
occurs simultaneously with antibiotic production and the growth of aerial hyphae. Spores are 
formed by simultaneous constriction of hundreds of FtsZ-rings, which are later released in 
order for life to start anew. 
Transcriptional regulation of aerial mycelium formation is due to ‘bld’ genes, 
named after the bald phenotype of a Streptomyces without aerial mycelia (Merrick, 
1976). The bld mutants do not form aerial hypae but are often also disturbed in 
carbon utilization and antibiotic production, emphasizing the relation between nu-
trient utilization, antibiotic production and development (Pope et al., 1996). Of the 
bld genes, bldD is a global transcription factor that represses most developmental 
genes during vegetative growth, including bldN, whiG, sigH and ssgB (den Hengst et 
al., 2010, Elliot et al., 2001). Especially interesting is the indirect regulation by bldA 
which specifies a leucyl-tRNA for the translation of UUA codons, which is extreme-
ly rare in the GC-rich streptomycetes. The BldA tRNA posttranslationally controls 
genes involved in development and antibiotic production (Lawlor et al., 1987, Leskiw 
et al., 1991). The whi genes are named after the white phenotype of Streptomyces 
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that fail to produce grey-pigmented spores (Chater et al., 1989), and typically en-
code transcriptional regulators that regulate processes related to the onset of spor-
ulation. WhiG is a sigma factor that controls the early stage of spore formation, with 
null mutants forming straight aerial hyphae without septa. WhiB controls the onset of 
sporulation and is the archetypal member of the Wbl (WhiB-like) proteins (Molle et 
al., 2000). WhiB and WhiA co-control sporulation, and whiA and whiB mutants have 
very similar phenotypes, producing long, curly aerial hyphae without spores (Ainsa 
et al., 2000, Ainsa et al., 1999). Sporulation is further regulated by the SsgA-like 
proteins (SALPS), which are small proteins (125-142 aa) with an average amino 
acid similarity of 30-40% between them (Traag & van Wezel, 2008). All sporulating 
actinobacteria have at least one SALP and the amount of SALPS increases with the 
complexity of the organism (Keijser et al., 2003). Deletion mutants lacking ssgA have 
sporulation defects, while overexpression of this gene causes an increase of the 
amount of germ tubes from a spore and a higher branching frequency (van Wezel et 
al., 2006, van Wezel et al., 2000a). 
When nutrients become scarce, the vegetative mycelium undergoes a large event 
of Programmed Cell Death (PCD), resulting in breakdown of the vegetative or sub-
strate hyphae for the benefit of the growth of aerial hyphae (Tenconi et al., 2018, 
Manteca et al., 2006, Miguelez et al., 2000). During PCD, a large part of the vege-
tative cell wall is hydrolyzed in order to reuse cell-wall derived aminosugars, and in 
particular N-acetyl Glucosamine (GlcNAc), or to recycle for de novo cell wall synthe-
sis (Urem et al., 2016, Rigali et al., 2008). At the time of PCD, streptomycetes are 
in a sensitive position when their own vegetative mycelium is partly hydrolyzed, as 
nutrients are being released at a time of scarcity. This will attract other bacteria via 
chemotaxis, and the only way for a slow growing bacterium to defend itself is by pro-
ducing bioactive compounds, and notably antibiotics. Prodigionines, DNA-damaging 
agents which serve as anti-cancer compounds, are produced as a molecular trigger 
to eradicate most of the vegetative mycelium and this way provide nutrients for the 
surviving, reproductive cells (Tenconi et al., 2018). Understanding cell growth and 
development, especially that of PCD, will greatly contribute to our understanding of 
antibiotic production and lead to the discovery of novel antibiotics. 
The Bacterial Cell Wall
At first, bacterial shape might seem a trivial feature, at most an easy way to distin-
guish one species from the other. However, cell shape is subject to heavy environ-
mental pressure and each shape requires a different type of regulation from cell wall 
biosynthetic machineries (Kysela et al., 2016). In Gram-positive bacteria, cell shape 
is maintained by the peptidoglycan (PG) layer. PG forms a dynamic macromolecule 
that is actively remodeled to enable cell growth and differentiation through a tightly 
regulated interplay of hydrolytic and biosynthetic enzymes (Egan et al., 2017). The 
chemical structure of PG is extremely well conserved, consisting of a glycan chain 
backbone of interchanging N-acetyl glucosamine (GlcNAc) and N-acetyl muramic 
acid (MurNAc). The glycan chain is cross-linked by peptide chains of non-ribosom-
ally synthesized L- and D- amino acids, which in turn are linked to the lactate group 
of MurNAc. Although the chemical composition is conserved, the structure (degree 
of cross-linking/glycan strand length) can vary widely, depending on the species, 
growth phase and environment (Vollmer et al., 2008a). PG architecture research is 
an important tool for bacterial biologists in finding mechanisms for cell shape deter-
mination. This has shown that the helical shape of Helicobacter pylori is maintained 
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by regulated cross-linking and hydrolysis (Sycuro et al., 2012). 
In Gram-positive bacteria, growth can be regulated in two different manners, 
namely via lateral growth or tip growth, depending on the phylogeny. Well-known 
representatives are firmictues (lateral growth) and actinobacteria (tip growth). These 
bacterial families can be discerned based on features such as G+C content of the 
DNA, lateral growth vs tip growth and the production of endospores as opposed 
to external spores. Growth and division in firmicutes and actinobacteria is shown 
in Figure 2. Firmicutes grow by lateral growth: the cytoskeletal protein MreB forms 
filaments around the lateral wall of the bacteria and supports PG incorporation and 
cross-linking, elongating the cell (Hussain et al., 2018). In contrast, actinobacteria 
grow by tip extension where new PG material is built in solely at the tips of rods or hy-
phae, a mechanism independent of MreB or FtsZ (Flärdh, 2010, Mazza et al., 2006, 
Flärdh & Buttner, 2009). Tip growth in actinobacteria is driven by DivIVA (Flärdh et 
al., 2012). This protein localizes at sites with a negative membrane curvature, and 
recruits the cell wall construction machinery (Hamoen & Errington, 2003). In Strep-
tomyces, DivIVA supports the growth of long hyphae. The signal or mechanism by 
which branching sites are decided is unknown. 
In Bacillus subtilis, localization of the septum at midcell is controlled by the Min 
and Noc systems. The  Min complex prevents cell division away from mid-cell, while 
the nucleoid occlusion system Noc ensures that the chromosomes are well segre-
gated prior to septum synthesis, to avoid DNA damage (Errington et al., 2003, Lut-
kenhaus, 2007, Margolin, 2005, Wu & Errington, 2011). In most unicellular bacteria, 
FtsZ is tethered to the membrane by FtsA. The FtsZA complex forms filaments, 
which encircle the cell at the division site referred to as an FtsZ-ring. The FtsZA 
complex then recruits PG synthases such as PBPs to build a septum that divides the 
cell in two (Bisson-Filho et al., 2017). In Streptomyces, canonical cell division that 
requires the divisome proteins exclusively occurs in aerial hyphae. Here, FtsZ is ac-
tively recruited to septal sites by SsgB in an SsgA-dependent manner (Willemse et 
al., 2011). The SsgB-FtsZ complex is tethered to the membrane by SepG (Zhang et 
al., 2016a). Thus, in streptomycetes, cell division is positively controlled, in contrast 
to the Min-dependent negative control systems found in many other bacteria. 
Regulation of both growth and division is fundamentally different in Actinobacteria 
and Firmicutes, not a single regulatory protein from Firmicutes has the same func-
tion in Actinobacteria. Together, this shows that the Actinobacteria are an especially 
interesting model organism to investigate cell growth and division. 
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Figure 2. Growth and division in Firmicutes and Actinobacteria is regulated differently. 
Firmicutes elongate along the lateral wall, driven by MreB. Actinobacteria grow at the tip, driv-
en by DivIVA. Firmicutes have a single division site in the center of the cell, where the FtsZ/A 
complex constricts the cell. Actinobacteria can have several division planes in a single cell 
during spore formation, regulated by positive control of SsgA and SsgB. 
Cell wall construction
Bacterial peptidoglycan construction is a highly conserved and regulated process. 
The amino acids in the pentapeptide chain consist of interchanging L- and D-ami-
no acids. This structure assists in resistance against non-specific peptidases, who 
would normally cleave chains of L-amino acids (Cava et al., 2011). The production of 
D-amino acids is performed by specialized racemases, which convert L-amino acids 
into D-Amino acids (Radkov & Moe, 2014). The alanine racemase (Alr) converts 
L-Ala to D-Ala, an essential part of the peptidoglycan. An alr knock-out mutant of 
S. coelicolor causes the strain to become dependent on exogenous D-Ala (Tassoni 
et al., 2017, Walsh, 1989). Lipid II, the building brick of PG, is constructed in the 
cytoplasms by a set of exceptionally well-conserved Mur-proteins, as shown in Fig-
ure 3. Mur-proteins ligate glycans and amino acids in a step-by-step manner, MurA 
and MurB produce undecaprenol (UDP) MurNAc from UDP-GlcNAc. MurC, MurD 
and MurE then together ensure the attachment of L-Ala, D-Glu and LL-DAP to the 
D-lactate group of MurNAc (Smith, 2006). The dipeptide D-Ala-D-Ala is ligated by 
the D-Ala-D-Ala ligase Ddl, and subsequently attached to the growing peptide chain 
by MurF. MraY connects the peptidoglycan precursors to the lipid-associated bacto-
prenyl-phosphate to yield Lipid I. Then MurG attaches GlcNAc and FemX connects 
Gly to LL-DAP, finishing the Lipid II molecule. The entire structure is then flipped 
across the lipid membrane by FtsW and/or MurJ. FtsW was shown in vitro to have 
affinity to Lipid II and for flipping activity (Mohammadi et al., 2014, Mohammadi et 
al., 2011). But this protein appeared to be inactive during in vivo studies. MurJ is an 
essential membrane protein of which a deletion causes accumulation of Lipid II in 
the cytoplasm and cell lysis. While in vitro data supports FtsW as a flippase, in vivo 
data prefers MurJ (Meeske et al., 2015, Sham et al., 2014, Mohammadi et al., 2011). 
Finally, Lipid II is displayed on the cell surface and can be incorporated into the ma-
ture murein by glycosyltransferases and transpeptidases, among which RodA, PBPs 
and LDT. Figure 3 features cytoplasmic production of Lipid II in S. coelicolor.
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Figure 3. Construction of Lipid II is performed by Mur-genes in the cytoplasm. UDP-Glc-
NAc is transferred into UDP-MurNAc. To MurNAc, the first three amino acids, L-Ala, D-Glu and 
LL-DAP are attached by MurC, MurD and MurE, respectively. L-Ala is modified to D-Ala by Alr, 
after which D-Ala and D-Ala are ligated by Ddl. Then, D-Ala-D-Ala is connected to the growing 
PG precursor by MurF. Following this, MurY connects the PG precursor to C55-phosphate, 
and thus connects it to the lipid membrane. MurG ligates UDP-GlcNAc to MurNAc and finally 
FemX attaches a single Gly to LL-DAP. This structure is flipped over the lipid membrane by 




Lipid II construction is highly conserved among bacteria, with minor modifications 
at the point of the interpeptide bridge (Schleifer & Kandler, 1972). The cross-linking 
process afterwards is dependent on cell shape and growth mode (Vollmer et al., 
2008a). The two major modes of growth, lateral and tip growth, are regulated in a 
different way and have different mechanistic constraints. During lateral growth, the 
cell wall expands along the lateral wall of a cell, where new tips are generated only 
during septation. During tip growth, only the bacterial tip extends. Mechanistically, 
this means that in laterally growing cells, ‘old’ cell wall material is located at the tip, 
whereas in tip growing bacteria the ‘old’ cell wall material is located along the lateral 
wall (Kysela et al., 2016). Bacteria that grow at the apex only generate novel pep-
tidoglycan at the spherical tip and require remodeling along the wall of the hyphae 
to generate a cylindrical cell wall. A lack of remodeling enzymes leads to a bloated, 
round cells (Baranowski et al., 2018). Here, we discuss PG cross-linking in tip grow-
ing bacteria. 
After Lipid II translocation over the cell membrane, the new building blocks are 
incorporated into glycan strands, which are connected to the growing murein by pro-
teins with glycosyltransferase (GT) activity, such as RodA and bifunctional Penicillin 
Binding Proteins (PBPs) (Emami et al., 2017, Meeske et al., 2016, Leclercq et al., 
2017). The peptide chain is cross-linked by transpeptidase (TP) activity by PBPs 
and L, D-transpeptidases (LDTs). PBPs have been discovered early on due to their 
ability to bind (and hence sensitivity to) penicillin, and only later it became clear that 
these proteins are mostly responsible for cell wall construction. Class A PBPs have 
bifunctional activity as both GT and TP, class B PBPs only have TP activity. PBPs 
form a 3-4 cross-link, conveniently named for creating a link between the 3rd and 
4th amino acid in the pentapeptide chain of muropeptides (Daniel et al., 2000). PBPs 
require at least one pentapeptide as a donor strand to form a cross-link, this donor 
strand loses the terminal D-Ala[5] and PBPs cross-link two muropeptides via the Gly 
cross-bridge of the acceptor strand. The requirement for pentapeptides demands 
that PBPs are present at the site of active peptidoglycan construction (Egan et al., 
2015). 
PBPs are mostly responsible for PG cross-linking in firmicutes and bacteria 
with lateral cell wall growth. LDTs are penicillin-insensitive proteins that are able 
to replace a part of the function of PBP’s by cross-linking two peptide chains at LL-
DAP[3] and LL-DAP[3], creating a 3-3 cross-link (Mainardi et al., 2005, Mainardi et 
al., 2002). 3-3 cross-links are especially prevalent in micro-organisms that grow at 
the apex and have been linked to penicillin-insensitivity. Many actinobacteria contain 
a high amount of 3-3 cross links, such as Mycobacterium (30-80%), Corynebacteri-
um (38%) and Streptomyces (30-60%) (Lavollay et al., 2011, Hugonnet et al., 2014, 
Lavollay et al., 2009, van der Aart et al., 2018). In contrast, bacteria with lateral cell 
wall growth like E.coli (>10%) and E.faecium (>3%) have a much lower amount of 
3-3 cross-links (Pisabarro et al., 1985, Sacco et al., 2010). LDTs attach to tetrapep-
tides and form a cross-link between glycine and LL-DAP[3]. Here, the D-Ala[4] is 
considered a donor for the cross-link. The requirement of tetrapeptides in contrast 
to pentapeptides allow LDTs to remodel the cell wall after in the post-apical area. In 
mycobacteria, 3-4 cross-linking by PBPs occurs solely at the tips, at the site of pepti-
doglycan construction. Along the lateral wall, where the peptidoglycan is more highly 
modified and has a higher amount of tetrapeptides, LDTs produce 3-3 cross-links to 
remodel the peptidoglycan (Figure 4) (Baranowski et al., 2018). 
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Figure 4. Peptidoglycan cross-linking at the tip and the lateral wall. In Streptomyces, cell 
wall construction takes place at the tips, with cell wall modifications along the lateral wall. At 
the tip, there is a high abundance of pentapeptides, the necessary donors for PBP’s to form 
a 4-3 cross-link. Further from the tip complex, pentapeptides are modified by D,D-carboxy-
peptidases and PBP’s, presenting a higher amount of tetrapeptides on the cell surface. At 
this point, LDT’s modify the peptidoglycan by forming 3-3 cross-links, using tetrapeptides as 
a donor muropeptide. 
Programmed Cell Death and cell wall hydrolysis
Over the course of growth, new peptidoglycan is continuously generated and 
broken down. Cell wall hydrolysis has several roles in the life of Streptomyces: hy-
drolyzing PG to allow incorporation of new glycan strands, hydrolyzing the cell wall 
material between mature spores to allow single spores to disperse, breaking down 
the thick spore wall during germination and the developmental step of PCD (Haiser 
et al., 2009). The function of different modifying proteins is summarized in Figure 5. 
The Streptomyces coelicolor genome contains a high amount of hydrolysis-asso-
ciated genes, consisting of 60 different genes encoding the four functional groups 
of amidases, carboxypeptidases, endopeptidases and N-acetylglucosaminidases 
(Haiser et al., 2009). The large number of cell-wall modifying enzymes suggests 
a high degree of redundancy, in line with the multi-stage lifecycle of Streptomyces. 
Amidases hydrolyze the lactyl bond between MurNAc and L-Ala, these enzymes 
are found to be essential for cell separation, as a knockdown of amidases or FtsE/
FtsX will generate filaments in E. coli (Uehara et al., 2010, Heidrich et al., 2001). 
FtsE and FtsX are suggested to act as ATP-binding cassette transporters (ABC 
transport proteins), which transport amidases across the membrane (Yang et al., 
2011a). In E.coli, FtsE and FtsX function in association with FtsZ, in order to sepa-
rate daughter cells after septum formation. An ftsX knockout mutant in Streptomyces 
still showed peptidoglycan linkage between spores, suggesting incomplete hydro-
lysis of the peptidoglycan (Noens, 2007). The S. coelicolor peptidoglycan contains 
a large amount of dimers which have a cross-linked set of amino acids but has lost 
one set of glycans, reflecting high activity of PG amidases (van der Aart et al., 2018). 
This effect was especially pronounced in vegetative cells grown in liquid media. As 
pellets grow and develop, the shift from exponential to stationary growth occurs with 
a round of PCD, during which a large part of the cell wall in the centre is hydrolyzed 
(Manteca et al., 2008). 
Carboxypeptidases cleave the terminal amino acid from muropeptides, D,D-car-
boxypeptidases cleave the 5th D-Ala from a pentapeptide, while L,D-carboxypepti-
dases cleave the 4th D-Ala from a tetrapeptide. D,D-carboxypeptidases play a key 
role in spore wall maturation in S. coelicolor (Rioseras et al., 2016), while the spore 
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cell walls mostly consist of tetrapeptides that lack a terminal D-Ala (van der Aart 
et al., 2018). The product of D,D-carboxypeptidases, namely tetrapeptides, are re-
quired as donor strands for 3-3 cross links by L,D-transpeptidases. In Streptomyces, 
the role of D,D-carboxypeptidases is partly associated with 3-3 cross-linking. 
Lysozyme-like proteins, muramidases and glucosamidases cleave the glycan 
strands between GlcNAc and MurNAc. In bacteria, muramidase or glycosamidase 
activity is especially important during the initiation of spore germination. In actino-
bacteria, ‘resuscitation promoting factors’ (RPFs) play a major role in spore germina-
tion and resuscitation of dormant cells (Keep et al., 2006). RPFs were first described 
as a growth factor for non-culturable Micrococcus luteus, where minute amounts of 
protein can resuscitate dormant cells (Mukamolova et al., 2002). Later it was shown 
that RPFs bind to the peptidoglycan and locally act as muralytic enzymes, similar to 
lysozyme (Mukamolova et al., 2006). Interestingly, RPFs can also resuscitate dor-
mant cells of mycobacteria (Nikitushkin et al., 2013), which shows their potential as 
target for drug development, particularly because dormant cells are a major problem 
in terms of drug treatment. In correspondence with this data, RPFs contribute to ger-
mination of Streptomyces spores, which can also be considered to be in a state of 
dormancy (Sexton et al., 2015). RpfA and another muramidase, SCO5466, are con-
trolled by the cAMP-receptor regulon (Piette et al., 2005). In Streptomyces, cAMP 
accumulates during germination and binds to the cAMP-receptor, an important tran-
scriptional regulator (Susstrunk et al., 1998). Mutants lacking the cAMP receptor 
protein CRP have a much thicker spore wall, suggesting that control mechanisms 
for spore wall synthesis are impaired (Piette et al., 2005). As a result, it takes much 
longer for spores to germinate. The germination defect of the crp null mutant is ex-
plained by the hydrolases encompassed by the crp-regulon, among which SCO5466 
and RpfA (Piette et al., 2005). 
Cell wall biosynthesis and hydrolysis are two inseparable processes, as suggest-
ed by the ‘make before break’ model, first suggested by Koch and Holtje (Höltje, 
1993, Koch, 1990). This model, also called the 3-for-1 model, proposes that trimers 
replace monomers, suggested that after a connection is made, old cell wall material 
has to be hydrolyzed to allow for expansion of the glycan strand. 
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Figure 5. Hydrolysis of the Streptomyces peptidoglycan. The peptidoglycan structure of S. 
coelicolor is shown, with LL-DAP at position 3 and Gly which forms the cross-link between two 
peptide chains. N-acetylglucosaminidases (glucosaminidases) cleave between GlcNAc and 
MurNAc, N-acetylmuramidases (muramidases) cleave between MurNAc and GlcNAc. RPFs 
have a muramidase activity. N-acetylmuramyl-L-alanine amidases (amidases) hydrolyze at 
the site of the lactyl group between MurNAc and L-Ala. L,D-endopeptidases cleave the site 
between an L-, and D-amino acid in the peptide chain.  D,D-, and L,D-carboxypeptidases 
remove C-terminal D- or L-amino acids. The acetyl group of MurNAc can be removed by a 
deacetylase, to generate MurN. 
18
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The bacterial cell wall and antibiotic resistance 
The bacterial cell wall is a favourite target for antibiotics, as it is highly conserved 
between bacteria, it is conveniently located on the outside of the cell and is essential 
for growth and the maintenance of turgor pressure. A major advantage for clinical 
application is that cell wall-targeting antibiotics generally have no cytotoxicity as hu-
man cells lack peptidoglycan, and more than 50% of our clinical antibiotics target the 
bacterial cell wall and cell wall synthesis (Schneider & Sahl, 2010). The PG precur-
sor Lipid II is a highly conserved structure; prior to cross-linking to the mature PG, 
the lipid tail is lost and can be recycled (Scheffers & Tol, 2015). Due to the essential 
nature of Lipid II, it is difficult for bacteria to generate resistance against cell wall and 
Lipid II targeting antibiotics. 
In order to prevent antibiotic production from becoming a suicide mission, actino-
mycetes carry many antibiotic resistance genes, in addition to potential to produce 
antibiotics (Marshall et al., 1998). Resistance mechanisms found in actinobacteria 
are also found in clinical isolates, suggesting that genes carrying antibiotic resis-
tance mechanisms readily travel across the bacterial realm, driven by an increase of 
fitness for the recipient (Perry & Wright, 2013). Here, we focus on (self) resistance 
against three cell wall antibiotics, vancomycin, D-cycloserine (DCS) and penicillin, 
and we discuss two new cell wall antibiotics of which resistance mechanisms are still 
largely unknown, daptomycin and teixobactin. 
Vancomycin
The glycopeptide antibiotic vancomycin targets the D-Ala-D-Ala terminus of Lipid 
II as it is exposed on the cell surface, this way preventing it from being incorporated 
into the mature peptidoglycan. Notably, vancomycin is incapable of passing the outer 
membrane of Gram-negative bacteria and only targets Gram-positives. Vancomy-
cin and the related drug Balhimycin, are both produced by Amycolatopsis orientalis 
and Amycolatopsis balhimicina, respectively, and both these species are resistant 
against the glycopeptide antibiotic they produce (Marshall et al., 1998, Schaberle et 
al., 2011). Vancomycin-resistant bacteria replace the terminal D-Ala-D-Ala by D-Ala-
D-Lac in order to decrease vancomycin susceptibility by a thousand-fold. Vanco-
mycin resistance is gained by a conserved set of genes of which the most import-
ant ones are: the two-component regulatory system consisting of VanR and VanS; 
VanH, which converts pyruvate into D-Lac; VanA, a D-Ala-D-Lac ligase; VanX, a di-
peptidase which cleaves D-Ala-D-Ala and VanY, a carboxypeptidase which cleaves 
D-Ala from a pentapeptide precursor (Hong et al., 2004, Arthur et al., 1994). These 
vancomycin resistance genes occur in the producing bacteria and in clinical isolated 
of Enterococcus, posing a large problem for the medical healthcare (Decousser et 
al., 2003, Courvalin, 2006). 
D-cycloserine
D-cycloserine (DCS) is a cyclic analogue of D-Ala produced by Streptomyces 
lavendulae (Noda et al., 2004a). This antibiotic binds to proteins which would oth-
erwise bind to D-Ala, such as Alr and Ddl, and this way prevents the formation of a 
functional peptidoglycan layer. In order for the producing bacteria to become resis-
tant against the antibiotic it produces, it has modified both Alr and Ddl to decrease 
affinity to DCS (Noda et al., 2004b). This modification is different from the resistance 
mechanism in Mycobacteria, which heavily upregulates Alr in order to gain resis-




Penicillin structurally resembles the D-Ala-D-Ala terminus of Lipid II, the rec-
ognition site of PBPs, and in this way functions as a suicide substrate for PBP’s 
(Park & Strominger, 1957). As a general rule, penicillin resistance is not gained by 
changing the function of PBPs, but by producing β-lactamases, which readily break 
down β-lactam antibiotics like penicillins and cephalosporins (Ogawara et al., 1999). 
The life of β-lactam antibiotics in the clinic has been extended by the discovery of 
clavulanic acid, produced by Streptomyces clavuligerus (Reading & Cole, 1977). 
However, PBPs are not the only proteins with GT and TP activity. It has recently 
been demonstrated that RodA is a penicillin-insensitive glycosyltransferase, of which 
the overexpression can relieve the absence of Class A PBPs (Emami et al., 2017, 
Meeske et al., 2016). While PBPs are the major TPs for laterally expanding bacteria, 
polar growing bacteria rely on LDTs for 30-70% of the cross-links (Lavollay et al., 
2008). LDTs in Streptomyces recognize the terminus of a tetrapeptide, consisting of 
LL-DAP and D-Ala, and are insensitive to Penicillin. Structural studies of LDTs have 
shown that carbapenem antibiotics, originally developed for Gram-negative infec-
tions, readily targets LDTs and stay functional in combination with β-lactamase ac-
tivity (Iannazzo et al., 2016). Potentially, carbapenems could be optimized to target 
only LDTs, this way producing an antibiotic which specifically targets mycobacteria. 
It remains open for discussion whether LDTs are developed to support tip growth, or 
to support antibiotic resistance (Mainardi et al., 2008). 
Teixobactin
Recently, the novel cell wall antibiotic Teixobactin has been discovered that 
uniquely binds to two different targets in the cell wall, which strongly reduces the 
chance of resistance development  (Ling et al., 2015). Teixobactin is a Lipid II tar-
geting antibiotic isolated from a Gram-negative soil bacterium Elefteria terrae, which 
binds to the pyrophosphate-sugar moiety of undecaprenyl-bound cell wall precur-
sors Lipid II and Lipid III. Lipid III is a precursor for teichoic acids, and this dual 
activity against PG and teichoic acid synthesis, combined with the fact that it does 
not bind to mature murein, makes this an especially interesting antibiotic (Homma 
et al., 2016). Teixobactin is active against several Gram-positive bacteria includ-
ing mycobacteria and staphylococci. Initial studies by the author showed no sign of 
development of resistance mechanisms by serial passaging of S. aureus with the 
compound, and the mechanism of self-resistance mechanism in the producing strain 
is also unknown. It is worth noting that vancomycin resistance in Staphylococci was 
also considered negligible during initial studies on vancomycin resistance in 1981 
(Griffith, 1981). Vancomycin resistant enterococci were isolated from clinical infec-
tions in 1988 (Leclercq et al., 1988). 
Daptomycin
Daptomycin is a membrane-targeting lipopeptide antibiotic with activity against 
Gram-positive bacteria and is clinically important to ward multidrug resistant infec-
tions, especially methicillin resistant Staphylococcus aureus (MRSA) and vanco-
mycin resistant enterococci (VRE). Daptomycin is produced by Streptomyces ro-
seosporus, and like for teixobactin, the self-resistance mechanism is yet unknown 
(McHenney et al., 1998). Daptomycin functions by depolarizing the lipid membrane 
(Taylor & Palmer, 2016). Resistance against daptomycin is unusual in clinical set-
tings, but is thought to relate to the charge or fluidity of the lipid membrane, or an 
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increase in the amount of teichoic acids, which prevent daptomycin from accessing 
the cell membrane (Gomez Casanova et al., 2017). 
Bacteria have been producing antibiotics for half a billion years, and resistance 
mechanisms co-evolved. This is emphasized by a recent expedition to a cave in 
Mexico, which had been sealed for 4 million years. Researchers had sampled the 
microbial community in this cave and encountered bacteria which showed resistance 
against many different clinical antibiotics, of which some species showed resistance 
against 14 antibiotics in total (Bhullar et al., 2012). As we isolate many more different 
species of bacteria and collect more full genome sequences every day, we expect 
to find novel antibiotics and also resistance mechanisms in for example rare actino-
bacteria,. Antibiotic resistance research will continue to show us amazing features 
of bacterial versatility. 
Figure 6. Summary of cell wall antibiotics and their targets. Vancomycin targets the D-Ala-
D-Ala terminus of Lipid II. Vancomycin resistant strains mostly replace the terminal D-Ala by 
D-Lac to relieve vancomycin sensitivity. Penicillin targets PBPs, sensitivity can partially be 
decreased by upregulation of LDTs and RodA. D-cycloserine targets proteins with a D-Ala 
binding site, Alr and Ddl. Daptomycin functions by destabilizing the plasma membrane. Teixo-




Outline of the thesis
Streptomycetes are especially interesting bacteria due to their complex morpholo-
gy and production of secondary metabolites, which has led to the isolation and char-
acterization of more than 600 type strains. Chapter 2 discusses the characterization 
and taxonomic classification of the novel species Streptomyces roseofaciens. This 
species of Streptomyces has an unusual mode of growth, producing spores perpen-
dicular to the aerial mycelia instead of septating the aerial hyphae into long spore 
chains. The phenotype could be correlated to a different household of SsgA-like pro-
teins, a set of actinobacteria-specific proteins which regulate growth and sporulation.
The complexity of the Streptomyces life cycle is astonishing and the consequenc-
es for cell wall synthesis are yet unclear. In Chapter 3, the peptidoglycan layer of 
S. coelicolor is analyzed over the course of growth and development. Spores were 
isolated separately from vegetative mycelium, so as to look for specific changes 
which could hint towards a germination mechanism. A high-resolution peptidoglycan 
analysis of Streptomyces coelicolor was performed by LC-MS, allowing for easy 
identification of all muropeptides despite potentially overlapping retention times. The 
analysis shows that the peptidoglycan is continuously modified and heavily broken 
down during PCD. An analysis of developmental mutants, ∆bldD which only produc-
es vegetative mycelium and ∆whiG which only produces aerial hyphae, emphasizes 
the function of a muropeptide which was specifically abundant in spores. 
Streptomyces and Kitasatospora are sister genera within the Streptomycetace-
ae. The genera are morphologically very similar, but can be readily distinguished 
based on their peptidoglycan composition. The stereoisomers of DAP, LL-DAP and 
MESO-DAP are a key diagnostic feature in the phylogeny of Actinobacteria, and 
while members of the genus Streptomyces carry LL-DAP, Kitasatosporae carry ME-
SO-DAP in vegetative mycelia and LL-DAP in their spore walls. Chapter 4 shows 
an in-depth peptidoglycan analysis of two species of Kitasatospora, K. setae and K. 
viridifaciens, to lay a connection between taxonomy and cell wall homeostasis. 
Antibiotic resistance is part and parcel of the ability of bacteria to produce anti-
bacterial compounds. S. coelicolor carries inducible resistance genes that mediate 
target resistance against vancomycin, an antibiotic produces by another species of 
actinomycetes. When vancomycin production is initiated, the molecule is sensed by 
the producer strain, and resistance is switched on. That results in to the production of 
an altered version of Lipid II with D-Ala-D-Lac as a terminus, resulting in a resistant 
cell wall, contrary to when the wild-type molecule with a D-Ala-D-Ala terminus is built 
in. In Chapter 5, we investigated whether vancomycin resistance can be counter-
acted via metabolic interference with exogenous D-Ala. The experiments revealed 
a possible novel approach by sensitizing cells with D-Ala in the presence of a VanX 
inhibitor. Indeed, vanX null mutants had a thousand-fold lower MIC against vanco-
mycin in the presence of D-Ala than with L-Ala. 
D-amino acids are an essential part of the peptidoglycan, and the D-Ala-D-Ala 
terminus is a universal part of bacterial peptidoglycan, with the exception being van-
comycin resistant bacteria. In Chapter 6 we biochemically and structurally charac-
terized the alanine racemase of S. coelicolor. The data in this chapter show that the 
lack of Alr makes a strain dependent on D-Ala for growth. The crystal structure of 
the enzyme was resolved at a 2.8 Å resolution, and compared to other Alr enzymes, 
including that of a strain that is resistant to the Alr-targeting antibiotic D-cycloserine.
The implications of the work for Streptomyces biology are discussed in Chapter 7. 
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Polyphasic classification of Streptomyces roseifaciens sp. nov. 
ABSTRACT
A polyphasic study was designed to establish the taxonomic status of a 
Streptomyces strain isolated from soil from the QinLing Mountains, Shaanxi Province, 
China, and found to be the source of known and new specialized metabolites. Strain 
MBT76T was found to have chemotaxonomic, cultural and morphological properties 
consistent with its classification in the genus Streptomyces. The strain formed a 
distinct branch in the Streptomyces 16S rRNA gene tree and was closely related to 
the type strains of Streptomyces hiroshimensis and Streptomyces mobaraerensis. 
Multi-locus sequence analyses based on five conserved house-keeping gene alleles 
showed that strain MBT76T is closely related to the type strain of S.hiroshimensis, as 
was the case in analysis of a family of conserved proteins. The organism was also 
distinguished from S. hiroshimensis using cultural and phenotypic features. Average 
Nucleotide Identity and digital DNA-DNA hybridization values between the genomes 
of strain MBT76T and S. hiroshimensis DSM 40037T were 88.96 and 28.4+/-2.3%, 
respectively, which is in line with their assignment to different species. On the basis 
of this wealth of data it is proposed that strain MBT76T (=DSM 106196T = NCCB 
100637T), be classified as a new species, Streptomyces roseifaciens sp.nov. 
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Strain MBT76T is an actinomycete isolated from a soil sample taken from the 
QinLing mountains in China. Many actinobacteria isolated from this niche turned 
out to be rich sources of bioactive compounds effective against multi-drug resistant 
bacterial pathogens (Zhu et al., 2014b). Based on its genome sequence, MBT76 
was positioned within the genus Streptomyces (Wu et al., 2016). Streptomyces sp. 
MBT76T is a gifted strain that produces various novel antibiotics and siderophores 
(Gubbens et al., 2017, Wu et al., 2017a, Wu et al., 2017b, Wu et al., 2016), its genome 
contains at least 44 biosynthetic gene clusters (BGCs) for specialized metabolites as 
identified by antiSMASH (Blin et al., 2017). The importance of validly naming novel 
industrially important streptomycetes is often overlooked despite improvements in 
the classification of the genus Streptomyces (Kämpfer, 2012, Labeda et al., 2017, 
Labeda et al., 2012) and adherence to the rules embodied in the International Code 
of Nomenclature of Prokaryotes (Parker et al., 2015). 
Actinobacteria are Gram-positive often filamentous bacteria that are a major 
source of bioactive natural products (Hopwood, 2007, Barka et al., 2016). The 
genus Streptomyces, the type genus of the family Streptomycetacae within the 
actinobacteria (Waksman & Henrici, 1943), encompasses over 700 species with 
valid names (http://www.bacterio.net/streptomyces.html), many of which have been 
assigned to multi- and single-membered clades in Streptomyces 16S rRNA gene 
trees (Labeda et al., 2012, Kämpfer, 2012). Despite being the largest genus in the 
domain Bacteria, a steady stream of new Streptomyces species are being proposed 
based on combinations of genotypic and phenotypic features (Kumar & Goodfellow, 
2010, Goodfellow et al., 2017). It is particularly interesting that multi-locus sequence 
analyses (MLSA) of conserved house-keeping genes are providing much sharper 
resolution of relationships between closely related Streptomyces species than 
corresponding 16S rRNA gene sequence studies (Labeda et al., 2017, Rong & 
Huang, 2014). Labeda and his colleagues observed correlations between certain 
morphological traits of streptomycetes and phylogenetic relationships based on MLSA 
data, as exemplified by the clustering of whorl-forming (verticillate) species (formerly 
Streptoverticillium) into a single well supported clade. Similarly, the sequences 
of highly conserved proteins (SALPS) have been used to resolve relationships 
between morphologically complex actinobacteria, including streptomycetes and 
closely related taxa classified in the family Streptomycetaceae (Girard et al., 2013, 
Traag & van Wezel, 2008). 
The aim of the present study was to establish the taxonomic status of Streptomyces 
sp. MBT76T using a polyphasic approach. The resultant data show that the strain 
forms the nucleus of a novel verticillate Streptomyces species for which we propose 
the name Streptomyces roseifaciens sp.nov.
Streptomyces sp. MBT76T was isolated from a soil sample (depth 10-20 cm), 
collected from Shandi Village in the QinLing mountains, Shaanxi Province, China 
(34˚03’28.1”N, 109˚ 22’39.0”E) at an altitude of 660 m (Zhu et al., 2014b). The soil 
sample (1 g) was enriched with 6% yeast extract broth (Hayakawa & Nomomura, 
1989) and incubated at 370C for 2 h in a shaking incubator. 0.1 mL aliquots of 10-2 
to 10-4 dilutions of the resultant preparations were spread over selective agar plates 
(Zhu et al., 2014b) supplemented with nystatin (50 µg/ml) and nalidixic acid (10 
mg/ml), that were incubated at 300C for 4 days. The colony of the test strain was 
subcultured onto Soy Flour Mannitol agar (SFM) (Kieser et al., 2000). The isolate 
and Streptomyces hiroshimensis DSM 40037T were maintained on yeast extract- 
malt extract agar slopes (International Streptomyces Project medium [ISP 2] 
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(Shirling & Gottlieb, 1966)) at room temperature and as suspensions of spores and 
hyphae in 20%, v/v glycerol at -200C and -800C. Biomass for the chemotaxonomic 
and molecular systematic studies was cultured in shake flasks (180 rpm) of ISP 2 
broth after incubation at 300C for 2 days and washed with distilled water, cells for 
the detection of the chemical markers were freeze-dried and then stored at room 
temperature. 
The test strain was examined for chemotaxonomic and morphological properties 
known to be of value in Streptomyces systematics (Kämpfer, 2012, Goodfellow et al., 
2017). Spore chain arrangement and spore surface ornamentation were determined 
following growth on oatmeal agar (ISP 3 (Shirling & Gottlieb, 1966)) for 14 days 
at 280C, by scanning electron microscopy on a JEOL JSM-7600F instrument 
(Piette et al., 2005). Key chemotaxonomic markers were sought using standard 
chromatographic procedures; the strain was examined for isomers of diaminopimelic 
acid (A2pm) (Hasegawa et al., 1983), menaquinones and polar lipids (Collins et al., 
1985) and whole-organism sugars (Hasegawa et al., 1983). In turn, cellular fatty 
acids were extracted, methylated and analysed by gas-chromatography (Hewlett 
Packard, model 6890) using the Sherlock Microbial Identification System (Sasser, 
1990) and the ACTINO version 6 database. 
Strain MBT76T was found to have chemotaxonomical and morphological 
properties consistent with its classification in the genus Streptomyces (Kämpfer, 
2012). The organism formed branched substrate hyphae that carried filaments 
bearing short chains of oval to cylindrical, smooth-surfaced spores arranged in 
verticils (Fig. 1). 
Figure 1. Scanning electron micrograph from a 14-day old culture of Streptomyces MBT76T 
grown on an ISP-3 agar plate showing the presence of smooth, round to cylindrical 
verticillate spores. A shows a full overview, the white and black arrows refer to the respective 
magnifications B and C. Scale bars 1 µM.
Whole-organism hydrolysate of the strain was rich in LL-diaminopimelic 
acid, glucose, mannose and ribose, the isoprenologues were composed of 
octahydrogenated menaquinone with nine isoprene units (MK-9[H8]) (47%) and 
lesser amounts of MK-9[H6] (8%) and MK-9[H4] (3%). The polar lipid pattern 
consisted of diphospatidylglycerol, glycophospholipid, phosphatidylethanolamine, 
phosphatidylinositol, and an unknown compound, as shown in Fig. S1. The cellular 
fatty acids of the organism contained major proportions (>10%) of anteiso- C15:0 
(34.40%), and anteiso- C17:0 (10.92%), lower proportions (i.e. <10%) of iso-C14:0 
(8.28%), iso-C15:0 (5.11%), iso-C16:0 (7.99%), anteiso-C16:0 (2.54%), C16:1 ω9 (2.84%), 
C16:0 (5.64%), C18:1 ω9 (8.93%), C20:11 ω11 (4.53%) and summed features C18:2 ω9,12/
C18:0 (8.81%).
A 16S rRNA gene sequence (1,416 nucleotides [nt]) taken from the genome 
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sequence of Streptomyces sp. MBT76T (Genbank accession number: 
LNBE00000000.1) was compared with corresponding sequences of the type 
strains of closely related Streptomyces species using the Eztaxon server (Yoon 
et al., 2017a). The resultant sequences were aligned using CLUSTALW version 
1.8 (Thompson et al., 1994)1994 and phylogenetic trees generated using the 
maximum-likelihood  (Felsenstein, 1981), maximum-parsimony (Fitch, 1971) and 
neighbour-joining (Saitou & Nei, 1987) algorithms taken from MEGA 7 software 
package (Tamura et al., 2011, Guindon & Gascuel, 2003, Kumar et al., 2016); an 
evolutionary distance matrix for the neighbour-joining analysis was prepared using 
the model of Jukes and Cantor (1969) (Jukes & Cantor, 1969). The topologies of 
the inferred evolutionary trees were evaluated by bootstrap analyses (Felsenstein, 
1985) based on 1,000 repeats. The root positions of unrooted trees were estimated 
using the sequence of Kitasatospora setae KM 6054T (Genbank accession number: 
AP010968) . 
Streptomyces sp. MBT76T formed a distinct phyletic line in the Streptomyces 
16S rRNA gene tree (Fig. 2; see also Fig. S2-S3). It was found to be most closely 
related to the type strains of Streptomyces hiroshimensis (Witt & Stackebrandt, 
1990, Shinobu, 1955), Streptomyces mobaraensis (Witt & Stackebrandt, 1990, 
Nagatsu & Suzuki, 1963) and Streptomyces cinnamoneus (Witt & Stackebrandt, 
1990, Benedict et al., 1952) sharing 16S rRNA gene sequence similarities with them 
of 99.37% (9 nt differences), (99.24%) (= 11 nt differences) and 99.17% (=12 nt 
differences), respectively. The corresponding 16S rRNA gene sequence similarities 
with the remaining strains fell within the range 98.13 to 99.10%. The test strain was 
also found to form a distinct phyletic line in the analysis based on the maximum-
parsimony and neighbour-joining algorithms. 
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Figure 2. Maximum-likelihood phylogenetic tree based on 16S rRNA gene sequences, showing 
relationships between isolate MBT76T and the type strains of closely related Streptomyces 
species. Asterisks indicate branches of the tree that were also recovered using the neighbour-
joining and maximum-parsimony tree-making algorithms. Numbers at the nodes indicate 
levels of bootstrap based on an analysis of 1,000 sampled datasets, only values above 50% 
are given. The root position of the tree was determined using Kitasatospora setae KM-6054T. 




The partial sequences of five house-keeping genes: atpD (encoding ATP synthase 
F1, β-subunit), gyrB (for DNA gyrase B subunit), recA (for recombinase A), rpoB 
(for RNA polymerase β-subunit) and trpB (for tryptophan synthase, β-subunit) were 
drawn from the full genome sequence of strain MBT76T and from corresponding 
sequences on the Streptomyces type strains used to generate the 16S rRNA gene 
tree (Fig. 3; sequences presented in Table S1). The multilocus sequence analysis 
was based on the procedure described by Labeda (Labeda, 2011), the sequences 
of the protein loci of the strains were concatenated head-to-tail and exported in 
FASTA format, yielding a dataset of 33 strains and 2351 positions. The sequences 
were inferred using MUSCLE (Edgar, 2004) and phylogenetic relationships defined 
using the maximum-likelihood algorithm from MEGA 7 software (Tamura et al., 2011, 
Kumar et al., 2016) based on the General Time Reversible model (Nei & Kumar, 
2000). The topology of the inferred tree was evaluated in a bootstrap analysis as 
described above. Phylogenetic trees were also generated using the maximum-
parsimony (Fitch, 1971) and neighbour-joining (Saitou & Nei, 1987) algorithms. 
Pairwise distances between the sequences of each locus were established using 
the two parameter model (Kimura, 1980). Strain pairs showing MLSA evolutionary 
distances <0.007 were taken to be conspecific as determined by Rong and Huang 
(Rong & Huang, 2012)validating the MLSA scheme for systematics of the whole 
genus, a value that corresponds to the 70% DNA-DNA threshold recommended for 
the discrimination of prokaryotic species (Wayne et al., 1987). 
MLSA have clarified relationships between closely related streptomycetes, 
thereby reflecting the strong phylogenetic signal provided by partial sequences of 
single copy house-keeping genes (Labeda, 2011, Labeda et al., 2017, Labeda et 
al., 2012, Rong & Huang, 2012). In the present study all of the verticillate-forming 
streptomycetes fell into a single clade that is sharply separated from associated 
clades composed of strains that form spores in straight, looped or spiral chains 
(Fig. 3). Strain MBT76T and the type strain of S. hiroshimensis were found to form 
a distinct phyletic line supported by all of the tree-making algorithms and a 100% 
bootstrap value. It can also be seen from Figure 3 that these strains are at the 
periphery of a well-supported branch composed of an additional eight Streptomyces 
type strains that produce verticillate spore chains. The discovery that the strain 
can be separated from its closest phylogenetic neighbours by MLSA distances 
well above 0.007 threshold (Table 1) indicates that it forms a distinct phyletic line 
within the evolutionary radiation of the genus Streptomyces (Rong & Huang, 2014). 
The results of this study underpin those presented by Labeda et al. (Labeda et al., 
2017) by showing that streptomycetes which produce verticillate spore chains form 
a recognizable group in the Streptomyces gene tree that can be equated with the 
genus “Streptoverticillium” (Baldacci & Locci, 1974, Baldacci et al., 1966).
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Figure 3. Phylogenetic tree inferred from concatenated partial sequences of house-keeping 
genes atpD, gyrB, recA, rpoB and trpB using the maximum-likelihood algorithm, based on the 
general time reversible model. The final dataset consisted of 2351 positions and 33 strains. 
Asterisks indicate branches of the tree that were recovered using the maximum-parsimony and 
neighbor-joining algorithms. Percentages at the nodes represent levels of bootstrap support 
from 1,000 resampled datasets with values with less than 60% not shown. Streptomyces 
morphology: a: verticillate spore chains. b: not determined c: Streptomyces with canonical 
(apical) spore chains. 
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Table 1. MLSA distances between strain MBT76T and the type strains of closely 
related Streptomyces species.
Strain MLSA (Kimura 2-parameter) distance
1 2 3 4 5 6 7 8 9 10 11 12
1 Strain MBT76T -




 NRRL B-5620 T
0.097 0.128 0.117
4 S. griseocarneus
 NRRL B-1350 T
0.059 0.121 0.067 0.075
5 S. hiroshimensis 
NRRL B-1823 T
0.014 0.114 0.084 0.070 0.063
6 S. kishiwadensis 
NRRL B-12326 T
0.062 0.106 0.093 0.080 0.068 0.107
7 S. lacticiproducens 
NRRL B-24800 T
0.065 0.106 0.089 0.090 0.083 0.112 0.078
8 S. lavenduligriseus 
NRRL B-3173 T
0.055 0.115 0.090 0.086 0.079 0.117 0.077 0.052
9 S. lilacinus 
NRRL B-1968 T
0.038 0.109 0.075 0.081 0.054 0.115 0.060 0.066 0.109
10 S. luteosporeus 
NRRL 2401 T
0.079 0.106 0.080 0.084 0.092 0.104 0.066 0.088 0.117 0.074
11 S. mashuensis 
DSM 40221 T
0.062 0.106 0.093 0.081 0.069 0.107 0.001 0.078 0.104 0.060
12 S. sparsogenes 
NRRL 2940 T
0.100 0.130 0.119 0.123 0.112 0.133 0.102 0.108 0.122 0.097 0.102
The SsgA-like proteins (SALPs) have recently been proposed as phylogenetic 
markers for the accurate classification of Actinobacteria (Girard et al., 2013). 
Members of the SALP protein family are typically between 130 and 145 amino acids 
(aa) long, and are unique to morphologically complex actinobacteria (Traag & van 
Wezel, 2008); they coordinate cell division and spore maturation (Noens et al., 2005, 
Willemse et al., 2011). SsgB shows extremely high conservation within a genus, 
while there is high diversity even between closely related genera (Girard et al., 
2013). Genes encoding SALPs were drawn from the genomes of strains MBT76T, 
S. cinnamoneus (NZ_MOEP01000440.1), S. mobaraensis (NZ_AORZ01000001.1) 
and S. hiroshimensis (NZ_JOFL01000001.1) and from those of non-verticillate 
reference organisms, namely “Streptomyces coelicolor” A3(2) (NC_003888.3), 
S. griseus subspecies griseus NBBC 13350T (NC_010572.1) and “Streptomyces 
lividans” TK24 (NZ_GG657756.1). A second BLAST search was undertaken 
based on a low cut-off value (e-value 10-5) to interrogate the genome sequence 
of “S. coelicolor” M145 (NC_003888.3) to verify that the initial hits were bona fide 
SALPs. Sequences showing their best reciprocal hits against SALPs were aligned 
using MUSCLE (Edgar, 2004) and trees generated using the maximum-likelihood 
algorithm with default parameters as implemented in MEGA 7 software (Tamura et 
al., 2011), the robustness of the resultant trees was checked in bootstrap analyses 
(Felsenstein, 1985) based on 1000 replicates. 
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The maximum-likelihood tree (Fig. 4) shows that all of the strains have genes that 
encode for the cell division proteins SsgA, SsgB, SsgD and SsgG (Noens et al., 2005, 
Traag & van Wezel, 2008). It is also evident that the SsgB-protein, which mediates 
sporulation-specific division in Streptomyces strains (Willemse et al., 2011) encodes 
for identical proteins in both the verticillate and reference strains. The sequences 
of the SALP proteins, SsgA and SsgG, underpin the close relationship between 
the test strain and S. hiroshimensis and separate them from the type strains of S. 
cinnamoneus and S. mobaerensis. It is particularly interesting that the verticillate 
strains lack an orthologue of SsgE, which is fully conserved in non-verticillate 
streptomycetes. SsgE proteins are considered to have a role in morphogenesis and 
the length of spore chains in “S. coelicolor” (Noens et al., 2005). Further comparative 
studies are needed to determine whether the absence of SsgE in the genomes of 
verticillate streptomycetes is correlated to their different mode of sporulation. 
Strain MBT76T and S. hiroshimensis DSM 40037T were examined for cultural 
and phenotypic properties known to be of value in the systematics of the genus 
Streptomyces (Williams et al., 1983, Goodfellow et al., 2017). The cultural properties 
were recorded from tryptone-yeast extract, yeast extract-malt extract, oatmeal, 
inorganic-salt starch, glycerol-asparagine, peptone- yeast extract-iron and tyrosine 
agar (ISP media 1-7, (Shirling & Gottlieb, 1966)) plates following incubation as 280C 
for 14 days. Aerial and substrate mycelium colours and those of diffusible pigments 
were determined by comparison against colour charts (Kelly, 1964). The strains 
grew well on all of the media forming a range of pigments (Table 2). In general, 
strain MBT76T produced a pink aerial spore mass, dark red substrate mycelia and 
pale brown diffusible pigments, black melanin pigments were formed on ISP 6 agar. 
In contrast, S. hiroshimensis formed a white aerial spore mass, cream, pink or white 
substrate mycelia and, when produced, a brown diffusible pigment, it also formed 
melanin pigments on ISP 6 agar. 
The enzyme profiles for the test strain and S. hiroshimensis were determined 
using API-ZYM kits (BioMerieux) and a standard inoculum corresponding to 5 on 
the Mc Farland scale (Murray et al., 1999) and by following the protocol provided by 
the manufacturer. Similarly, a range of biochemical, degradative and physiological 
properties were acquired using media and methods described previously (Williams 
et al., 1983). Identical results were obtained for all of the duplicate cultures. 
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Figure 4. A composite maximum-likelihood tree showing the relationships between strain 
MBT76T, the type strains of S. cinnamoneus, S. hiroshimensis, S. mobaraensis and reference 
strains “S. coelicolor”, “S. lividans” and S. griseus, based on the sequences of SALP proteins. 
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The full genome sequence of strain MBT76T (GenBank accession number 
GCF_001445655) was elucidated using Illumina sequencing. The sequences 
assembled into 18 contigs, giving a total genome size of 8.64 Mb with a G+C 
content of 72.1%, with an N50 of 2,514,044 and a 200x genome coverage. The 
genome is predicted to encode 73 RNAs and 7,598 proteins. Gene functions were 
distributed among different classes using the RAST annotation tool (Fig. S4) (Aziz et 
al., 2008). A total number of 44 secondary metabolites are predicted by antiSMASH 
4.2.0 (Blin et al., 2017), as shown in Table S2. Several genomic metrics are now 
available to distinguish between orthologous genes of closely related prokaryotes, 
including the calculation of average nucleotide identity (ANI) and digital DNA-DNA 
hybridization values (Yoon et al., 2017b, Meier-Kolthoff et al., 2013). In the present 
study, ANI and dDDH values were determined from the genomes of strain MBT76T 
and S. hiroshimensis DSM 40037T using the ortho-ANIu algorithm from Ezbiotaxon 
(Yoon et al., 2017b) and the genome-to-genome distance calculator (GGDC 2.0) at 
http://ggdc.dsmz.de. The dDDH value between the genomes of the two strains was 
28.4% ± 2.3 %, a result well below the 70% threshold for assigning strains to the 
same species (Wayne et al., 1987), the digital DNA G+C value recorded for strain 
MBT76T was 71.9 mol%. Similarly, a low ANI value of 88.96 was found between 
the two organisms, a result well below the threshold used to delineate prokaryote 
species (Richter & Rossello-Mora, 2009, Chun & Rainey, 2014). 
It can be concluded from the chemotaxonomic, cultural, morphological and 
phylogenetic data that strain MBT76T belongs to the genus Streptomyces. It can 
be distinguished from the type strain, S. hiroshimensis, its closest phylogenetic 
neighbour using genotypic and phenotypic procedures, notably by low ANI and 
dDDH values. Consequentially, strain MBT76T should be recognised as a new 
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Polyphasic classification of Streptomyces roseifaciens sp. nov. 
Table 3. Phenotypic properties that distinguish strain MBT76 T from 
S.hiroshimensis DSM 40037T
Characteristics Strain MBT76T S. hiroshimensis DSM 
40037T
Cultural characteristics on yeast extract-malt extract agar
Aerial spore mass Pink White
Substrate mycelium Dark red Cream
Diffusible pigment Pale brown Brown
API ZYM tests:
α-Chymotrypsin + -
β- Glucosidase + -
Lipase (C14) + -




Growth on sole carbon source
Sucrose + -
Fructose - +
Growth in presence of:
3% w/v sodium chloride - +
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Description of Streptomyces roseifaciens sp. nov.
Streptomyces roseifaciens (ro.se.i.fa’ci.ens L. masc. adj. roseus [italic type] rosy; 
L. pres. part. faciens [italic type] producing; N.L. part. adj. roseifaciens [italc type] 
producing rosy colour). Aerobic, Gram-stain positive actinobacterium which forms an 
extensively branched substrate mycelium that carries long straight filaments bearing 
at more or less regular intervals branches arranged in verticils. Each branch of the 
verticils produces at its apex short chains of 3-5 spores with smooth surfaces. Grows 
well on all ISP media. A red substrate mycelium, a pink aerial spore mass and a 
pale brown diffusible pigment are produced on oatmeal agar. Grows from 20-50˚C, 
optimally at ~30˚C, from pH 5.0 to pH 11, optimally at pH ~7, and in the presence 
of 2% NaCl. Produces acid and alkaline phosphatase, α-chymotrypsin, α-cysteine 
arylamidase, esterase (C4), esterase lipase (C8), N-acetyl-β-glucosaminidase, 
α- and β-glucosidase, α-mannosidase, naphthol-AS-B1-phosphatase, trypsin and 
valine arylamidase, but not α-fucosidase, α- or β-galactosidase or β-glucoronidase 
(API-ZYM tests). Degrades casein, gelatin, hypoxanthine, starch and L-tyrosine. 
Glucose, inositol and sucrose are used as sole carbon sources. Additional 
phenotype properties are given in Tables 1 and 2. Major fatty acids are anteiso-C15:0, 
and anteiso-C17:0, the predominant menaquinone is MK-9 (H8), the polar lipid profile 
contains diphospatidylglycerol, phosphatidylethanolamine, phosphatidylinositol, 
glycophospholipid, and an unidentified lipid, the DNA G+C composition is 71.9 mol% 
and the genome size 8.64 Mbp. The genome contains 44 biosynthetic gene clusters 
many of which encode for unknown specialized metabolites. 
The type strain MBT76T (=NCCB 100637T =DSM 106196T) was isolated from a 
soil sample from the QinLing mountains, Shaanxi Province, China. The species 
description is based on a single strain and hence serves as a description of the type 
strain. The GenBank accession number for the assembled genome of Streptomyces 
roseifaciens is GCA_001445655.1.
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High-resolution analysis of the peptidoglycan composition in Streptomyces coelicolor
ABSTRACT
The bacterial cell wall maintains cell shape and protects against bursting by the 
turgor. A major constituent of the cell wall is peptidoglycan (PG), which is continu-
ously modified to allow cell growth and differentiation through the concerted activity 
of biosynthetic and hydrolytic enzymes. Streptomycetes are Gram-positive bacteria 
with a complex multicellular life style alternating between mycelial growth and the 
formation of reproductive spores. This involves cell-wall remodeling at apical sites 
of the hyphae during cell elongation and autolytic degradation of the vegetative my-
celium during the onset of development and antibiotic production. Here, we show 
that there are distinct differences in the cross-linking and maturation of the PG be-
tween exponentially growing vegetative hyphae and the aerial hyphae that undergo 
sporulation. Liquid chromatography-tandem mass spectrometry (LC-MS/MS) anal-
ysis identified over 80 different muropeptides, revealing that major PG hydrolysis 
takes place over the course of mycelial growth. Half of the dimers lacked one of 
the disaccharide units in transition-phase cells, most likely due to autolytic activi-
ty. De-acetylation of MurNAc to MurN was particularly pronounced in spores, and 
strongly reduced in sporulation mutants with a deletion of bldD or whiG, suggesting 
that MurN is developmentally regulated. Taken together, our work highlights dynamic 
and growth phase-dependent construction and remodeling of PG in Streptomyces.
IMPORTANCE
Streptomycetes are bacteria with a complex lifestyle, which are model organisms 
for bacterial multicellularity. From a single spore, a large multigenomic multicellular 
mycelium is formed, which differentiates to form spores. Programmed cell death is 
an important event during the onset of morphological differentiation. In this work, we 
provide new insights into the changes in the peptidoglycan composition and over 
time, highlighting changes over the course of development and between growing 
mycelia and spores. This revealed dynamic changes in the peptidoglycan when the 
mycelia aged, with extensive PG hydrolysis and, in particular, an increase in the 
proportion of 3-3-cross-links. Additionally, we identified a muropeptide that is highly 




Peptidoglycan (PG) is a major component of the bacterial cell wall. It forms a 
physical boundary that maintains cell shape, protects cellular integrity against the 
osmotic pressure and acts as a scaffold for large protein assemblies and exopoly-
mers (Vollmer et al., 2008a). The cell wall is a highly dynamic macromolecule that is 
continuously constructed and deconstructed to allow for cell growth and to meet en-
vironmental demands (Kysela et al., 2016). PG is built up of glycan strands of alter-
nating N-acetylglucosamine (GlcNAc) and N-acetylmuramic acid (MurNAc) residues 
that are connected by short peptides to form a mesh-like polymer. PG biosynthesis 
starts with the synthesis of PG precursors by the Mur enzymes in the cytoplasm and 
cell membrane, resulting in Lipid II precursor, undecaprenylpyrophosphoryl-Mur-
NAc(GlcNAc)-pentapeptide. Lipid II is transported across the cell membrane by 
MurJ and/or FtsW/SEDS proteins and the PG is polymerized and incorporated into 
the existing cell wall by the activities of glycosyltransferases and transpeptidases 
(Egan et al., 2017, Leclercq et al., 2017, Sham et al., 2014).
 The Gram-positive model bacterium Bacillus subtilis grows via lateral cell-
wall synthesis followed by binary fission; in addition, B. subtilis forms heat- and des-
iccation-resistant spores (Popham, 2002, Keep et al., 2006). In contrast, the vegeta-
tive hyphae of the mycelial Streptomyces grow by extension of the hyphal apex and 
cell division results in connected compartments separated by cross-walls (Flärdh & 
Buttner, 2009, Barka et al., 2016, Celler et al., 2016). This makes Streptomyces a 
model taxon for bacterial multicellularity (Claessen et al., 2014). Multicellular veg-
etative growth poses different challenges to Streptomyces, including the synthesis 
of many chromosomes during vegetative growth and separation of the nucleoids 
in the large multi-genomic compartments during cross-wall formation (Jakimowicz 
& van Wezel, 2012, Wolanski et al., 2011). In submerged cultures, streptomycetes 
typically form complex mycelial networks or pellets (van Dissel et al., 2014). On sur-
face-grown cultures, such as agar plates, these bacteria develop a so-called aerial 
mycelium, whereby the vegetative or substrate mycelium is used as a substrate. 
The aerial hyphae eventually differentiate into chains of spores, a process whereby 
many spores are formed almost simultaneously, requiring highly complex coordina-
tion of nucleoid segregation and condensation and multiple cell division (Jakimowicz 
& van Wezel, 2012, McCormick, 2009, Noens et al., 2005). Streptomycetes have an 
unusually complex cytoskeleton, which plays a role in polar growth and cell-wall sta-
bility (Celler et al., 2013, Holmes et al., 2013). Mutants that are blocked in the vege-
tative growth phase are referred to as bald or bld, for lack of the fluffy aerial hyphae 
(Merrick, 1976), while those producing aerial hyphae but no spores are referred to 
as white (whi), as they fail to produce grey-pigmented spores (Chater, 1972)
The Streptomyces genome encodes a large number of cell wall-modifying en-
zymes, such as cell wall hydrolases (autolysins), carboxypeptidases and penicil-
lin-binding proteins (PBPs), a complexity that suggests strong heterogeneity of the 
PG of these organisms (Haiser et al., 2009, Peters et al., 2016). Several concepts 
that were originally regarded as specific to eukaryotes also occur in bacteria, such 
as multicellularity (Lyons & Kolter, 2015, Claessen et al., 2014, Shapiro, 1988), and 
programmed cell death (Hochman, 1997, Rice & Bayles, 2003). Programmed cell 
death (PCD) likely plays a major role in the onset of morphological development, 
required to lyse part of the vegetative mycelium to provide the nutrients for the aerial 
hyphae (Manteca et al., 2005, Miguelez et al., 1999). PCD and cell-wall recycling are 
42
High-resolution analysis of the peptidoglycan composition in Streptomyces coelicolor
linked to antibiotic production in Streptomyces (Urem et al., 2016). 
All disaccharide peptide subunits (muropeptides) in the PG are variations on the 
basic building block present in Lipid II, which in Streptomyces typically consists of 
GlcNAc-MurNAc-L-Ala-D-Glu-LL-diaminopimelate(Gly)-D-Ala-D-Ala (Hugonnet et 
al., 2014, Schleifer & Kandler, 1972). Here, we have analyzed the cell wall composi-
tion of vegetative mycelium and mature spores of Streptomyces coelicolor by liquid 
chromatography-mass spectrometry (LC-MS), to obtain a detailed inventory of the 
monomers and dimers in the cell wall. This revealed extensive cell wall hydrolysis 
and remodeling during vegetative growth and highlights the difference in cell wall 




Bacterial strain and culturing conditions
Streptomyces coelicolor A3(2) M145 (Kieser et al., 2000), and its bldD, 
J774 (cysA15 pheA1 mthB2 bldD53 NF SCP2* (Merrick, 1976) and whiG,  J2400 
(M145 whiG::hyg (Flärdh et al., 1999)) mutants, were obtained from the John Innes 
Centre strain collection. All media and methods for handling Streptomyces are de-
scribed in the Streptomyces laboratory manual (Kieser et al., 2000). Spores were 
collected from Soy Flour Mannitol (SFM) agar plates. Liquid cultures were grown 
shaking at 30°C in a flask with a spring, using normal minimal medium with phos-
phate (NMM+) supplemented with 1% (w/v) mannitol as the sole carbon source; 
polyethylene glycol (PEG) was omitted to avoid interference with the MS identifi-
cation. Cultures were inoculated with spores at a density of 106 CFU/ML. A growth 
curve was constructed from dry-weight measurements by freeze-drying washed bio-
mass obtained from 10 mL of culture broth (three biological replicates). To facilitate 
the harvest of mycelium from agar plates, they were grown on cellophane slips, after 
which the biomass was scraped of the cellophane. Spores were collected from SFM 
agar plates by adding 0.01% (w/v) SDS to facilitate spore release from the aerial my-
celium, scraping them off with a cotton ball and drawing the solution with a syringe. 
Spores were filtered with a cotton filter to separate spores from residual mycelium.
PG extraction
Cells were lyophilized for a biomass measurement, 10 mg biomass was directly 
used for PG isolation. PG was isolated according to (Kühner et al., 2014), using 2 
mL screw-cap tubes for the entire isolation. Biomass was first boiled in 0.25% SDS 
in 0.1 M Tris/HCl pH 6.8, thoroughly washed, sonicated, treated with DNase, RNase 
and trypsin, inactivation of proteins by boiling and washing with water. Wall teichoic 
acids were removed with 1 M HCl. PG was digested with mutanolysin and lysozyme 
(Arbeloa et al., 2004). Muropeptides were reduced with sodium borohydride and the 
pH was adjusted to 3.5-4.5 with phosphoric acid. 
To validate the method, we compared it to the method described previously (Bui 
et al., 2012). For this, S. coelicolor mycelia were grown in 1 L NMM+ media for 24 
h. After  washing of the mycelia, pellets were resuspended in boiling 5% (w/v) SDS 
and stirred vigorously for 20 min. Instead of sonicating the cells, they were disrupted 
using glass beads, followed by removal of the teichoic acids with an HF treatment at 
4°C as described.
LC-MS analysis of monomers
The LC-MS setup consisted of a Waters Acquity UPLC system (Waters, Milford, 
MA, USA) and a LTQ Orbitrap XL Hybrid Ion Trap-Orbitrap Mass Spectrometer 
(Thermo Fisher Scientific, Waltham, MA, USA) equipped with an Ion Max electro-
spray source. 
Chromatographic separation was performed on an Acquity UPLC HSS T3 C18 col-
umn (1.8 µm, 100 Å, 2.1 × 100 mm). Mobile phase A consist of 99.9% H2O and 0,1% 
Formic Acid and mobile phase B consists of 95% Acetonitrile, 4.9% H2O and 0,1% 
Formic Acid. All solvents used were of LC-MS grade or better. The flow rate was set 
to 0.5 ml/min. The binary gradient program consisted of 1 min 98% A, 12 min from 
98% A to 85% A, and 2 min from 85% A to 0% A. The column was then flushed for 
3 min with 100% B, the gradient was then set to 98% A and the column was equili-
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brated for 8 min. The column temperature was set to 30°C and the injection volume 
used was 5 µL. The temperature of the autosampler tray was set to 8°C. Samples 
were run in triplicates. 
MS/MS was done both on the full chromatogram by data dependent MS/MS and 
on specific peaks by selecting the mass of interest. Data dependent acquisition was 
performed on the most intense detected peaks, the activation type was Collision 
Induced Dissociation (CID). Selected MS/MS was performed when the resolution 
of a data dependent acquisition lacked decisive information. MS/MS experiments in 
the ion trap were carried out with relative collision energy of 35% and the trapping of 
product ions were carried out with a q-value of 0.25, and the product ions were ana-
lyzed in the ion trap., data was collected in the positive ESI mode with a scan range 
of m/z 500–3000 in high range mode. The resolution was set to 15.000 (at m/z 400). 
Data analysis
Chromatograms were evaluated using the free software package MZmine (http://
mzmine.sourceforge.net/ (Pluskal et al., 2010)) to detect peaks, deconvolute the 
data and align the peaks. Only peaks corresponding with a mass corresponding 
to a muropeptide were saved, other data was discarded. The online tool Metabo-
Analyst (Xia et al., 2015) was used to normalize the data by the sum of the total 
peak areas, then normalize the data by log transformation. The normalized peak 
areas were exported and a final table which shows peak areas as percentage of 
the whole was produced in Microsoft Excel. 
Muropeptide identification 
The basic structure of the peptidoglycan of S. coelicolor has been published pre-
viously (Hugonnet et al., 2014). Combinations of modifications were predicted and 
the masses were calculated using ChemDraw Professional (PerkinElmer). When a 
major peak had an unexpected mass, MS/MS helped resolve the structure. MS/MS 




To assess how growth and development translate to variations in the PG com-
position, we isolated the PG and analyzed the muropeptide profile of spores and 
of vegetative hyphae during different phases of growth in liquid-grown cultures. In 
submerged cultures, S. coelicolor does not sporulate, while it forms aerial hyphae 
and spores on solid media. Vegetative mycelia of S. coelicolor M145 were harvested 
from cultures grown in liquid minimal media (NMM+). Samples taken after 18 h and 
24 h represented exponential growth, while samples taken after 36 h and 48 h repre-
sented mycelia in transition phase (Figure 1A,B). Samples from solid-grown cultures 
were taken at 24 h to represent vegetative growth, 48 h, representing growth of ae-
rial hyphae and 72 h, when the strain has formed spores (Figure 1C). Spores were 
harvested from SFM agar plates and filtered to exclude mycelia fragments. 
Figure 1. Growth of S. coelicolor in liquid and solid medium. (A) Growth curve on NMM+ 
medium based on triplicate dry weight measurements. (B) Pellet morphology in liquid medi-
um. After spore germination, hyphae emerge through top growth and branching that form an 
intricate network or pellet. The center of the pellets eventually lyses due to PCD (gray). (C) 
Growth on solid medium, starting with development of vegetative mycelium, after which aerial 
hyphae grows into the air, coinciding with an event of PCD at the vegetative mycelium, indi-
cated by grey hyphae. Spores are generated by septation of the aerial hyphae. 
To allow analyzing a large number of samples simultaneously and in a reasonable 
time frame, we adapted a method for rapid PG purification (Kühner et al., 2014) for 
S. coelicolor. The advantage of this method is that it requires only a small amount 
of imput biomass and much faster sample handling. For this, 10 mg of lyophilized 
cell wall material was isolated by boiling cells in 0.25% SDS in 2-ml microcentrifuge 
tubes, and secondary cell-wall polymers such as teichoic acids were removed by 
treatment for 4 h with hydrochloric acid (HCl) (see Materials and Methods section for 
details). As a control for the validity of the method, it was compared to a more elab-
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orate method that is used routinely (Bui et al., 2012). In the latter method, biomass 
from a 1-liter culture of S. coelicolor was boiled in 5% SDS and subsequently treated 
for 48 hours with hydrofluoric acid (HF) to remove teichoic acids. Comparison of the 
two methods revealed comparable outcomes between the two methods in peak de-
tection (Table S5). This validated the more rapid method using 0.25% SDS and HCl, 
which was therefore used in this study. 
The isolated PG was digested with mutanolysin (Kühner et al., 2014, Glauner, 
1988) and the muropeptide composition was analyzed by LC-MS. Peaks were iden-
tified in the m/z range from 500-3000 Da, whereby different m/z’s in co-eluting peaks 
were further characterized by MS/MS. The eluted m/z values were compared to a 
dataset of theoretical masses of predicted muropeptides. Table 1 shows a summary 
of the monomers and dimers that were detected during growth in liquid medium, and 
Table 2 shows a summary of muropeptides on solid medium. The full datasets are 
given in Tables S1,S2, S3 and S4. We identified several modifications, including the 
amidation of D-iGlu to D-iGln at position 2 of the stem peptide, deacytelation of Mur-
NAc to MurN, removal of amino acids to generate mono-, di-, tri- and tetrapeptides, 
loss of LL-DAP-bound glycine, and the presence of Gly (instead of Ala) at position 
1,4 or 5. The loss of GlcNac or GlcNAc-MurNAc indicates hydrolysis (Figure 2). For 
all amino acids in the pentapeptide chain, the position is indicated as [n], whereby n 
is the number in the chain (with [1] the position closest to the PG backbone, i.e., the 
MurNAc residue, and [5] being the last amino acid residue. 
Growth phase dependent changes in the PG composition
The muropeptide that is incorporated from Lipid II by glycosyltransferases con-
tains a pentapeptide with a Gly residue linked to LL-DAP [3]. In many bacteria penta-
peptides are short-lived muropeptides that occur mostly at sites where de novo cell-
wall synthesis takes place, i.e. during growth and division (Kuru et al., 2015, Morales 
Angeles et al., 2017). This is reflected by the high abundance of pentapeptides in 
the samples obtained from exponentially growing cells, with a pentapeptide content 
of 21% during early exponential growth (18 h), as compared to 14% and 11% during 
late exponential growth (24 h), transition phase (36 h) and stationary phase (48 h), 
respetively. Conversely, tripeptides increased over time, from 24% during early ex-
ponential phase to 32% in transition-phase cultures. Addition of Gly to the medium 
and, in consequence, incorporation of Gly in the peptidoglycan can cause changes 
in morphology (Hammes et al., 1973, Takacs et al., 2013). This property was applied 
to facilitate lysozyme-mediated formation of protoplasts in Streptomyces, used for 
protoplast transformation methods (Okanishi et al., 1974, Hopwood et al., 1977, 
Kieser et al., 2000). In S.coelicolor, Gly can be found instead of Ala at position 1, 4 
or 5 in the pentapeptide chain. During liquid growth, tetrapeptides carrying Gly at 
position 4 increased from 3% during early growth to 8% during the latest time points. 
The relative abundance of pentapeptides carrying Gly at position 5 (4-5%) did not 
vary over time. On solid-grown cultures, the Gly content of the peptidoglycan was 
around 1%, which is significantly lower than in liquid-grown cultures.
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Table 1. Relative abundance(%)a of muropeptides in vegetative cells from liquid 
NMM+. 
Muropeptidea Abundance (%)b in S. coelicolor M145 
Monomers 18h 24h 36h 48h
Mono 1.6 2.1 3.3 3.3
Di 14.2 15.5 14.5 13.2
Tri 27.4 32.2 35.1 35.8
Tetra 26.7 24.4 23.9 23.9
Tetra[Gly4]c 3.5 5.3 6.9 8.2
Penta 22.7 16.9 13.1 12.9
Penta[Gly5]c 4.7 4.8 4.7 4.4
D-Glutamine 67 62 61.1 63.7
Deacetylated 3.9 6.0 7.9 8.0
MurN-Tri 0.1 0.7 1.2 2.3
GlcNAc-MurN-Tri 1.8 2.2 2.6 2.1
Dimers 18h 24h 36h 48h
TriTri (3-3) 4.1 4.8 6.5 7.0
TriTri - MurNAcGlcNAc 8.7 14.8 23.7 34.3
TriTetra(3-3) 23.9 24.2 22.3 16.9
TriTetra(3-4) 1.0 8.7 8.2 6.1
TriTetra - MurNAcGlcNAc 9.6 15.1 16.1 16.2
TetraTetra(3-4) 23.3 13.5 10.1 8.6
TetraTetra - MurNAcGlcNAc 6.0 7.3 4.8 5.6
TetraPenta (3-4) 24.6 9.1 5.6 3.0
MurN 1.8 1.2 1.5 1.2
 -GlcNac 0.3 0.6 1.1 1.2
missing MurNAcGlcNAc 24.3 37.2 44.6 56.1
Proportion(%) of 3-3 cross-links 36.5 48.0 54.5 57.3
aMonomers and dimers are treated as separate datasets.
bRelative abundance is calculated as the ratio of the peak area over the sum of all peak areas 
recognized in the chromatogram. 
c Gly detected instead of Ala
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Table 2. Relative abundance(%)a of muropeptides over growth on solid SFM-medi-
um and spores.
Muropeptidea Abundance (%)b in S. coelicolor M145
Monomers 24h 48h 72h spores
Mono 3.6 4.3 4.1 4.5
Di 21.6 17.6 17.9 13.1
Tri 29.6 34.3 34.2 28.1
Tetra 25.4 29.5 32.0 48.3
Tetra[Gly4]c 0.9 1.1 1.0 2.3
Penta 16.8 9.9 7.2 5.3
Penta[Gly5]c 1.2 1.4 1.3 4.0
Deacatylated 3.7 4.4 6.1 4.5
D-Glutamine 76.2 80.3 82.9 74.0
Missing GlcNAc 1.5 3.4 5.0 4.8
MurN-Tri 0.6 1.7 3.1 3.5
GlcNAc-MurN-Tri 1.9 1.4 1.6 0.1
Dimers 24h 48h 72h spores
Tri-Tri (3-3) 7.4 10.5 12.6 4.9
Tri-Tri - MurNacGlcNac 0.6 0.6 0.3 7.1
Tri-Tetra(3-3) 20.4 22.2 21.8 19.1
Tri-Tetra(3-4) 9.7 12.7 11.8 4.7
Tri-Tetra - MurNacGlcNac 13.3 14.5 13.0 6.3
Tetra-Tetra(3-4) 13.3 15.8 15.7 38.9
Tetra-Tetra - MurNacGlcNac 17.3 13.7 13.2 17.1
Tetra-Penta (3-4) 12.7 7.3 5.4 0.7
MurN 1.0 0.3 1.2 0.4
 -GlcNAc 0.4 0.2 0.4 0.1
missing MurNAcGlcNAc 31.1 28.7 26.5 30.4
Proportion(%) of 3-3 cross-links 43.8 47.8 51.1 35.1
aMonomers and dimers are treated as separate datasets.
bRelative abundance is calculated as the ratio of the peak area over the sum of all peak areas 
recognized in the chromatogram. 
c Gly detected instead of Ala
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The abundance of 3-3 cross-links increases over time
Two types of cross-links are formed via separate mechanisms, namely the canon-
ical D,D-transpeptidases (PBPs) producing 3-4 (D,D) cross-links between LL-DAP[3] 
and D-Ala[4] and L,D-transpeptidases that form 3-3 (L,D) cross-links between two 
LL-DAP[3] residues (Figure 2). These types of peptidoglycan cross-linking can be 
distinguished based on differences in retention time and their MS/MS fragmentation 
patterns. Dimers containing a tripeptide and a tetrapeptide (TetraTri) may have either 
cross-link, giving rise to isomeric forms that elute at different retention times, allow-
ing for assessment by MS/MS (Figures 3A and 3B). In S. coelicolor, the ratio of 3-3 
cross-linking increased over time towards transition phase; the relative abundance 
increased from 37% of the total amount of dimers at 18 h (exponential phase) to 57% 
of all dimers at 48 h (Figures 3A and 3B). 
PG hydrolysis increases as the culture ages
PG hydrolysis is associated with processes such as separation of daughter cells 
after cell division and autolysis, and in E. coli and other species deletion mutants 
lacking PG amidases grow in chains of unseparated cells (Heidrich et al., 2002, 
Vollmer et al., 2008b). On solid media, vegetative hyphae of Streptomyces under-
go programmed cell death (PCD) and hydrolysis. During spore maturation, spores 
are separated hydrolytically from one another. Some streptomycetes sporulate in 
submerged culture, but this is not the case for S. coelicolor (Girard et al., 2013). 
Our data show that as growth proceeds in submerged cultures, the S. coelicolor 
peptidoglycan progressively loses GlcNAc and GlcNAc-MurNAc moieties (Table 1), 
as a result of N-acetylglucosamidase activity. The proportion of dimers lacking Glc-
NAc-MurNAc thereby increases in time from 24% at 18 h to 56% at 48 h. Figure 3C 
shows MS/MS profiles of a TriTri-dimer with a single set of glycans. During growth on 
solid media the trend was inversed. This may be due to the different developmental 
stages, whereby 24 h corresponds to early developmental events and PCD, 48 h to 
aerial growth and sporulation at 72 h. This analysis shows the relative abundance of 
muropeptides of the total amount of biomass, when hydrolysis has occurred at the 
vegetative mycelium, while the strain has simultaneously produces a large amount 
of aerial hyphae, the relative abundance of muropeptides of the entire culture could 
be misleading (Table 2).
Deacetylation of MurNAc is associated with mycelial aging and sporulation
Modifications to the glycan strand are commonly linked to lysozyme resistance 
(Meyrand et al., 2007). In particular, N-deacetylation of PG strands is widespread 
among bacteria, which can occur both at GlcNAc and at MurNAc (Vollmer, 2008). In 
the case of S. coelicolor, the only glycan modification is the deacetylation of MurNAc 
to MurN. Our data show that this modification becomes more prominent as the vege-
tative mycelium ages, from 5% during early growth to 8% during later growth stages. 
On agar plates, 3.7% of the monomers was deacetylated at 24 h, 4.4% at 48 h and 
6.1% at 72h. The PG composition of spores and vegetative mycelia was compared 
to get more insights into the possible correlations between PG composition and im-
portant processes such as dormancy and germination. Muropeptides in spores were 
strongly biased for tetrapeptides, making up 44% of the monomers, as compared to 
23-25% of the vegetative PG. Conversely, pentapeptides were found in much lower
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Figure 2. MS/MS fragmentations of TetraTri dimers with either 3-3 cross-link (A) or 3-4 cross-
link (B). Differentiation between these two types of cross-links is possible at the point of asym-
metry, at Gly attached to LL-DAP. The 3-3 cross-linked dimer (A) fragments into masses of 
966.0 m/z and 941.3 m/z, which can be found in the respective MS/MS spectrum. The 3-4 
cross-linked dimer (B) fragments into masses of 1037.4 m/z and 870.5 m/z. These masses 
are found in the MS/MS spectrum. Boxed MS/MS spectra show a magnification of masses 
between m/z 850 and 1050 to show masses present in lower abundance. (C) a TriTri dimer 




amounts in spores ( 5% of the monomers), as compared to 10-22% in vegeta-
tive hyphae. A previous study showed that mutation of the gene dacA that encodes 
D-alanyl-D-alanine carboxypeptidas disrupts spore maturation and germination, 
where one could influence the other. This indicates that either pentapeptides inhibit 
spore maturation, or that a high amount of tetrapeptides is important (Rioseras et 
al., 2016). The muropeptide that stood out in the analysis of the spore PG was a 
tripeptide which lacks GlcNAc and contains a deacetylated MurNAc, called MurN-Tri 
(Figure 2). In spores, MurN-Tri made up 3.5% of the monomers, whereas the less 
modified muropeptide, GlcNAcMurN-Tri only made up 0.2% of the monomers. 
To further investigate this interesting phenomenon, we analyzed two developmen-
tal mutants, namely the bldD and whiG mutants. The bldD gene product is a global 
transcription factor that controls the transcription of many developmental genes and 
is therefore blocked in an early stage of morphogenesis (den Hengst et al., 2010), 
while the whiG gene product is a σ factor that controls early events of aerial growth. 
The monomer profile of S. coelicolor M145 and its bldD and whiG mutants are sum-
marized in Table 3. For the wild-type strain M145, 24 h represents vegetative growth, 
48 h aerial growth and 72 h spore formation. In line with the notion that MurN-Tri 
accumulates particularly in spores, the bldD mutant accumulated hardly any MurN-
Tri (0-0.2%) over the course of time and the whiG mutant 0.4%, 0.6% and 1.3% 
after 24 h, 48 h, and 72 h. respectively. In contrast, M145 had 0.6%, 1.7% and 3.1% 
MurN-Tri at these time points, strongly suggesting that MurN-Tri accumulates in a 
sporulation-specific manner. 
Table 3. Summary of relative abundance (%)a of monomers from developmental 
bldD- and whiG-mutants and the parent strain, M145. 






ΔbldD 24h 4.5 25.7 28.0 23.0 10.8 6.5 0.0 5.3
48h 4.3 26.3 38.3 23.4 11.1 8.5 0.2 6.6
72h 4.3 27.2 40.9 19.9 9.5 7.6 0.2 5.8
ΔwhiG 24h 3.5 23.2 27.0 32.5 15.2 3.0 0.4 1.3
48h 3.6 17.5 44.3 25.5 7.9 5.0 0.6 3.2
72h 4.1 18.5 48.8 20.9 6.9 6.2 1.3 3.8
M145 24h 3.6 21.6 29.6 25.4 16.8 3.7 0.6 1.9
48h 4.3 17.6 34.3 29.5 9.9 4.4 1.7 1.4
72h 4.1 17.9 34.2 32.0 7.2 6.1 3.1 1.6
spores 4.5% 13.1 28.1 48.3 5.3 4.5 3.5 0.1
aRelative abundance is calculated as the ratio of the peak area over the sum of all peak areas 
recognized in the chromatogram.
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DISCUSSION
The Streptomyces cell wall is essential for structural rigidity and, in a pinch, a 
source of nutrients (Rigali et al., 2008). Here, we analyzed the peptidoglycan com-
position over the course of growth and development. All masses are identified by MS 
and MS/MS, by which we were able to identify between dimers which were cross-
linked by either 3-3- or 3-4 cross-links. A large event of peptidoglycan recycling was 
recognized in the hydrolysis of GlcNAc-MurNac from up to 56% of the dimers in 
late-exponential cultures. One muropeptide is linked to development, which was 
confirmed in developmental mutants. In conclusion, Streptomyces peptidoglycan 
is dynamic, being constantly constructed and deconstructed while maintaining cell 
shape and solidity.
Implications for the biology of actinobacteria
Sporulation is a key feature of Streptomyces biology and the spore wall is a ma-
jor line of defense against environmental stresses, allowing the bacteria to survive 
under adverse conditions such as heat and cold stress, osmotic pressure, starvation 
or drought (van der Meij et al., 2017, Okoro et al., 2009). The spores are spread to 
a new environment, where they germinate as soon as the right conditions are met 
and start a new mycelium. Not much is known about the environmental and genetic 
factors that control the onset of germination. In terms of the genetics, we have previ-
ously shown that mutants deficient for the cAMP-receptor protein Crp have a much 
thicker spore wall, presumably due to reduced expression of cell-wall hydrolases and 
consequently germinate slowly (Piette et al., 2005). Additionally, Crp is an positive 
regulator of secondary metabolite production where the expression of Crp increases 
undecylprodigiosin production (Gao et al., 2012). Conversely, strains over-express-
ing the cell-division activator protein SsgA show an increase in the number of germ 
tubes per spore (Noens et al., 2007), with on average three germ tubes emerging 
from a single spore (instead of the two in wild-type spores and significantly less than 
that in ssgA mutants). It is yet unclear how future sites of branching in the hyphae 
or germination in the spores are marked. However, even after very long storage of 
spores, germination still occurs at the spore ‘poles’, suggesting physical marks to 
the PG, such as rare modifications. Yet, in our analysis, we did not find muropeptide 
moieties such as muramic d-lactam, which is uniquely found in the spore-cortex of 
B. subtilis, but which is absent in vegetatively growing cells (Popham et al., 1996). 
The only major difference was the relatively high amount of MurN-Tri in the spore 
PG, which was hardly seen in bldD mutants, and also much less prominent in the 
whiG mutant. This strongly suggests that incorporation of MurN-Tri directly relates 
to sporulation. It will be interesting to see why this moiety is overrepresented in the 
spore PG. At the same time, this also shows the importance of analyzing the cell wall 
of different culture types as it reveals novel features that may play a key role in de-
velopment. L,D-transpeptidases (LDTs) are especially prevalent in the actinobacte-
rial genera Mycobacterium, Corynebacterium and Streptomyces, and, suggestively, 
these bacteria have a much higher percentage of 3-3 cross-links, with an abundance 
of at least 30% 3-3-cross links in investigated actinobacterial peptidoglycan as com-
pared to bacteria with lateral cell-wall growth such as E. coli (<10%) and E. faecium 
(3%) (Cameron et al., 2014, Hugonnet et al., 2014, Lavollay et al., 2009). LDTs 
attach to D-Ala[4] and form a cross-link between glycine and LL-DAP[3]. D-Ala[4] is 
considered a donor for this type of cross-link (Mainardi et al., 2005). An interesting 
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feature of these two mechanisms is that 3-4 cross-links can only be formed when a 
pentapeptide is present to display the D-Ala[5] donor, whereas 3-3 cross-links can 
be formed with a tetrapeptide as a donor strand.  The data agrees with the idea that 
3-3 cross-links could be required for remodeling of the cell wall beyond the tip-com-
plex, using available tetrapeptides contrary to newly constructed pentapeptides (La-
vollay et al., 2008, Sanders et al., 2014, Sacco et al., 2010, Baranowski et al., 2018). 
The cell wall and programmed cell death
Evidence is accumulating that, like eukaryotes, bacteria undergo a process of 
programmed cell death (PCD). Bacterial multicellularity implies a lifestyle involving 
cellular heterogeneity and the occasional sacrifice of selected cells for the benefit of 
survival of the colony (Zhang et al., 2016b, Yague et al., 2010, Yague et al., 2013). 
PCD is likely a major hallmark of multicellularity (Claessen et al., 2014), and has 
been described in the biofilm-film forming Streptococcus (Guiral et al., 2005) and 
Bacillus (Engelberg-Kulka et al., 2006), in Myxobacteria that form fruiting bodies 
(Sogaard-Andersen & Yang, 2008), in the filamentous cyanobacteria (Bornikoel et 
al., 2017, Ning et al., 2002), and in the branching Streptomyces (Manteca et al., 
2006, Miguelez et al., 1999, Tenconi et al., 2018). In streptomycetes, cell-wall hy-
drolases support developmental processes like branching and germination (Haiser 
et al., 2009). Additionally, PCD is likely an important event during the onset of de-
velopment from a vegetative lifestyle to a reproductive lifestyle, as autolytic degra-
dation of the cell wall is intrinsically linked with the onset of antibiotic production and 
spore formation (Tenconi et al., 2018). Conceptually, GlcNAc accumulates at high 
concentrations around colonies during PCD, and GlcNAc is an important signaling 
molecule for the onset of morphological differentiation and antibiotic production in 
streptomycetes (Rigali et al., 2008, Urem et al., 2016). The linkage of PCD and 
antibiotic production is logical from a biological perspective; autolytic dismantling of 
the vegetative (substrate) mycelium generates building blocks in a nutrient-depleted 
soil, which will inevitably attract motile competitors. Antibiotics likely serve to fend off 
these competitors and protect the food source. Thus, cell-wall hydrolysis may facili-
tate the correct timing of development. 
CONCLUSIONS
We have provided a detailed analysis of the peptidoglycan of Streptomyces 
mycelia and spores, and developed a reliable and fast method to compare larger 
numbers of samples. Our data show significant changes over time, among which 
changes in the amino acid chain, hydrolysis of dimers, and the accumulation of 
the rare MurN-Tri specifically in the spores. The cell wall likely plays a major role in 
the development of streptomycetes, with implications for germination and the switch 
to development and antibiotic production (via PCD-released cell wall components). 
The dynamic process that controls the remodeling of the cell wall during tip growth 
is poorly understood, but we anticipate that the local cell-wall structure at sites of 
growth and branching may well be different from that in older (non-growing) hyphae. 
This is consistent with the changes we observed over time, between the younger 
and older mycelia. Detailed localization of cell-wall modifying enzymes and of specif-
ic cell-wall modifications, in both time and space, is required to further reveal the role 
of the cell wall in the control of growth and development of streptomycetes.
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Figure 3. Summary of structures of main monomers and dimers observed in PG from S. coe-
licolor. Modification to the PG include: alteration of the length of the amino acid chain; [Gly1], 
L-Ala is replaced by Gly; [Glu], where Glutamic acid (Glu) is present instead of D-Glutamine 
(Gln); [Gly4], where D-Ala(4) is replaced by Gly; [Gly5], where D-Ala(5) is replaced by Gly. 
Specific for dimers: (3-3) shows a cross-link between LL-DAP(3) to LL-DAP(3) with a Gly-
bridge; (3-4) shows a cross-link between LL-DAP(3) and D-Ala(4) with a Gly-bridge; (-Mur-
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Peptidoglycan composition of Kitasatospora setae and Kitasatospora viridifaciens
ABSTRACT: 
Members of the genus Kitasatospora are Gram-positive actinomycetes that be-
long to the family of Streptomycetaceae, and strongly resemble Streptomyces in 
terms of their genetics and morphology. However, there are also differences, such as 
that key developmental genes are missing and their cell wall composition differs sig-
nificantly. Kitasatosporae have a unique switch in peptidoglycan composition during 
their life cycle, producing a vegetative mycelium with meso-DAP in the peptidogly-
can, while the spore peptidoglycan contains LL-DAP. Here, we investigate the bio-
logical implications of the growth phase-dependent changes in the PG composition. 
Our work shows that the peptidoglycan of Kitasatospora setae and Kitasatospora 
viridifaciens changes composition between the point of vegetative growth and sporu-
lation. An ssgB null mutant of K. viridifaciens, which fails to sporulate (Ramijan et al., 
2018), accumulated muropeptides with a modification at the site of MurNAc, a high-
er amount of hydrolyzed dimers as compared to the parent strain and has minimal 
amounts of peptidoglycan with LL-DAP. The data suggests that at the switch from 
vegetative growth to reproductive growth, Kitasatospora species actively hydrolyze 
most of the vegetative mycelium, potentially in a meso-DAP directed manner in order 




Actinomycetes are Gram-positive bacteria well known for their capability to pro-
duce a wide array of secondary metabolites, among which most of our clinical antibi-
otics (Barka et al., 2016; Hopwood, 2007). The search for novel antibiotic-producing 
actinobacteria has resulted in the isolation of an huge diversity of taxonomically 
described actinomycetes. Many of these belong to the genus Streptomyces, of 
which no fewer than 550 type species have been described (Kämpfer, 2012). Be-
sides Streptomyces, the family of Streptomycetaceae includes Kitasatospora and 
Streptacidiphilus (Goodfellow, 2012; Labeda et al., 2012; Labeda et al., 2017). Kita-
satospora are a sister genus to Streptomyces with an indistinguishable morphology, 
which has caused many Kitasatospora species to be mis-assigned to the genus 
Streptomyces (Girard et al., 2014; Ramijan et al., 2017). 
During growth of Kitasatospora, a single spore germinates and develops vegeta-
tive hyphae, which extend by tip growth and branching, thereby developing an intri-
cate vegetative mycelium. Reproductive growth starts with the development of aerial 
hyphae, which grow into the air and eventually differentiate into long spore chains 
(Barka et al., 2016). Development from vegetative to aerial mycelium is regulated 
by the bld genes, named after the nonsporulating phenotype of mutants, whereby 
colonies have a ‘bald’ appearance; spore formation is regulated by the whi genes, 
so-called because whi mutants are white, due to their failure to produce the grey-pig-
mented spores (Chater, 1972; Merrick, 1976). Kitasatosporae lack the regulatory 
genes bldB and whiJ that are important for development in Streptomyces, and the 
cytoskeletal gene mbl, for an MreB-like protein (Celler et al., 2013). BldB is a small 
protein involved in the regulation of development and antibiotic production, WhiJ 
mediates repression of Streptomyces development (Ainsa et al., 2010; Pope et al., 
1998).
These data suggest that at least some aspects of Kitasatospora development is 
regulated different from Streptomyces (Girard et al., 2014). Another major difference 
lies in the so-called SsgA-like proteins. Sporulation of actinobacteria requires one 
or more proteins that belong to the SsgA-like proteins (SALPS) (Traag, 2008; van 
Dissel, 2014). All actinobacteria that sporulate contain an orthologue of ssgB, while 
more complex actinomycetes like streptomycetes encode several SALPS (Noens et 
al., 2005). Of these, ssgA and ssgB are required for sporulation in streptomycetes; 
mutants deleted for ssgA only form spores on minimal media (van Wezel et al., 
2000), while ssgB mutants fail to sporulate under any growth condition (Keijser et 
al., 2003). SsgB recruits FtsZ to septum sites so as to initiate sporulation-specific 
cell division (Willemse et al., 2011). Several Kitasatosporae lack ssgA and/or its 
regulatory gene ssgR, again suggesting that the control of development is different 
in Kitasatospora and Streptomyces. 
One determining feature that sets Kitasatospora apart from Streptomyces is found 
in the cell wall composition: diaminopimelic acid (DAP) is a diagnostic features in ac-
tinomycetales, and this modified amino acid contains two stereocenters of which two 
stereoisomers are found in bacteria, LL-DAP and L,D(meso)-DAP (Lechevalier and 
Lechevalier, 1965). Streptomyces PG exclusively contains LL-DAP, but Kitasatospo-
ra species carry meso-DAP in PG of the vegetative mycelium and LL-DAP in spore 
PG, as shown in Figure 1 (Takahashi, 2017; Zhang et al., 1997). Analysis of the cell 
wall composition of Streptomyces failed to identify muropeptides that were unique 
for either vegetative mycelia or spores; instead, the major differences were seen in 
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the abundance of muropeptides (van der Aart et al., 2018). 
The switch from meso- to LL-DAP in the PG between vegetative mycelium and 
spores of Kitasatospora species suggests a form of regulation at the point of the cell 
wall construction (Takahashi, 2017). In this study, we analyzed the peptidoglycan 
composition of mycelia and spores of Kitasatospora setae KM 6054T and Kitasato-
spora viridifaciens DSM40239. Analysis of the muropeptides by MS/MS revealed 
major changes in cell wall composition between vegetative mycelium and spores of 
both strains. An ssgB deletion mutant of K. viridifaciens showed a higher degree of 
cell wall hydrolysis and an unindentified modification at the site of MurNAc. 
Figure 1. Kitasatospora produces a vegetative mycelium with LL-DAP, followed by an aerial 
mycelium that develops into spores with LL-DAP. Over the course of development, the veg-





Bacterial strain and culturing conditions:
Kitasatospora setae KM 6054T and Kitasatospora viridifaciens DSM40239 are 
both obtained from the DSMZ. K. viridifaciens was grown on MYM-medium, K. setae 
was grown on ISP-2. Spores are isolated by craping them off with a cotton ball and 
drawing the solution with a syringe. The ssgB-mutant of K. viridifaciens was gener-
ated by Karina Ramijan (Ramijan et al., 2018). 
PG extraction
Cells were lyophilized for a biomass measurement, 10 mg biomass was directly 
used for PG isolation. PG was isolated according to Kühner et al. (Kühner et al., 
2014), using 2 mL screw-cap tubes for the entire isolation. Biomass was first boiled 
in 0.25% SDS in 0.1 M Tris/HCl pH 6.8, thoroughly washed, sonicated, treated with 
DNase, RNase and trypsin, inactivation of proteins by boiling and washing with wa-
ter. Wall teichoic acids were removed with 1 M HCl (van der Aart et al., 2018). PG 
was digested with mutanolysin and lysozyme (Arbeloa et al., 2004). Muropeptides 
were reduced with sodium borohydride and the pH was adjusted to 3.5-4.5 with 
phosphoric acid. 
LC-MS analysis of monomers
The LC-MS setup consisted of a Waters Acquity UPLC system (Waters, Milford, 
MA, USA) and a LTQ Orbitrap XL Hybrid Ion Trap-Orbitrap Mass Spectrometer 
(Thermo Fisher Scientific, Waltham, MA, USA) equipped with an Ion Max electro-
spray source. 
Chromatographic separation was performed on an Acquity UPLC HSS T3 C18 col-
umn (1.8 µm, 100 Å, 2.1 × 100 mm). Mobile phase A consist of 99.9% H2O and 0,1% 
Formic Acid and mobile phase B consists of 95% Acetonitrile, 4.9% H2O and 0,1% 
Formic Acid. All solvents used were of LC-MS grade or better. The flow rate was set 
to 0.5 ml/min. The binary gradient program consisted of 1 min 98% A, 12 min from 
98% A to 85% A, and 2 min from 85% A to 0% A. The column was then flushed for 
3 min with 100% B, the gradient was then set to 98% A and the column was equili-
brated for 8 min. The column temperature was set to 30°C and the injection volume 
used was 5 µL. The temperature of the autosampler tray was set to 8°C. Samples 
were run in triplicates. 
MS/MS was done both on the full chromatogram by data dependent MS/MS and 
on specific peaks by selecting the mass of interest. Data dependent acquisition was 
performed on the most intense detected peaks, the activation type was Collision 
Induced Dissociation (CID). Selected MS/MS was performed when the resolution 
of a data dependent acquisition lacked decisive information. MS/MS experiments in 
the ion trap were carried out with relative collision energy of 35% and the trapping of 
product ions were carried out with a q-value of 0.25, and the product ions were ana-
lyzed in the ion trap., data was collected in the positive ESI mode with a scan range 
of m/z 500–2500 in high range mode. The resolution was set to 15.000 (at m/z 400). 
Data analysis
Chromatograms were evaluated using the free software package MZmine (http://
mzmine.sourceforge.net/ (Pluskal et al., 2010)) to detect peaks, deconvolute the 
data and align the peaks. Only peaks corresponding with a mass corresponding 
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to a muropeptide were saved, other data was discarded. The peak areas were ex-
ported and a final table which shows peak areas as percentage of the whole was 
produced in Microsoft Excel. 
Muropeptide identification 
The base structure and modifications of S.coelicolor PG has been resolved (Hu-
gonnet et al., 2014). Different combinations of modifications were predicted and the 
masses were calculated using ChemDraw Professional (PerkinElmer). When a ma-
jor peak had an unexpected mass, MS/MS helped resolve the structure. MS/MS was 
used to identify differences in cross-linking and to confirm predicted structures. 
DAP characterization 
2-3 mg of freeze-dried material was dissolved in 200 µL 6M HCl and boiled for 
16 hours. After cooling, the tubes were transferred to the rotary evaporator and 
dried. The remaining material was dissolved in 100 µL H2O. 2µL of each sample 
was applied to the baseline of a cellulose TCL-plate. The tank was filled with Meth-




Diaminopimelic acid composition in vegetative mycelium and spores. 
Mycelia from K. setae and K. viridifaciens were harvested from solid ISP-2 or 
MYM agar plates at 16 h (vegetative growth), 30 h (aerial growth), 42 h (onset of 
sporulation) and 64 h (mature spores) and spores separated from the mycelia by 
filtering through cotton wool. Mycelium of the non-sporulating ssgB null mutant of K. 
viridifaciens was harvested after 64 h, when abundant aerial hyphae were formed, 
as shown in figure S1. This mutant was used to analyse aerial mycelium after pro-
longed incubation, in the absence of spores. Then, cell wall material was isolated 
from all the mycelia and spores as described (Lechevalier et al., 1971). The di-
aminopimelic acid (DAP) stereochemistry of the samples was assessed by TLC. In 
agreement with the literature, during vegetative growth (16 h) only meso-DAP was 
identified, while spore samples exclusively contained LL-DAP. Interestingly, K. se-
tae cell walls contained a major amount of LL-DAP in 42 h samples and apparently 
exclusively LL-DAP was found in 64 h samples. For K. viridifaciens, this effect was 
less pronounced, but mycelia that had grown for 64 h had a DAP profile that is highly 
similar to that of spores. This suggests that after 64h, a large part of the vegetative 
mycelium has been used as a substrate for the aerial mycelium. The ssgB deletion 
mutant of K. viridifaciens carried mostly meso-DAP after 64 h of growth, with trace 
amounts of LL-DAP, suggesting that aerial hyphae are modified before the point of 
sporulation (Figure S2). 
Peptidoglycan analysis 
Cell wall material of K. setae and K. viridifaciens was isolated from the same sam-
ples as the DAP isolation, from both K. setae and K. viridifaciens after 16 h, 30 h , 42 
h, and 64 h of growth. Spores were filtered through cotton wool, mycelium from the 
ssgB-mutant of K. viridifaciens was harvested at 64 h. PG was isolated as described 
previously (van der Aart et al., 2018). Most muropeptides found in the profiles of 
K. setae and K. viridifaciens have previously been described for S. coelicolor. The 
basal structure of the muropeptides is a glycan backbone consisting of GlcNAc and 
MurNAc, where a pentapeptide chain is attached to MurNac consisting of L-Ala-D-
Glu-meso/LL-DAP-D-Ala-D-Ala with Gly attached to the DAP residue. Cross-links 
can be formed via the DAP-linked Gly, which then connects to the opposite D-Ala in 
the case of a 3-4 cross-link or DAP in the case of a 3-3 cross-link. 
Modifications to monomers 
After 16 h of growth, the PG from both Kitasatospora species contained only me-
so-DAP. From 30 h onwards, their PG contained minor amounts of LL-DAP, which 
is seen in the muropeptide profile where double peaks started to appear. The major 
switch from meso-DAP to LL-DAP occurred with a switch in PG modification, where-
by both species of Kitasatospora showed major changes in cell wall composition at 
the time of sporulation. Modification to the PG structure involve: peptidolytic cleavage 
of amino acids to generate tetra-, tri-, di- or monopeptides, loss of Gly, amidation of 
Glu to glutamine (Gln) (Figueiredo et al., 2012), and amidation of DAP (Levefaudes 
et al., 2015). Modifications to the glycan strand include de-acetylation of MurNAc to 
MurN, as often seen in older mycelia and spores of Streptomyces and amidation of 
the glycan strands whereby MurNAc-GlcNAc is cleaved off, to give a dimer with a 
single set of glycans (van der Aart et al., 2018) (Vollmer, 2008). 
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Table 1. Relative abundance(%)b of muropeptides from K. setae. 
Muropeptidea K. setae
Monomers 16h 30h 42h 64h spores
Mono 2.1 2.3  2.4  0.2  0.0  
Di 24.5  27.7  27.4  28.8  22.6  
Tri 6.0  9.1  6.8  6.2  8.2  
Tri (-Gly) 9.8  10.9  13.0  10.4  5.3  
Tetra 5.7  7.4  12.8  27.5  51.2  
Tetra (-Gly) 37.2  34.3  30.9  21.3  7.3  
Penta 0.4  0.2  0.4  1.2  2.5  
Penta (-Gly) 13.9  7.9  6.1  3.5  0.5  
Penta [Gly5] 0.4  0.2  0.2  0.9  2.3  
Deacetylation 0.3  0.8  1.2  1.0  0.9  
K. setae
Dimers 16h 30h 42h 64h spores
TriTri [deAc/deAc] 13.7  11.9  15.5  5.3  1.3  
TriTri (-GM/ -Gly) 4.0  6.0  3.9  1.6  2.1  
TriTri (-GM) [deAc] 12.1  22.6  21.2  10.0  1.8  
TriTetra 0.0  0.0  0.0  3.6  6.5  
TriTetra [deAc] 23.0  11.3  11.6  4.6  0.3  
TriTetra (-GM) 1.8  0.1  1.3  6.6  16.5  
TriTetra (-GM) [deAc] 34.1  32.2  25.6  12.4  0.4  
TriTetra (-GM) (-Gly) 3.7  6.5  4.7  2.8  1.8  
TetraTetra 0.5  0.5  2.7  17.8  25.5  
TetraTetra [deAc] [Gly4] 3.9  1.3  0.6  0.1  0.0  
TetraTeta [Gly4] 2.6  6.8  7.1  18.1  7.7  
TetraTetra (-GM) 0.5  0.8  5.8  17.0  38.1  
Deacetylation 86.8  79.3  74.6  32.5  3.8  
missing MurNAcGlcNAc 56.2  68.2  62.5  50.5  60.7  
3-3 cross-links 92.4  90.7  83.8  47.1  28.8  
a The labels correspond to the labels in Figure 2. (-Gly) misses the DAP-linked Gly, [Gly4] 
or [Gly5] has Gly instead of the 4th or 5th D-Ala, [deAc] carries MurN instead of MurNAc, (-G) 
lacks GlcNAc, (-GM) lacks GlcNAcMurNAc. Monomers and dimers are treated as separate 
datasets.
bRelative abundance is calculated as the ratio of the peak area over the sum of all peak areas 
recognized in the chromatogram. 
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Figure 2. Separation of muropeptides from vegetative cells (top) and spores (bottom) 
of K. setae. Major peaks are labeled and correspond to the labels in Table 1. In vegetative 
PG, the major peaks are tetrapeptides lacking Gly, Tetra(-Gly), and pentapeptides lacking Gly, 
Penta(-Gly) with a high amount of de-acetylated, [deAc], dimers. In spore PG, the major peaks 
are tetrapeptides (Tetra) and TetraTetra dimers lacking GlcNac-MurNAc, TetraTetra(-GM). The 
x-axis shows the retention time in minutes, the y-axis the base peak intensity in arbitrary units. 
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Table 2. Relative abundance(%)b of muropeptides from K. viridifaciens 
Muropeptides a K. viridifaciens
Monomers 16h 30h 42h 64h spores ΔssgB
Mono 1.4  1.3  1.8  1.8  2.3  0.5  
Di [deAc] 0.1  0.2  0.3  0.3  0.2  0.1  
Di 8.4  11.6  14.6  13.7  7.5  8.5  
Tri (-Gly) 1.0  0.9  1.1  0.9  0.7  0.5  
Tri [NH2] 0.2  1.1  1.1  9.4  39.9  6.1  
Tri-X 0.3  2.4  0.1  0.6  0.1  14.1  
Tri (-G) [deAc] 0.4  0.6  0.7  1.5  2.4  0.6  
Tri 31.6  27.3  31.7  24.2  17.3  16.9  
Tetra (-Gly) 0.8  0.7  0.7  0.9  0.7  0.4  
Tetra [Gly4] 2.2  0.9  0.8  0.8  0.5  0.4  
Tetra-X 0.2  2.6  0.1  0.5  0.3  14.8  
Tetra 29.5  31.3  28.9  31.5  22.8  17.8  
Penta [Gly5] 3.1  1.6  1.6  1.3  1.0  0.7  
Penta -X 0.2  1.4  0.1  0.3  0.1  8.9  
Penta 20.6  16.2  16.9  12.7  4.2  9.6  
Deacetylation 0.4  0.8  1.0  1.8  2.7  0.7  
amidation DAP 0.2  1.1  1.1  9.4  39.9  6.1  
Modification ‘X’c 0.8  6.4  0.2  1.4  0.5  37.8  
K. viridifaciens
Dimers 16h 30h 42h 64h spores ΔssgB
TriTri 1.4  1.2  2.9  1.1  3.4  1.5  
TriTri (-GM) 6.1  4.6  8.1  6.3  3.2  7.8  
TriTetra 35.1  33.0  31.5  31.5  45.0  25.5  
TriTetra (-GM) (-Gly) 2.8  3.2  3.3  2.3  0.7  2.5  
TriTetra (-GM) 5.5  16.4  16.0  15.0  8.0  22.4  
TetraTetra 19.9  18.1  18.3  20.4  13.7  12.9  
TetraTetra [Gly] 1.2  3.0  0.5  1.3  12.9  2.3  
TetraTetra (-GM) 16.6  11.9  7.4  10.5  7.3  15.7  
TetraPenta 9.7  6.1  9.6  8.8  2.9  7.9  
missing MurNAcGlcNAc 31.0  36.1  34.9  34.0  19.3  48.4  
 3-3 cross links 50.9  58.4  61.9  56.1  55.8  56.5  
a The labels correspond to the labels in Figure 3. (-Gly) misses the DAP-linked Gly, [Gly4] 
or [Gly5] has Gly instead of the 4th or 5th D-Ala, [deAc] carries MurN instead of MurNAc, (-G) 
lacks GlcNAc, (-GM) lacks GlcNAcMurNAc.
bRelative abundance is calculated as the ratio of the peak area over the sum of all peak areas 
recognized in the chromatogram. 
c The molecular mass assumed with ‘-X’ is 2.01 Da. 
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Figure 3. separation of muropeptides from K. viridifaciens vegetative mycelium (top), 
spores (middle) and the ∆ssgB deletion mutant (bottom). Major peaks are labeled and 
correspond to the labels in Table 2. Major peaks in vegetative mycelium are tripeptides, tetra-
peptides and pentapeptides, Tri, Tetra and Penta. In spores, the major peaks are tripeptides 
with amidated DAP, Tri [NH2] Tetra and the dimer consisting of a tetrapeptide and tripeptide, 
TetraTri. The muropeptide profile of the ssgB deletion mutant shows major amounts of muro-
peptides with modification ‘X’. The x-axis shows the retention time in minutes, the y-axis the 
base peak intensity in arbitrary units.
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In K. setae, the primary modifications in vegetative cells are the loss of the DAP-
bound Gly and the de-acetylation of MurNAc, giving MurN, as shown in Figure 2 and 
Table 1. The major muropeptides seen in vegetative cells after 16 h of growth were 
tetrapeptides lacking Gly (Tetra (-Gly)) and dipeptides (Di), making up 37.2% and 
24.5% of the total monomer content, respectively. This switches to tetrapeptides with 
Gly (tetra) and dipeptides (Di) at 51.2% and 22.6% of the monomers in spores. The 
amount of pentapeptides (-Gly) is higher in vegetative cells (14.5% of monomers) 
than in spores (3% of monomers).
The PG profile of K. viridifaciens is shown in Figure 3 and Table 2. The main dif-
ference between vegetative cells and spores was the amidation of DAP in spores. 
Vegetative hyphae of K. viridifaciens grown for 16 h had large amounts of tri-, tetra- 
and pentapeptides, 31.6%, 29.5% and 20.6% of the total content, respectively. In 
spores, this changed to tripeptides with an amidated DAP (Tri [NH2]) and tetrapep-
tides (tetra), making up 39.9% and 22.8% of the total, respectively. The total mono-
mer fraction with an amidated DAP was 40% in spores, whereas this modification 
was present only in trace amounts in vegetative mycelia (0.2 and 1.1% after 16 and 
42 h, respectively). After 64 h, 9.4% of the muropeptides carried an amidated DAP, 
consistent with the formation of spores. Spore monomers carry a low amount of 
de-acetylated monomers, though a specific muropeptide contributed to this amount, 
MurN-tripeptides as have been found in S. coelicolor, mostly as LL-DAP (1.9% LL-
DAP, 0.5% meso-DAP). 
Modifications to dimers 
Dimers are cross-linked via the DAP-bound Gly and, like in Streptomyces, Ki-
tasatospora PG contains both 3-3 and 3-4 cross-links. Penicillin Binding Proteins 
(PBPs) recognize a pentapeptide as a donor strand, catalyze the cross-link of an 
DAP-bound Gly to D-Ala(4) on the opposite strand and cleave off the terminal D-Ala 
from the pentapeptide donor strand. L,D-transpeptidases recognize tetrapeptides 
and catalyze a cross-link between DAP-bound Gly and DAP, this way generating 
a 3-3 cross-link, and finally remove the terminal D-Ala from the tetrapeptide donor 
strand. TetraTetra dimers are cross-linked by a 3-4 cross-link, while TriTri dimers 
are cross-linked by a 3-3 cross-link. However, TetraTri dimers can be cross-linked 
by either 3-3 or 3-4 bonds; these two isomers have the same mass but they can be 
discriminated based on the difference in retention times. The cross-linking pattern 
was resolved by MS/MS (data not shown). In addition, cleavage of the glycan strand 
at the lactyl bond between MurNAc and L-Ala will give rise to dimers lacking one set 
of glycans.
Analysis of the PG dimers of K. setae showed that deacetylation of the glycan 
strands occurred mostly in vegetative cells (86.8% at 16 h) and far less frequently 
in spores (3.8%). In vegetative cells, both dimers with a double and a single set of 
glycans shows de-acetylated MurNAc, where 80% of the TetraTetra dimers lacking a 
set of glycans still caries MurN, suggesting that amidases are more likely to cleave 
off the dimers containing MurNAc than those containing MurN. Conversely, K. setae 
has an exceptionally high amount of dimers that have lost a set of glycans, repre-
senting 56-68% of the dimers throughout growth. The amount of 3-3 cross-links is 
higher in vegetative mycelium than in spores, at 92.4% at 16 h, 90.7 % at 30 h, 83.8 
at 42 h, 47.1 at 64 h and 28.8% in spores. The PG dimers of K. viridifaciens had 
undergone less extensive hydrolysis as compared to those of K. setae, whereby 
31-36% of the dimers of 16-64 h old cultures lacked a set of glycans, compared to 
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50-68% in K. setae. The amount of 3-3 cross-links in K. viridifaciens was relatively 
stable over time, between 50 and 62%. 
Figure 4. MS/MS fragmentations of (A), a tripeptide (Tri), which has a m/z of 927.41, (B) a 
tripeptide with an amidated DAP (Tri [NH2]) , with an m/z of 926.43, and (C) a tripeptide with a 
‘X’ modification (Tri [-X]) with an m/z of 925.40. The base structure shows the major fragment 
masses, which are given in bold in the mass spectrum. 
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Transition from mycelium to spores
The ssgB deletion mutant of K. viridifaciens forms normal vegetative and aerial 
mycelia but does not form spores. Studying this mutant therefore allows us to ob-
serve modifications specific for older aerial mycelia even after prolongued incuba-
tion, without having to take spores into account. Interestingly, the muropeptide profile 
of the ssgB null mutant contained many muropeptides with an unknown modifica-
tion, here named ‘X’. Canonical tripeptides have a mass of (M+H) 927.41, while the 
Tri [-X] peptides from ssgB mutants had a mass of (M+H) 925.40. Therefore, the 
‘X’ modification represents a 2.01 Da mass reduction as compared to other muro-
peptides. This suggests that a double bond is present in the Tri [-X] while the bond 
is reduced in canonical tripeptides. After recognizing this modification in the ssgB 
mutant, we revisited the PG profiles of K. viridifaciens and scrutiny of these samples 
also identified minor amounts of modification ‘X’ in 30 h old samples, namely 5.7% of 
the monomers. Suggestively, this is the moment the strain has produced aerial hy-
phae but does not yet form spores. Modification ‘X’ most likely occurs at the MurNAc 
moiety, as MS/MS analysis showed the initial loss of GlcNAc, and this still showed 
the mass difference, while the mass difference was resolved at the pentapeptide 




Kitasatosporae are characterized by the striking difference in stereochemistry of 
DAP between vegetative and spore PG (Takahashi, 2017). We show that besides 
the DAP stereochemistry, the entire PG composition changes between these two 
growth phases in their life cycle. Despite the similarity in their life cycles, this has 
not been seen in Streptomyces (van der Aart et al., 2018). Vegetative mycelia of 
K. setae lack the DAP-bound Gly and has heavily de-acetylated MurNAc, whereas 
spore PG carries the DAP-bound Gly and shows less de-acetylation. K. viridifaciens 
vegetative mycelium carries no modifications, whereas spores carry N-deacetylated 
MurN lacking GlcNAc, called MurN-Tri, and a large amount of amidated DAP. The 
amidation of DAP in K. viridifaciens occurs mostly in the spore wall, where 40% 
of all monomers carry an amidated version of DAP, in contrast to 0.2% in the 16 h 
old vegetative mycelium. Interestingly, 6.1% of the DAP residues in the cell wall of 
the non-sporulating ssgB mutant was amidated. Amidation of DAP contributes to 
lysozyme resistance by slightly decreasing the negative charge of the PG, that way 
reducing affinity of the positively charged lysozyme (Levefaudes et al., 2015). How-
ever, this modification was not found in K. setae, and is therefore not a trait that is 
typical of all members of the genus kitasatospora. 
PG cross-linking is performed by two different types of proteins, penicillin bind-
ing proteins (PBPs) and L, D-transpeptidases (LDTs). PBPs produce canonical 3-4 
cross-links between the DAP-bound Gly and the 4th amino acid of the next strand, 
D-Ala. LDTs produce 3-3 cross-links between the DAP-bound Gly and the 3rd amino 
acid of the next strand, DAP. Tip growing bacteria have a relatively high amount of 
3-3 cross-links due to the remodeling of the lateral wall by LDTs (Baranowski et al., 
2018). We have shown that in Kitasatospora the cross-linking is similar as in Strep-
tomyces, as was apparent from the MS/MS patterns. In K. setae, the amount of 3-3 
cross-links is high in vegetative (92% at 16 h) and lower during sporulation (47% at 
64 h) and in spore preparations (29%). In K. setae and in S. coelicolor the proportion 
of 3-3 cross-links is higher in vegetative mycelium than in spores, which makes a 
correlation to specific DAP-isomers unlikely. In K. viridifaciens, the amount of 3-3 
cross-links remained stable throughout growth at 50-62%, in contrast to what was 
observed for the PG of K. setae, where the amount of 3-3 cross-links was growth 
phase-dependent. The high amount of dimers lacking a set of glycans in K. setae 
is striking, as this type of dimer does not contribute to strengthening the PG struc-
ture (Vollmer et al., 2008). Even of the dimers found in spores 61% lacked glycans, 
whereby a TetraTetra dimer lacking GlcNAc-MurNAc (TetraTetra(-GM)) prevailed 
(38.1%). In K. viridifaciens, the amount of dimers lacking glycans was lower, namely 
31%- 36% in vegetative mycelium and 19.3% in spores. 
The cell wall of the ssgB null mutant of K. viridifaciens showed a mass that could 
not be explained, and may therefore represent a unique modification. Ms/Ms anbal-
ysis showed that the loss of 2.01 Da took place at the MurNac moiety, and could be 
accounted for by formaitn of a double bond and hence loss of two hydrogens, such 
as in non-reduced MurNAc. The modification is highly abundant in the peptidoglycan 
of the ssgB mutant, but also occurred in small amounts over the course of growth, 
especially after 30 h of growth, coinciding with the onset of aerial mycelium forma-
tion by K. viridifaciens. This is precisely the stage where ssgB mutants are blocked 
in development, and we may therefore see the consequence of a specific cell-cycle 
arrest. Modification “X” may be part of a hydrolytic event. Peptidoglycan amidases 
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recognize tri-, tetra- and pentapeptides and targets the site between MurNac and 
L-Ala, then the muropeptide is cleaved between the MurNAc-associated D-Lac and 
L-Ala (Rocaboy et al., 2013; Wang et al., 2003). The exact nature of the ‘-X’ modifi-
cation requires further investigation. 
Figure 5. summary of muropeptides found in K. setae and K. viridifaciens vege-
tative mycelium and spores. Vegetative mycelium of K. setae shows muropeptides with 
Meso-DAP, lacking Gly (-Gly) and with de-Acetylated MurNAc [deAc], spore cell walls carry 
muropeptides with LL-DAP, Gly and less deacetylation. K. viridifaciens carries Meso-DAP in 
vegetative mycelium, in transition phase, modification X occurs at the site of MurNAc. Spore 
mycelium shows LL-DAP and amidated DAP [NH2]. In all life stages, some dimers lack a set 
of glycans (-GM).
Cell wall construction
DapF is responsible for the isomerization of LL-DAP into meso-DAP, while K. 
setae has 3 copies of this gene, other species of Kitasatospora have a single copy 
(Girard et al., 2014). Streptomyces species, which only have LL-DAP, also carry 
DapF but meso-DAP can be an intermediate in the production of Lysine. During the 
process of cell wall construction, the well-conserved MurE adds LL- or meso-DAP to 
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UDP-MurNac-L-Ala-D-Glu (Smith, 2006). The only other bacterium that carries both 
LL- and meso-DAP, the Gram-negative Myxococcus xanthus, has a single version 
of MurE (Bui et al., 2009). Kitasatosporae apparently carry two versions of MurE, 
one of which is encoded by a gene in the dcw (division of cell wall) cluster and one 
by a gene elsewhere on the genome. It needs to be analyzed whether the second 
MurE paralogue is functional and if so, whether it has similar bioactivity as the ca-
nonical MurE. In any case, the murE genes of Kitasatosporae (LL- and meso-DAP) 
are placed in a separate clade from Streptomyces (LL-DAP) and Mycobacterium 
(meso-DAP), suggesting that the canonical MurE could be adapted to ligate both 
LL- and meso-DAP (Hwang et al., 2015). 
Implications for taxonomy
The switch from incorporation of meso-DAP to incorporating LL-DAP in the PG 
allows us to recognize the difference between these different types of mycelia, which 
is more elusive in Streptomyces. Notably, Kitasatosporae appear to hydrolyze most 
of the mycelia with meso-DAP at the switch to spore formation, and although the 
concept of programmed cell death is not novel, the hydrolysis of practically all PG 
with meso-DAP comes as a surprise. After 64 h, the cell wall of both Kitasatospo-
rae mostly contains LL-DAP, indicating that extensive hydrolysis of the vegetative 
mycelium has taken place. This implies that if chemotaxonomy is performed on old-
er cultures of Kitasatosporae, the data could be confused with those obtained for 
Streptomyces. Previous amino acid composition analyses had already shown that 
K. setae carries very little glycine in the vegetative mycelium, but an equal amount 
of Gly per DAP in spores (Takahashi et al., 1999). However, this shift in the amount 
of Gly is not specific for Kitasatosporae, as K. viridifaciens has equal amounts of Gly 
per DAP throughout its life cycle. 
In summary, our data show that Kitasatosporae have different modifications in 
vegetative mycelium and in spores, besides just the switch from meso-DAP to LL-
DAP. This switch requires different modifying and hydrolyzing proteins and empha-
sizes that tip growth and sporulation are regulated by two different systems. Myce-
lium of the ssgB contained a yet unidentified modification, which suggests loss of 
2.01 Da in the MurNAc moiety. The presence of only trace amounts of LL-DAP in this 
mutant indicates that the DAP stereochemistry of the Kitasatospora cell wall chang-
es at a time prior to the onset of septation. It is difficult to say whether the difference 
in stereochemistry is a consequence or a cause of the switch in regulation between 
vegetative- and reproductive growth. 
Acknowledgements





Appendix 1. Supplemental information belonging to Chapter 4 
Figure S1. Development of K. setae and K. viridifaciens grown on SFM agar plates. 
After 42 h, K. setae had developed white spores, as seen with an impression print, while K. 
viridifaciens developed white aerial mycelium at 42 h and grey spores after 64 h. The ssgB 
mutant of K. viridifaciens only formed aerial hyphae and did not develop spores. 
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Figure S2. DAP analysis of K.setae and K.viridifaciens over growth. At 16 h, both 
strains only carry meso-DAP in the PG, after 42 hours this shifts to LL-DAP. At 64 h both 
strains carry mostly LL-DAP. The ssgB-mutant consists mostly of meso-DAP but has trace 
amounts of LL-DAP. 
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Table S1. Muropeptides identified in K. setae peptidoglycan
Monomers Observed mass K. setae
[M+H] rt 16 h 30 h 42 h 64 h spores
Mono 570.25 4.68 2.1% 2.3% 2.4% 0.2% 0.0%
Di [deAc] 656.30 4.08 0.3% 0.8% 1.2% 1.0% 0.9%
Di 698.31 4.54 20.2% 22.5% 21.6% 22.9% 17.5%
Di [Glu] 699.30 4.99 4.0% 4.4% 4.6% 4.9% 4.2%
Tri (-Gly) 870.40 4.02 8.5% 9.5% 10.9% 8.9% 4.7%
Tri (-Gly) [Glu] 871.38 4.29 1.3% 1.4% 2.1% 1.5% 0.6%
Tri 927.42 4.28 5.1% 7.6% 4.2% 2.5% 0.0%
Tri 927.42 4.52 0.0% 0.3% 1.5% 3.0% 6.2%
Tri [Glu] 928.40 4.76 0.0% 0.0% 0.1% 0.3% 0.7%
Tri [Glu] 928.40 4.51 0.9% 1.2% 0.7% 0.0% 0.0%
Tetra (-Gly) 941.43 4.67 32.8% 28.4% 25.1% 17.8% 6.4%
Tetra (-Gly) [Glu] 942.42 4.92 4.4% 5.9% 5.8% 3.6% 0.9%
Tetra 998.46 4.53 3.5% 3.2% 2.0% 0.0% 0.0%
Tetra 998.46 4.97 0.7% 3.2% 8.8% 23.4% 44.0%
Tetra [Glu] 999.44 4.76 0.7% 0.4% 0.0% 0.0% 0.0%
Tetra [Glu] 999.44 5.19 0.7% 0.6% 2.1% 4.1% 7.2%
Penta [deAc] 1012.47 4.95 13.8% 6.7% 5.2% 3.0% 0.4%
Penta [Glu/ deAc] 1013.46 5.21 0.1% 1.1% 0.9% 0.5% 0.1%
Penta [Gly5] 1055.48 4.78 0.1% 0.1% 0.1% 0.9% 2.2%
Penta [Gly5] 1055.48 4.29 0.0% 0.1% 0.1% 0.0% 0.0%
Penta [Glu /Gly5] 1056.46 4.61 0.3% 0.0% 0.0% 0.0% 0.0%
Penta 1069.49 5.18 0.0% 0.2% 0.4% 1.1% 2.2%
Penta [Glu] 1070.48 5.44 0.3% 0.0% 0.1% 0.1% 0.3%
Dimers
[M+H] rt 16 h 30 h 42 h 64 h spores
TriTri (-GM /-Gly) 1298.60 4.59 2.1% 4.0% 1.7% 1.1% 1.8%
TriTri (-GM /-Gly) [Glu] 1299.60 4.60 1.9% 2.0% 2.2% 0.6% 0.3%
GnacMN-tritri 1313.60 5.06 1.8% 4.2% 3.7% 1.9% 0.6%
GnacMN-tritri 1313.60 5.61 3.7% 8.9% 7.8% 3.1% 0.5%
GnacMN-tritri 1314.60 5.60 1.8% 0.7% 3.3% 2.2% 0.4%
GnacMN-tritri 1314.62 4.91 4.8% 8.9% 6.4% 2.8% 0.4%
TetraTri (-GM) (-Gly) 1369.64 4.63 1.9% 5.8% 2.9% 1.9% 0.9%
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TetraTri (-GM) (-Gly) 1370.63 4.80 1.8% 0.7% 1.8% 0.9% 0.8%
GMN-TetraTri 1383.65 5.08 27.3% 26.0% 20.0% 9.8% 0.4%
GMN-TetraTri 1384.64 5.27 6.8% 6.2% 5.6% 2.6% 0.0%
TetraTri (-GM) 1426.66 5.01 0.0% 0.1% 0.5% 4.9% 12.0%
TetraTri (-GM) [Glu] 1427.66 4.95 1.8% 0.0% 0.7% 1.7% 2.5%
TetraTri (-GM) [Glu,-
Glu] 1497.68 4.97 0.0% 0.0% 0.0% 0.0% 2.0%
GM-tetratetra 1497.70 5.32 0.3% 0.6% 3.2% 15.5% 30.8%
GM-tetratetra 1498.68 5.48 0.2% 0.2% 2.6% 1.5% 5.2%
TriTri [deAc,deAc] 
(3-3) 1792.81 5.94 8.6% 8.3% 7.0% 2.3% 0.7%
TriTri [deAc,deAc] 
(3-3) 1793.80 6.13 2.5% 0.5% 5.3% 2.1% 0.4%
TriTri [deAc,deAc] 
(3-3) 1794.82 5.92 2.5% 3.0% 3.2% 0.9% 0.3%
TetraTri [deAc] (3-3) 1863.85 6.18 22.2% 9.5% 5.9% 1.8% 0.1%
GnacMN-tritetraGM 
(3-3) 1864.84 6.41 0.8% 1.8% 5.7% 2.8% 0.1%
GnacMnac-AEm(G)
A-(G)mEA-GM 1906.86 6.08 0.0% 0.0% 0.0% 1.8% 3.9%
GnacMnac-AEm(G)
A-(G)mEA-GM 1906.86 6.02 0.0% 0.0% 0.0% 0.5% 0.7%
GM-tri-tetra-MG 1907.84 6.25 0.0% 0.0% 0.0% 0.1% 0.2%
GM-tri-tetra-MG 1907.86 6.03 0.0% 0.0% 0.0% 1.2% 1.7%
TetraTetra [Gly4 / 
deAc] 1934.89 6.31 3.9% 1.3% 0.6% 0.1% 0.0%
TetraTetra [Gly4 / Glu] 1964.76 4.54 0.8% 2.1% 4.4% 3.7% 2.2%
TetraTetra [Gly4 / Glu] 1964.76 4.96 1.3% 2.3% 0.8% 5.5% 4.9%
TetraTetra [Gly4 / Glu] 1964.76 6.08 0.3% 1.2% 0.8% 3.7% 0.3%
TetraTetra [Gly4 / Glu] 1964.78 6.41 0.3% 1.2% 1.2% 5.2% 0.3%
GM-tetra-tetra-MG 1977.90 6.50 0.2% 0.3% 1.2% 5.4% 11.1%
GM-tetra-tetra-MG 1978.88 6.76 0.2% 0.1% 0.7% 6.1% 2.7%
GM-tetra-tetra-MG 1978.90 6.49 0.2% 0.1% 0.7% 6.3% 11.4%
GM-tetra-tetra-MG 1979.39 6.50 0.0% 0.0% 0.0% 0.0% 0.3%
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Table S2. Muropeptides identified in K. viridifaciens peptidoglycan
Monomers observed mass K. viridifaciens
m/z ID [M+H] rt (min) 16 h 30 h 42 h 64 h spores ∆ssgB
570.25 Mono 570.25 4.67 1.4% 1.3% 1.8% 1.8% 2.3% 0.5%
656.30 Di [deAc] 656.30 4.07 0.1% 0.2% 0.3% 0.3% 0.2% 0.1%
682.27 Tri [deAc] (-G) 682.27 4.99 0.0% 0.0% 0.1% 1.0% 1.9% 0.0%
682.30 Tri [deAc] (-G) 682.30 4.58 0.4% 0.6% 0.6% 0.5% 0.5% 0.6%
698.31 Di 698.31 4.52 7.0% 10.1% 12.3% 11.5% 6.3% 7.3%
699.30 Di [Glu] 699.30 4.98 1.4% 1.3% 2.0% 1.9% 0.9% 1.1%
724.34 Tri (-G) 724.34 4.49 2.1% 1.9% 2.1% 1.6% 0.7% 1.1%
725.32 Tri (-G) [Glu] 725.32 4.71 0.3% 0.1% 0.2% 0.2% 0.0% 0.1%
781.36 Tetra (-G) [Gly4] 781.36 4.55 0.1% 0.1% 0.0% 0.0% 0.0% 0.0%
795.38 Tetra (-G) 795.38 4.95 1.7% 2.0% 1.8% 2.1% 1.4% 1.2%
796.36 Tetra (-G) [Glu] 796.36 5.18 0.2% 0.1% 0.2% 0.2% 0.1% 0.1%
870.40 Tri (-Gly) 870.40 4.02 0.9% 0.9% 1.0% 0.9% 0.7% 0.5%
871.38 Tri (-Gly) [Glu] 871.38 4.28 0.1% 0.1% 0.1% 0.1% 0.1% 0.0%
925.40 Tri-X 925.40 4.72 0.1% 0.7% 0.0% 0.2% 0.1% 3.8%
925.40 Tri-X 925.40 5.17 0.2% 1.7% 0.0% 0.4% 0.1% 10.3%
926.43 Tri [NH2] 926.43 3.63 0.0% 0.0% 0.0% 0.4% 9.9% 2.7%
926.43 Tri [NH2] 926.43 4.12 0.2% 1.1% 1.1% 9.0% 30.1% 3.4%
927.42 Tri 927.42 4.39 0.0% 0.0% 0.0% 0.0% 5.0% 0.0%
927.42 Tri 927.42 4.50 25.0% 22.8% 26.2% 19.9% 10.2% 13.9%
928.40 Tri [Glu] 928.40 4.71 4.2% 2.4% 3.2% 2.5% 1.4% 1.8%
941.43 Tetra (-Gly) 941.43 4.67 0.8% 0.7% 0.7% 0.9% 0.7% 0.4%
984.44 Tetra [Gly4] 984.44 4.55 1.9% 0.9% 0.7% 0.7% 0.5% 0.4%
985.42 Tetra [Glu/Gly4] 985.42 4.75 0.2% 0.0% 0.0% 0.0% 0.1% 0.0%
996.44 Tetra -X 996.44 5.22 0.0% 0.6% 0.0% 0.0% 0.0% 3.8%
996.44 Tetra -X 996.44 5.69 0.2% 1.4% 0.0% 0.4% 0.2% 8.3%
997.43 Tetra [Glu/ -X] 997.43 5.89 0.0% 0.3% 0.0% 0.1% 0.0% 2.0%
997.43 Tetra [Glu / -X] 997.43 5.39 0.0% 0.3% 0.0% 0.0% 0.0% 0.8%
998.46 Tetra 998.46 4.95 23.4% 26.0% 24.2% 25.9% 18.6% 14.6%
999.44 Tetra [Glu] 999.44 5.18 4.1% 3.1% 2.7% 3.4% 2.7% 2.0%
1055.48 Penta [Gly5] 1055.48 4.76 2.7% 1.5% 1.4% 1.2% 1.0% 0.6%
1056.46 Penta [Glu /Gly5] 1056.46 4.98 0.4% 0.1% 0.1% 0.1% 0.0% 0.0%
1067.48 Penta -X 1067.48 5.87 0.1% 0.4% 0.0% 0.2% 0.0% 5.2%
1067.48 Penta -X 1067.48 5.33 0.1% 0.9% 0.0% 0.0% 0.0% 2.0%
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1068.46 Penta [Glu / -X] 1068.46 6.18 0.0% 0.1% 0.0% 0.0% 0.0% 1.2%
1068.46 Penta [Glu / -X] 1068.46 5.62 0.0% 0.0% 0.0% 0.0% 0.0% 0.5%
1069.49 Penta 1069.49 5.14 17.5% 14.5% 14.9% 11.2% 3.7% 8.4%
1070.48 Penta [Glu] 1070.48 5.41 3.2% 1.8% 2.0% 1.5% 0.5% 1.3%
Dimers Dimers
m/z ID [M+H] rt(min) 16 h 30 h 42 h 64 h spores ∆ssgB
1298.60 TriTri (-GM /-Gly) 1298.60 5.07 2.9% 1.2% 2.9% 2.1% 2.0% 0.9%
1355.62 TriTri (-GM) 1355.62 4.60 3.2% 3.4% 5.2% 4.2% 1.2% 6.9%
1369.64
TetraTri (-GM) 
(-Gly) 1369.64 5.25 2.8% 3.2% 3.3% 2.3% 0.7% 2.5%
1426.66 TetraTri (-GM) 1426.66 4.93 5.5% 16.4% 16.0% 15.0% 8.0% 22.4%
1497.70 TetraTetra (-GM) 1497.70 5.30 5.0% 5.2% 4.4% 6.8% 3.9% 4.7%
1498.68
TetraTetra (-GM) 
[Glu] 1498.68 6.18 7.8% 4.5% 2.5% 3.1% 2.5% 8.5%
1499.68
TetraTetra (-GM) 
[Glu/Glu] 1499.68 6.16 3.7% 2.2% 0.6% 0.6% 0.9% 2.4%
1835.82 TriTri (3-3) 1835.82 5.62 1.4% 1.2% 2.9% 1.1% 3.4% 1.5%
1904.84 TetraTri [-X] 1904.84 6.62 0.0% 0.0% 0.0% 0.0% 0.0% 3.2%
1906.87 TetraTri (3-4) 1906.87 5.42 0.0% 0.0% 0.0% 0.0% 4.5% 0.0%
1906.87 TetraTri (3-3) 1906.87 5.63 0.7% 0.9% 0.4% 2.9% 20.1% 0.0%
1906.86 TetraTri (3-3) 1906.86 5.83 0.0% 0.0% 0.0% 0.0% 3.4% 0.0%
1906.86 TetraTri (3-3) 1906.86 6.04 17.4% 17.0% 16.3% 14.6% 9.4% 11.7%
1907.86
TetraTri [Glu] 
(3-3) 1907.86 6.03 17.0% 15.0% 14.8% 14.0% 7.6% 10.6%
1907.84
TetraTri [Glu] 
(3-4) 1907.84 6.25 1.9% 2.5% 2.3% 3.0% 2.8% 1.5%
1964.75 TetraTetra[Gly4] 1964.75 5.15 1.2% 3.0% 0.5% 1.3% 12.9% 2.3%
1977.89 TetraTetra 1977.89 6.45 8.6% 9.2% 9.1% 10.2% 8.8% 6.6%
1978.90 TetraTetra [Glu] 1978.90 6.37 11.2% 9.0% 9.2% 10.2% 4.9% 6.3%
2048.93 PentaTetra 2048.93 6.63 5.3% 2.3% 4.3% 3.4% 1.7% 3.8%




The amino acid composition in the cell wall of K.setae was previously assessed 
to be: 
Cell type DAP Ala Glu Gly
Aerial spores 1.0 (LL) 1.6 0.5 1.0
Vegetative mycelium 1.0 (meso) 1.6 0.7 0.2
Amino acid composition in the cell walls of K.setae (Molar ratio). Table adapted from 
(Takahashi et al., 1999)

Substrate inhibition of 
VanA by D-alanine reduces 
vancomycin resistance in a 
VanX-dependent manner 
Lizah T. van der Aart, Nicole Lemmens, Willem J. van Wamel and Gilles P. van 
Wezel
Adapted from: Antimicrobal Agents and Chemotherapy (2016) 
vol. 60 no. 8 4930-4939




Substrate inhibition of VanA by D-alanine reduces vancomycin resistance in a VanX-de-
pendent manner 
ABSTRACT
The increasing resistance of clinical pathogens against the glycopeptide antibiotic 
vancomycin, a last resort drug against infections with Gram-positive pathogens, is 
a major problem in the nosocomial environment. Vancomycin inhibits peptidoglycan 
synthesis by binding to the D-Ala-D-Ala terminal dipeptide moiety of the cell-wall 
precursor Lipid II. Plasmid-transferable resistance is conferred by modification of 
the terminal dipeptide into the vancomycin-insensitive variant D-Ala-D-Lac which is 
produced by VanA. Here we show that exogenous D-Ala competes with D-Lac as a 
substrate for VanA, increasing the ratio of wild-type over mutant dipeptide, an effect 
that was augmented by several orders of magnitude in the absence of the D-Ala-D-
Ala peptidase VanX. LC-MS analysis showed that high concentrations of D-Ala led 
to the production of a significant amount of wild-type cell-wall precursors, while vanX 
null mutants produced primarily wild-type precursors. This enhanced the efficacy 
of vancomycin in the vancomycin-resistant model organism Streptomyces coelicol-
or, and the susceptibility of vancomycin-resistant clinical isolates of Enterococcus 
faecium (VRE) increased by up to 100-fold. The enhanced vancomycin sensitivity 
of S. coelicolor cells correlated directly to increased binding of the antibiotic to the 
cell wall. We isolated the VanX protein from E.faecium (VanB-type) and developed 
an assay with a fluorescent readout which can easily be adapted to a high through-
put system for a potential inhibitor screen. Our work offers new perspectivesfor the 
treatment of diseases associated with vancomycin-resistant pathogens and for the 




Infectious diseases caused by multi-drug-resistant (MDR) pathogens are spread-
ing rapidly and are among the biggest threats to human health (Arias & Murray, 
2009, Boucher et al., 2009, Laxminarayan et al., 2013, WHO, 2014). To deal with 
the increasing antibiotic resistance, novel antibiotics are called for, or alternatively 
the lifespan of the current drugs must be prolonged by compounds counteracting 
resistance. Exemplary is amoxillin-clavulanic acid (Augmentin), which is a combina-
tion of  a β-lactam antibiotic (amoxilin), and a β-lactamase inhibitor (clavulanic acid) 
(Reading & Cole, 1977). 
The cell wall and its biosynthetic machinery are a major target of the action of 
clinical antibiotics, including fosfomycin, bacitricin, cycloserine, β-lactam antibiotics 
(penicillins, cephalosporins) and glycopeptide antibiotics (vancomycin and teico-
planin) (Breukink & de Kruijff, 2006, Bugg et al., 2011, Silver, 2013). Enterococci 
and many other Gram-positive pathogenic bacteria are resistant to a wide spec-
trum of antibiotics and can often only be treated with specific β-lactam antibiotics 
or with vancomycin (Rice, 2001, Frieden et al., 1993, Bell et al., 1998). Vancomycin 
resistance was first discovered in the 1950s (Walsh et al., 1996). Vancomycin re-
sistance is exchanged between bacteria via movable elements such as transposon 
Tn1546, which is carried by many vancomycin-resistant enterococci (VRE) (Cour-
valin, 2006). The most common forms of transferable vancomycin resistance are 
the VanA- and VanB-type resistance, the expression of which is inducible by van-
comycin. VanA-type strains are resistant to high levels of vancomycin as well as 
to another glycopeptide antibiotic, teicoplanin, while VanB-type strains only show 
inducible resistance to vancomycin but retain susceptibility to teicoplanin (Aslangul 
et al., 1997). While vancomycin resistance is most prevalent in enterococci (Murray, 
2000), resistance has spread to methicillin-resistant Staphylococcus aureus (MRSA) 
(Howden et al., 2010). 
Vancomycin targets the cell wall and prevents cell growth by specifically binding 
to the D-alanyl-D-alanine (D-Ala-D-Ala) termini of the peptidoglycan (PG) precur-
sor Lipid II, prior to its incorporation (Reynolds, 1989, Fischer et al., 2013). The 
terminal D-Ala-D-Ala dipeptide is almost universally conserved in bacteria, the only 
exceptions being D-Ala-D-Lac or D-Alanyl-D-Serine in strains with either natural or 
acquired resistance to vancomycin (Vollmer et al., 2008a). The VanA-type vancomy-
cin resistance gene cluster in S. coelicolor consists of seven genes in four different 
operons: VanRS, VanJ, VanK and VanHAX that together mediate the substitution of 
the terminal D-alanine (D-Ala) by D-lactate (D-Lac), thereby decreasing the affinity of 
vancomycin for lipid II by three orders of magnitude (Walsh et al., 1996, Smith et al., 
1999). The vancomycin resistance gene cluster provides resistance to both vanco-
mycin and to teicoplanin and is located on the genome of the vancomycin producer 
Amycolatopsis mediterranei (Marshall et al., 1998, van Wageningen et al., 1998) as 
well as that of other actinomycetes, including the model species Streptomyces coe-
licolor A3(2) (Hong et al., 2004).
Streptomycetes are Gram-positive soil bacteria with a complex multicellular life 
style (Claessen et al., 2014, Flärdh & Buttner, 2009, Barka et al., 2016). Strepto-
mycetes are a major source of antibiotics and many other natural products of med-
ical and biotechnological importance, such as anticancer, antifungal or herbicidal 
compounds (Bérdy, 2005, Hopwood, 2007). Due to the competitive environment of 
the soil, these microorganisms readily exchange genetic material, including antibi-
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otic biosynthetic clusters and antibiotic resistance (Wiener et al., 1998, Allen et al., 
2010). S. coelicolor is a non-pathogenic and genetically tractable model system for 
vancomycin resistance, with a well-annotated genome (Bentley et al., 2002). The 
vancomycin resistance cluster of S. coelicolor consists of vanRS, a two-component 
regulatory system (TCS) consisting of sensory kinase VanS, and response regulator 
VanR that together ensure the transcription of the resistance genes in response to 
vancomycin challenge, and five resistance genes in the order vanJKHAX, with van-
HAX forming a single transcription unit. Vancomycin resistant enterococci classically 
carry vanRSHAX, the function of which is highly similar to that in S. coelicolor, with 
the gene products VanH, VanA, VanX sharing 61%, 63% and, 64% aa identity, re-
spectively, will the TCS components VanR and VanS share 31% and 25% aa identity, 
respectively (Hong et al., 2004, Reynolds et al., 1994). In response to vancomycin 
at the cell membrane, VanRS ensure the induction of the expression of vanHAX, 
and in the case of S.coelicolor also vanK and vanJ (Hutchings et al., 2006). VanH 
produces D-Lac from pyruvate (Bugg et al., 1991b), VanA is a D-alanyl-D-lactate 
(D-Ala-D-Lac) ligase (Wright & Walsh, 1992, Marshall et al., 1997), VanX hydroly-
ses the D-Ala-D-Ala dipeptide and has been the target of previous studies assess-
ing vancomycin sensitivity and resistance (Reynolds et al., 1994, Wu et al., 1995). 
VanX acts highly specific, it cleaves D-Ala-D-Ala, D-Ala-Gly, D-Ala-D-Ser, D-Ala-D-
Val and D-Ala-D-Asn, but does not cleave D-Ala-L-Ala, L-Ala-D-Ala, L-Ala-L-Ala or 
the tripeptide D-Ala-D-Ala-D-Ala (Wu et al., 1995). VanK attaches glycine to lipid 
II with D-Lac as the terminal residue (Hong et al., 2004, Hong et al., 2005). VanJ 
is not required for vancomycin resistance but is instead involved in the resistance 
to teicoplanin (Novotna et al., 2012). Importantly, VanA is a bifunctional enzyme, 
which besides D-Ala-D-Lac can also produce the wild-type D-Ala-D-Ala dipeptide, 
although this is negligible during vancomycin challenge. (Hong et al., 2005, Hong et 
al., 2004, Verkade, 2008, Bugg et al., 1991a). In this work, we show that D-Ala, but 
not L-alanine (L-Ala), acts as an inhibitor of the D-Ala-D-Lac ligase activity of VanA, 
an effect which is visible in the presence of vancomycin sensitive and resistant PG 
precursors. This effect was augmented by several orders of magnitude in vanX null 
mutants, effectively sensitizing the strains to vancomycin. We propose that a com-





Bacterial strains, culturing conditions and minimal inhibitory concentration 
(MIC)
Escherichia coli strains JM109 (Sambrook et al., 1989) and ET12567 (Kieser et 
al., 2000) were used for routine cloning procedures and for extracting non-methylat-
ed DNA, respectively. Cells of E.coli were grown in Luria-Bertani broth (LB) at 37°C. 
Streptomyces coelicolor A3(2) M145 was the parent of all mutants described in this 
work. All media and routine Streptomyces techniques were carried out as described 
(Kieser et al., 2000). SFM (soy flour mannitol) agar plates were used for propagating 
S. coelicolor strains and to prepare spore suspensions. For liquid-grown cultures, 
S. coelicolor mycelia were grown in normal minimal media with phosphate (NMMP) 
supplemented with 1% (w/v) mannitol as the sole carbon source. The MIC of van-
comycin against S. coelicolor M145 and its mutant derivatives were determined by 
growth on minimal media (MM) agar plates supplemented with 1% mannitol as the 
sole carbon source, and 0, 2, 4, 8, 16, 32, 64, 128, 256 or 512 µg.ml-1 vancomycin, 
in combination with 0, 1, 5, 10 or 50 mM of D-Ala or L-Ala. Due to their much high-
er vancomycin sensitivity, vanX mutants were tested with 1, 5, 10, 50 and 100 µM 
D-Ala and L-Ala.
Five vanA-positive Enterococcus faecium (E. faecium) strains collected in 2011 
and 2014 from patients in the Erasmus University Medical Centre, Rotterdam, The 
Netherlands were used. Presence of the vanA gene was confirmed by real-time 
PCR with the Light Cycler® 480 instrument (Roche Diagnostics, Almere, The Neth-
erlands) with primers vanA F1 and vanA R1, and a vanA-specific probe labeled with 
6-fluorescein amidite (FAM) at the 5’ end and with black hole quencher (BHQ1) at 
the 3’ end. The resistance profile of these isolates (Supplemental Table S2) was de-
termined using the VITEK II (BioMerieux) system AST-P586. To determine the MIC 
of vancomycin against E. faecium, cells were grown overnight on Tryptic Soy Agar 
(TSA) blood agar plates (Becton Dickinson, Breda, The Netherlands) and suspend-
ed in 0.9% NaCl until OD600 0.5 (± 0.05). Of this suspension, 10 μl was dispensed 
into wells of sterile flat-bottom 96-well polystyrene tissue culture plates (Greiner Bio-
One, Alphen a/d Rijn, The Netherlands) containing serial dilutions of vancomycin in 
190 μl of a 1:1 mixture of Fetal Bovine Serum (FBS) (Gibco, Bleiswijk, The Nether-
lands) and Iscove’s Modified Dulbecco’s Medium (IMDM) (without phenolred, Gibco, 
Bleiswijk, The Netherlands), and in the presence or absence of 50 mM D-alanine 
(Alfa Aesar, Ward Hill, MA, USA). Plates were incubated for 18-24 h at 37°C and 
MIC values determined visually following the CLSI guidelines, or by absorbance at 
600 nm.
VanX overexpression and isolation: 
VanX was amplified from the genome of Enterococcus faecium (vanB-type) 
with primers pVanX_FW and pVanX_RV. The resulting product was inserted as 
a NdeI/BamHI fragment into pET28a resulting in vector: VanX-Pet28a. VanX-Pe-
t28a was transformed to expression strain BL21(DE3) (fermentas) for protein ex-
pression. BL21(DE3) carrying VanX-Pet28a was grown in LB medium with 200µM 
ZnSO4 and 50µg/ml kanamycin. For protein expression, the strain was grown at 
30˚C to an OD of 1.8, at this point 1mM IPTG was added, biomass was harvested 
after 75 minutes(Wu et al., 1995). The medium was centrifuged and the supernatant 
discarded. The pellet was frozen at -80˚C overnight. The following day the sample 
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was sonicated for 7.5 minutes in total. Cell debris was removed by several rounds 
of centrifugation (10.000g, 10 minutes ; 30.000g, 30 minutes ; 100.000g for 90 min-
utes). The supernatant was incubated overnight with Ni-column resin and purified 
the following day. 
Buffer: PBS pH 7.4 + 200mM NaCl. Wash buffer: 20mM imidazole. Elution buf-
fer: 200mM imidazole. The fractions were tested for activity by adding 5µL of each 
respective fraction to a reaction mix with 10mM Tris-HCl Ph7.0 with 100µM D-Ala-D-
Ala. After an hour, 1µL from the reaction mix is spotted on a TLC.
TLC conditions for separation of D-Ala-D-Ala and D-Ala.
Samples were spotted on a silica TLC with D-Ala and D-Ala-D-Ala as controls. 
The running buffer was: n-butanol:acetic acid:water, 3:1:1. After the running buffer 
reached the top of the TLC plate, this was dried and afterwards stained with a Ninhy-
drin solution of: 0.1g Ninhydrin, 0.5mL acetic acid and 100mL acetone. After staining 
with ninhydrin, the plate was developed at 100 degrees for 5 minutes. 
Conditions VanX activity assay. 
The activity of VanX was measured by quantifying the amount of D-Ala generated 
by the dipeptidase activity. Each reaction contained: 20µM Amplex Red, 1µg/mL 
D-amino acid oxidase, 10µg/mL peroxidase and 100µM D-Ala-D-Ala (Arthur et al., 
1998). The reaction was read out in a TECAN Spark 10M plate reader with an exci-
tation wavelength of 550 nm and a bandwidth of 20nm. The emission was measured 
at 590nm with a bandwidth of 20nm. The reaction needs to be prepared in the dark, 
UV light can catalyze the reaction from Amplex Red to resorufin. 
Constructs for gene disruption and complementation
Deletion mutants were constructed according to a method described previously 
(Braun et al., 2015). For deletion of ddl, the -948/+20 and +1173/+2638 regions rela-
tive to the translational start of ddl were amplified by PCR using primer pairs ddl_LF 
and ddl_LR, and ddl_RF and ddl_RR, using PCR conditions as described (Colson 
et al., 2007). The left and right flanks were cloned into the multi-copy vector pWHM3 
(Vara et al., 1989), which is highly unstable in Streptomyces and therefore allows ef-
ficient gene disruption (van Wezel et al., 2005). Subsequently, the apramycin resis-
tance cassette aac(3)IV flanked by loxP sites was cloned into the engineered XbaI 
site to create deletion construct pGWS1152. The same strategy was used to create 
a construct for the deletion of vanX. In this case, the -1477/+30 and +572/+2035 
regions relative to the start of vanX (SCO3596) were PCR-amplified using prim-
er pairs vanX_LF and vanX_LR, and vanX_RF and vanX_RR (Supplemental table 
S3). Insertion of aac(3)IV-loxP site in the engineered XbaI site generated deletion 
construct pGWS1164. The presence of loxP sites allows the efficient removal of the 
apramycin resistance cassette from the chromosome following the introduction of 
plasmid pUWLCRE that expresses the Cre recombinase (Fedoryshyn et al., 2008).
Complementation constructs
A construct for the genetic complementation of ddl was made by amplifying the 
promoter- and coding region of ddl using primers ddlcomp_F and ddlcomp_R (nt 
positions: -573/+1184 relative to the start of ddl (Supplemental table S3), and insert-
ed as an EcoRI/BamHI fragment in the low copy vector pHJL401 (Larson & Hersh-
berger, 1986), a highly stable low-copy number vector that is well suited for genetic 
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complementation (van Wezel et al., 2000b), resulting in pGWS1159.
Fluorescence microscopy 
Samples were grown for 18 h in liquid NMMP after which a sample was tak-
en from the culture to stain with BODIPY FL vancomycin (Vanco-FL) as described 
(Daniel & Errington, 2003). Equal amounts of unlabeled vancomycin and Van-FL 
were added to the sample to a final concentration of 1 µg/ml and was incubated for 
10-20 min at 30°C. Directly after taking the first sample, 50 mM D-Ala was added to 
the medium and was left to grow for another hour before imaging the effect of added 
D-Ala. Imaging was done as described previously (Willemse & van Wezel, 2009). A 
Zeiss observer with a Plan-Neofluar 40x/0.9 lens was used, and GFP was excited 
with a wavelength of 488 nm and observed at 515 nm with filter BP505-550, with 
illumination power set to 7.5%. The images were analyzed with ImageJ, all the flu-
orescent images were processed identically. The final figure was made with Adobe 
Photoshop CS6. 
Isolation of cytoplasmic peptidoglycan precursors
For the cytoplasmic PG precursor isolation and identification we used a modi-
fication of the method described previously by Hong and colleagues (Hong et al., 
2004). Where applicable, 10 µg vancomycin was added to the strains at the moment 
of inoculation. The strains were grown in NMMP (1% (w/v) Mannitol, 50 mM MgCl2) 
until mid-log phase (OD-0.3-0.4) and mycelia were harvested by centrifugation at 
4°C and washed in 0,9% NaCl. Mycelia was extracted with 5% cold trichloric acid 
(TCA) for 30 minutes at 4°C. This was centrifuged and the supernatant desalted on a 
Sephadex G-25 column (Illustra NAP-10 Columns, GE Healthcare, Pittsburgh), and 
concentrated by rotary evaporation. The concentrated precursors were dissolved in 
HPLC-grade water and separated by LC-MS using a gradient of 0-20% acetonitrile 
in water with 0,1% TFA. The elution was monitored at absorbance 254 nm and by 
the sizes eluted (1193.8 - 1195.3 m/z).
For the measurement over time, the protocol was adjusted in the following way: 
300 ml NMMP cultures were grown until exponential phase (OD 0.3-0.4), at which 
point a 10 ml sample was taken (sample t=0) and 50 mM of D-Ala or L-Ala was add-
ed to the original culture, followed by further sampling after 1, 5, 15, 30, 60, 120 and 
180 minutes. Samples were rapidly filtered with a vacuum pump and washed with 
0.9% (w/v) NaCl, mycelia scraped off the filter and transferred to 5% TCA. 
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RESULTS
D-Ala reduces vancomycin resistance
The bifunctional activity and structural analysis of the VanA enzyme implies that 
it can use both D-Lac and D-Ala as a substrate (Roper et al., 2000, Wright & Walsh, 
1992), suggesting that D-Ala might be able to compete with D-Lac in the active site 
of the enzyme. To test the applicability of this concept, we used the naturally van-
comycin-resistant S. coelicolor M145 as a model system. The strain was grown on 
minimal media (MM) agar plates with increasing concentrations of D-Ala and vanco-
mycin. D-Ala was thereby added in concentrations of 5, 10 or 50 mM and the effect 
on the MIC of vancomycin assessed. As controls we added either L-Ala or neither 
alanine stereoisomer. In the absence of added amino acids, the MIC of vancomycin 
against S. coelicolor was 128 µg/ml. Supplementing the media with up to 50 mM 
L-Ala did not have any effect on the susceptibility to vancomycin (Table 1 and Fig 
S1). Sensitivity to vancomycin increased significantly when D-Ala was added; at 
10 mM D-Ala, the MIC decreased to 32 µg/ml (4-fold reduction), while at 50 mM 
D-Ala the MIC was reduced to 4 µg/ml (32-fold reduction) (Table 1 and Fig S1). This 
supports the concept that D-Ala can reduce VanA-based vancomycin resistance, 
presumably by competing with the substrate D-Lac at the active site of the VanA 
enzyme (Arthur et al., 1994, Zarlenga et al., 1992). 
Table 1. Effect of D-Ala on the MIC of vancomycin (in µg/ml) against S. coelicolor 
M145 and its mutant LAG2. 
No AA D-Ala L-Ala
Strain 5 mM 10 mM 50 mM 5 mM 10 mM 50 mM
M145 128 32 32 4 128 128 128
Δddla 128 32 32 4 128 128 128
LAG2 128 64 32 4 128 128 128
a. The ddl null mutant is not viable on medium without vancomycin but furthermore had an 
identical MIC value to M145.
Creation of a vancomycin-independent ddl mutant
To study the molecular basis of this effect in more detail, a strain was required 
that depends on vanA for the synthesis of the D-Ala-D-Ala dipeptide and thus for 
cell-wall synthesis. The wild-type gene for D-Ala-D-Ala ligase is ddl (SCO5560 in 
S. coelicolor), which is essential for normal growth, but it’s absence can be rescued 
by the vancomycin-inducible expression of vanA, the only other paralogue of ddl on 
the S.coelicolor genome (Wright & Walsh, 1992, Kwun et al., 2013). To allow direct 
comparison with other mutants related to GlcNAc and cell-wall metabolism previ-
ously made in our laboratory (Nothaft et al., 2010, Rigali et al., 2008, Swiatek et al., 
2012), a ddl (SCO5560) null mutant was created in our specific S. coelicolor M145 
laboratory host, thereby ensuring that all of the mutants have the same isogenic 
background. This was done by replacing the entire ddl coding region by the apra-
mycin resistance cassette (aacC4) via homologous recombination and subsequent 
removal to leave an in-frame deletion of ddl in the genome. The aacC4 gene was 
flanked by loxP sites, allowing the subsequent removal by expression of the Cre 
recombinase, resulting in a markerless deletion mutant of ddl (see Materials and 
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Methods section). To compensate for the absence of D-Ala-D-Ala, the ddl mutant 
was created in the presence of vancomycin, so as to elicit the production of the 
alternative precursor dipeptide D-Ala-D-Lac by VanA (Hong et al., 2005). Many can-
didate ddl null mutants were obtained, all of which failed to grow in the absence of 
vancomycin and showed normal sporulation. One of these strains was selected for 
further characterization. The absence of ddl in this mutant was confirmed by PCR 
(data not illustrated). Expectedly, the ddl mutant could only grow on agar plates with 
vancomycin (Fig. 1). Introduction of plasmid pGWS1159, which expresses the ddl 
gene from its own promoter, into the ddl null mutant restored normal development 
and growth in the absence of D-Ala (data not illustrated).
To allow studying the sensitivity of VanA to inhibitory molecules regardless of the 
presence or absence of vancomycin, we selected for suppressor mutants by plating 
spores (107 cfu) of the ddl null mutant onto SFM agar plates lacking vancomycin, 
so as to select for suppressors with constitutive expression of the vancomycin re-
sistance cluster. This yielded a small number of spontaneous suppressor mutants, 
which occurred at a frequency of around 10-6. One of these mutants has been select-
ed and designated LAG2. These constitutively expressed the vancomycin resistance 
cluster, as this is a requirement to compensate for the absence of ddl. One of the 
suppressor mutants was selected and designated LAG2 (Fig. 1)
Figure 1. Effect of D-Ala on growth of S. coelicolor M145 and derivatives. Strains are S. 
coelicolor M145 (parental strain), its vanX mutant, suppressor mutant LAG2, LAG2 ΔvanX 
and M145 Δddl. Strains were streaked on MM with from left to right, no additives (control); 
MM with 10 µg/ml vancomycin; 10 mM D-Ala; 10 µg/ml vancomycin + 10 mM D-Ala. The ddl 
mutant fails to grow in the absence of vancomycin, a phenotype that is suppressed in LAG2 
due to constitutive expression of the van resistance cluster. Note the high sensitivity of the 
vanX null mutants of M145 and LAG2 to the combination of vancomycin and D-Ala. Plates 
were incubated for 3 days at 30˚C. 
DNA sequencing of the vancomycin resistance genes vanRSJKHAX of strain 
LAG2 revealed that the insertion element IS466A (SCO3469) (Yamasaki et al., 2000, 
Hong et al., 2008, Courvalin, 2006) had inserted at nt position 55 relative to the 
translational start of vanS, causing loss-of-function. This spontaneous integration 
event in vanS had been observed before in both Streptomyces and in strains of 
Enterococcus, and results in constitutive upregulation of the vancomycin resistance 
cluster (Hutchings et al., 2006, Thaker et al., 2015, Arthur et al., 1997). The ddl sup-
pressor mutant LAG2 had a similar level of vancomycin resistance as the parental 
strain, with an MIC of 128 µg/ml (Table 1). Similar as seen for wild-type cells, addition 
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of L-Ala did not affect the MIC for vancomycin, while addition of D-Ala decreased 
the MIC to 4 µg/ml when 50 mM D-Ala was added to the agar plates (Table 1). Thus, 
while LAG2 constitutively expresses the vancomycin resistance cluster, it has a com-
parable MIC to vancomycin as wild-type cells, which in both cases could be strongly 
reduced by the addition of D-Ala.
Deletion of vanX amplifies the effect of D-Ala on vancomycin sensitivity
We then wondered if targeting vanX could further potentiate the effect of D-Ala 
as inhibitor of vancomycin resistance. VanX hydrolyzes D-Ala-D-Ala, thereby coun-
teracting the accumulation of wild-type precursors and supporting vancomycin re-
sistance (Lessard & Walsh, 1999, Tan et al., 2002). A vanX null mutant was created 
using a similar strategy as for ddl, replacing the coding region of vanX by the apra-
mycin resistance cassette aacC4. The mutant was created in both the parental strain 
S. coelicolor M145 and in its ddl suppressor mutant LAG2, generating M145 ΔvanX 
and LAG4 (LAG2 ΔvanX), respectively.
The respective vanX mutants of M145 and LAG2 grew on medium supplemented 
with 10µg/ml vancomycin, and 10 mM D-Alanine but failed to grow on media contain-
ing both vancomycin and D-Alanine at a concentration where M145 and LAG2 did 
not show sensitivity to vancomycin (Figure 1). LAG2∆vanX produced 20% wild-type 
precursors prior to the addition of D-Ala. This strongly suggests that VanA produc-
es a significant amount of D-Ala-D-Ala in vivo, which accumulates in the absence 
of VanX. Consistent with this idea, the MIC of vancomycin was lower for the vanX 
mutant, namely 32 µg/ml for the vanX mutant, and 64 µg/ml for LAG2ΔvanX, as 
compared to 128 µg/ml for the parental strain M145 (Table 2) 
In wild-type cells, 50 mM D-Ala was required to reduce the MIC for vancomycin 
to 4 µg/ml. However, only 50 µM D-Ala was required to reduce the MIC of vanco-
mycin for the vanX mutant to 1 µg/ml. This spectacular difference means that D-Ala 
is around 4000 times more effective in the absence of the D-Ala-D-Ala peptidase 
activity of VanX. This is consistent with the very strong accumulation of wild-type 
precursors in vanX null mutants as compared to the vanX-positive parental strain. 
Table2. The MIC of vancomycin (µg/ml) on S.coelicolor vanX-mutants with D-Ala.
No AA D-Ala L-Ala
Strain 10 µM 50 µm 100 µM 10µM 50µM 100µM
M145ΔvanX 32 16 1 1 32 32 32
LAG2ΔvanX 64 32 8 2 32 32 32
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Analysis of peptidoglycan precursors
In order to get more insight into the synthesis of vancomycin-sensitive (i.e. wild-
type) or vancomycin-resistant PG, the pool of PG precursors was analyzed by Liquid 
Chromatography coupled to Mass Spectrometry (LC-MS) (Arthur et al., 1994, Arthur 
et al., 1998, Kwun et al., 2013) When cells produce wild-type PG, only MurNAc-pen-
tapeptides with a D-Ala-D-Ala terminus are detected, while vancomycin-resistant PG 
precursors have a D-Ala-D-Lac terminus. Wild-type precursors ending with D-Ala-
D-Ala are characterized by a peak with a monoisotopic mass of 1994 Da and a re-
tention time of around 7.2 minutes, while vancomycin-insensitive precursors ending 
with D-Ala-D-Lac are characterized by a peak of a monoisotopic mass of 1995 Da 
and a significantly higher retention time of around 8.2 minutes (Fig. 3A). 
In extracts from the parental strain grown in the absence of vancomycin, only wild-
type precursors were observed (Fig. 3B). Expectedly, when S. coelicolor M145 was 
grown in the presence of 10 µg/ml vancomycin, the vast majority of the precursors 
(91.5%) represented the vancomycin-insensitive variant. Similarly, 95.7% of the pre-
cursors from the ddl null mutant grown in the presence of vancomycin contained the 
terminal D-Ala-D-Lac dipeptide (Fig. 3B). This indicates that VanA produces a low 
level of the D-Ala-D-Ala dipeptide. In the ddl suppressor mutant LAG2, which consti-
tutively expresses the vancomycin resistance gene cluster, nearly all PG precursors 
terminated with D-Ala-D-Lac (99.8% and 99.7% for cultures grown with and without 
vancomycin, respectively) (Fig. 3B). We then wondered how D-Ala would affect the 
accumulation of wild-type precursors over time in the suppressor mutant. The con-
stitutive expression of the vancomycin resistance cluster in the suppressor mutant 
allows growth of ddl null mutants without the need for vancomycin and ensures that 
the result is caused by substrate competition, not a difference in the expression of 
the vancomycin resistance cluster. For the time-lapse experiment, 300 ml NMMP 
cultures were supplemented with either D-Ala or L-Ala (control) at 50 mM end con-
centration, and 10 ml samples were collected prior to and 1, 5, 15, 30, 60, 120 and 
180 min after the addition of either alanine stereoisomer. Prior to the addition of 
D-Ala or L-Ala (t=0), LAG2 did not accumulate any wild-type precursors. However, 
addition of 50 mM D-Ala resulted in the production of small amounts of wild-type 
precursor (1%) within 1 min. After 15 min this amount had increased to 4%, which 
appeared to be close to the maximum, with levels of wild-type precursors never ex-
ceeding 5%. L-Ala did not result in detectable levels of wild-type precursors in LAG2.
Strikingly, analysis of PG precursors in vanX null mutants revealed that the ad-
dition of even low levels of D-Ala facilitated the accumulation of high levels of wild-
type precursors, up to as much as 80% wild-type precursors 3 h after the addition 
of D-Ala (Figure 3). This supports the notion that in the absence of VanX, wild-type 
precursors are incorporated much more frequently into the cell wall, with increased 
sensitivity to vancomycin as a consequence.
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Figure 2. LC-MS analysis of peptidoglycan precursors. (A) Example peak profile and 
corresponding precursors of S. coelicolor M145 grown with vancomycin, with the peak area 
corresponding to a precursor terminating in D-Ala-D-Ala shown in black, and the peak corre-
sponding to a precursor terminating in D-Ala-D-Lac in grey. (B) Ratio (in %age) of wild-type 
(black) and vancomycin-resistant (grey) precursors in S. coelicolor M145, its ddl null mutant 
and suppressor mutant LAG2, grown with or without vancomycin (10 µg/ml). The ddl mutant 
is only shown with vancomycin as it fails to grow in its absence. LAG2 with and without vanco-
mycin have less than 1% wild-type (vancomycin-sensitive) peptidoglycan. Strains were grown 
with or without vancomycin until OD 0.3-0.4 before harvesting.(C) Accumulation of wild-type 
and vancomycin-resistant precursors over time in LAG2 and LAG2ΔvanX. The samples were 
grown until OD 0.3-0.4 prior to the addition of 50 mM D‐Ala. Samples were taken prior to (0) or 
1, 5, 15, 30, 60, 120 or 180 minutes after the addition of D-Ala. (D) Same as (C), but with L-Ala 
instead of D-Ala.Bars representing the precursors shown as percentages (total set to 100%). 
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Visualization of vancomycin binding by fluorescence microscopy 
To qualitatively determine the ability of vancomycin to bind to the cell walls of dif-
ferent Streptomyces strains and also visualize the effect of D-Ala, mycelia of S. co-
elicolor were fluorescently stained with BODIPY-FL vancomycin (Vanco-FL). In van-
comycin-sensitive bacteria, vancomycin localizes in foci at sites of de novo cell wall 
synthesis (Daniel & Errington, 2003). In S. coelicolor, which grows by tip extension 
(Gray et al., 1990), these sites are in particular the hyphal tips and cell division septa.
While hyphae of S. coelicolor M145 were stained well by Vanco-FL, hardly any 
Vanco-FL bound to the hyphae of strains constitutively expressing vancomycin re-
sistance (LAG2 or LAG2DvanX) (Fig. 4A). However, addition of D-Ala resulted in 
marginal staining by Vanco-FL of the LAG2 hyphal tips (Fig. 4B); in contrast, its vanX 
mutant derivative LAG4 was stained very well, in line with the strongly enhanced 
vancomycin sensitivity of the mutant (Fig. 4). 
Taken together, our mutational, microscopy and LC-MS experiments show that 
D-Ala effectively and specifically enhances the sensitivity of vancomycin resistant S. 
coelicolor to vancomycin, by allowing accumulation of wild-type cell-wall precursors 
and thus binding of vancomycin to sites of active cell-wall biosynthesis. This effect 
was strongly enhanced in vanX mutants (which lack D-Ala-D-Ala peptidase activity).
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Figure 3. Fluorescence micrographs of Vanco-FL stained hyphae. To analyze vancomy-
cin binding, S. coelicolor strains M145, M145 ΔvanX, LAG2 and LAG2 ΔvanX, were grown 
in liquid NMMP for 12 h, and continued to grow for 1 h in the absence (A) or presence (B) of 
50 mM D‐Ala. Mycelia were then stained with Vanco-FL and imaged. Top, fluorescence mi-
crographs (inverted greyscale); bottom, corresponding light images. S. coelicolor M145 and 
its vanX mutant were readily stained by Vanco-FL. Constitutively vancomycin resistant strain 
LAG2 was not stained by Vanco-FL in the absence of D-Ala, and showed some binding after 
the addition of D-Ala. Extensive Vanco_FL staining was seen for LAG2ΔvanX only after the 
addition of D-Ala. Inserts are magnifications of the areas indicated by arrows in the respective 
image. Scale bar, 10 μm.
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Analysis of the effect of D-Ala on the MIC of clinical isolates of VRE 
Having established that D-Ala enhances the efficacy of vancomycin against van-
comycin-resistant S. coelicolor, we then assessed its effect on the resistance of 
vanA-positive clinical isolates of E. faecium. MIC values were calculated by testing 
a serial (two-fold) dilution of vancomycin in the presence or absence of D-Ala in 
triplicate (Table 3). ]Similar as seen for S. coelicolor, addition of 50 mM D-Ala to the 
growth media resulted in a strong increase in the efficacy of vancomycin against all 
clinical isolates, with reduction of 4-7 dilution steps. Even in the worst cases, the MIC 
of vancomycin was still reduced 16-32 fold (from 4096 µg/ml to 256 µg/ml or 128 µg/
ml), while we also noted a further decrease to values as low as 16 µg/ml for strain 
vanA10. This value corresponds to intermediate resistance.
Table 3. MIC of vancomycin (µg/ml) against VRE in the presence or absence of 
D-Ala.
 Strain 0 mM D-Ala 50 mM D-Ala steps down
vanA1 4096 256 4
vanA2 4096 256 4
vanA3 4096 128 5
vanA4 4096 128 5
vanA10 2048 16 7
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VanX isolation and characterization. 
Here, we have found that VanX is an essential protein in the vancomycin resistant 
complex, a knockout of the vanX gene in S.coelicolor causes it to become a thousand 
fold more sensitive to vancomycin when combined with D-Ala. For this reason, we 
expressed and isolated the VanX protein from Enterococcus faecium and developed 
an assay with a fluorescent readout. VanX is a 23.35Da protein with dipeptidase 
activity which is highly specific for D-Ala-D-Ala, it does not cleave the stereoisomer 
L-Ala-D-Ala or L-Ala-L-Ala. The binding pocket for D-Ala-D-Ala is located in the cen-
ter of the protein and requires a Zn2+ cofactor (Figure 5). The protein was amplified 
from the genome of a VanB-type Enterococcus faecium, this was cloned into pET-
28a, which carries a HIS-tag at the N-terminus and expressed in E.coli BL21 (DE3). 
The protein was purified using a nickel column and the activity was initially tested 
by adding 5µL of the fraction to a 20µL reaction mix in 10mMTris-HCl, pH 7.0 and 
100µM D-Ala-D-Ala. After an hour incubation, the mix is spotted on a silica TLC with 
running buffer n-butanol:acetic acid:water, 3:1:1, until the solution almost hit the top 
of the TLC plate. The plate was developed with a ninhydrin stain. this showed that 
the protein was still active after purification. 
Figure 5. (A) Structural model of VanX. PHYRE2(Kelley et al., 2015) model of VanX, The N- to 
C-terminus is rainbow-coloured. (B) The D-Ala-D-Ala binding site prediction, a small pocket of 
amino acids makes up the active site, associated with a Zn2+ cofactor. 
To measure the activity of VanX, it is neccesary to differentiate between D-Ala 
and D-Ala-D-Ala. Although this is straightforward by TLC, this method would not be 
feasible for a high-throughput assay. An assay with a fluorescent output was devel-
oped based on the activity of a D-amino acid oxidase (DAO), this protein oxidases 
D-Ala, but not D-Ala-D-Ala. CAO converts D-Ala to pyruvate, ammonia and hydro-
gen peroxide, after which Horseradish peroxidase catalyzes the reaction of hydro-
gen peroxide and Amplex Red to the fluorescent Resorufin and oxygen, as shown in 
Figure 6. The reaction without VanX (0 VanX) showed a flat slope, the reaction with 
D-Ala instead of D-Ala-D-Ala showed high initial fluorescence and bleached after-
wards. An increasing amount of VanX (5-50 µg/ mL) increased the primary reaction 
speed, from 10µg/mL on, the slope was the same, indicating that another protein 
is the limiting step. With these concentrations, 5-10 µg VanX would be ideal for a 
high-throughput set up. 
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Figure 6. A: The fluorescence assay is based on two reactions: 1. The oxidation of D-Ala by 
DAO which gives pyruvate, ammonia and hydrogen peroxide. 2. Hydrogen peroxide is then 
converted to oxygen by horseradish peroxidase for which Amplex red is the electron donor 
converting that into Resorufin which gives a strong fluorescent signal. B: Fluorescence assay 
to measure D-Ala, the plate was measured every ten minutes, 5 wells are averaged for every 
data point. The y-axis shows the emission at 550 nm, measured in arbitrary units (au). The 
x-axis shows time in minutes. The reaction was performed with 0, 5, 10, 20 and 50µg/mL VanX 
protein and with 100µM D-Ala as a control. 
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DISCUSSION
With the rapid spread of vancomycin resistance, new efforts are needed to main-
tain this last resort antibiotic as a clinical drug against multi-drug resistant bacterial 
infectious diseases. So far, attempts included engineering VanX-inhibitors (Muthyala 
et al., 2014, Wu et al., 1995, Aráoz et al., 2000), or re-engineering vancomycin itself 
to target not only the cell-wall precursors with D-Ala-D-Ala termini, but also those 
ending with D-Ala-D-Lac (Xie et al., 2011). As a basis to develop new approaches to 
target vancomycin resistance, we studied the model organism S. coelicolor, which 
has a very similar set of vancomycin resistance genes as the pathogenic VRE (Wie-
ner et al., 1998).
VanA, a variant of Ddl that ligates D-Ala to D-Lac to form D-Ala-D-Lac, plays a 
key role in vancomycin resistance. VanA is a bifunctional enzyme which can pro-
duce both D-Ala-D-Lac and D-Ala-D-Ala, the affinity for either D-Lac or D-Ala as a 
substrate being highly dependent of substrate and pH (Verkade, 2008, Healy et al., 
2000, Lessard et al., 1999). The extracellular addition of high concentrations D-Ala 
results in increased accumulation of wild-type cell-wall precursors and consequently 
the build-up of vancomycin-sensitive PG, due to competition with D-Lac at the ac-
tive site of VanA, while supplementing D-Lac leads to a high abundance of precur-
sors terminating in D-Ala-D-Lac (Kwun et al., 2013, Arthur et al., 1998, Arthur et al., 
1994) This effect is specific for vancomycin and did not work on A40926, the natural 
product of the novel glycopeptide dalbavancin, of which the mechanism is similar 
but different from vancomycin. We analyzed the accumulation of precursors, which 
revealed that supplementing cultures of a constitutively vancomycin-resistant variant 
of S. coelicolor M145 with excess D-Ala, resulted in accumulation of up to 5% wild-
type precursors. While interesting, the effect is too low to be effective in treatment 
of vancomycin-resistant pathogens. However, we here show that the effect of D-Ala 
is massively enhanced in the absence of VanX, with up to 80% of the precursors 
accumulated in vanX null mutants containing the wild-type dipeptide. As support 
of the biochemical data, active incorporation of wild-type precursors at apical sites 
was visualized with Vanco-FL, which fluorescently stains all sites of active cell-wall 
synthesis, i.e. the hyphal tips and newly synthesized septa. While wild-type cells and 
vanX mutant cells were stained very well by Vanco-FL, derivatives with constitutive 
vancomycin resistance were hardly stained. However, addition of D-Ala recovered 
fluorescence even to cells with constitutive vancomycin resistance, indicative of the 
incorporation of wild-type cell-wall material concomitant with increased sensitivity 
to vancomycin. Other ways D-Ala could affect vancomycin sensitivity could be by 
D,D-transpeptidases in the periplasm substituting D-Lac for D-Ala on the precur-
sors (Hugonnet et al., 2014). The strong direct correlation between PG precursor 
accumulation and vancomycin binding (as determined by imaging fluorescent van-
comycin) argues against a major influence of D,D-transpeptidases in this work. The 
fluorescence correlated with the level of wild-type cell-wall precursors in the various 
strains, and this method therefore offers rapid qualitative assessment of vancomycin 
sensitivity, which could be applied in high-throughput screening for compounds that 
potentiate vancomycin resistance. By combining the precursor analysis and staining 
with Vanco-FL it is also clear that D-Ala is not only incorporated in PG precursors 
but the pentapeptides terminating in D-Ala-D-Ala are displayed at the cell surface. A 
question which remains though is which amount of vancomycin sensitive PG would 
be sufficient to regain sensitivity against vancomycin. 
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Previous work indicated that the deletion of vanX increases the sensitivity to van-
comycin (Arthur et al., 1998). However, as our work shows, significant changes in 
the MIC are only brought about when D-Ala is added as competitive inhibitor for 
D-Lac. This change in response to the deletion of vanX may well depend on the 
target organism, which is underlined by the differential effect of added D-Ala on the 
MICs of independent clinical VRE isolates. Based on the findings presented in this 
work, we propose a model for vancomycin resistance in which the catalytic activity of 
VanA depends largely on the available substrate (Fig. 5). In the presence of excess 
of D-Ala, VanA is bifunctional and synthesizes both D-Ala-D-Ala and D-Ala-D-Lac, 
but the wild-type dipeptide is then cleaved by the VanX peptidase. However, excess 
of D-Ala will result in such large amounts of D-Ala-D-Ala that VanX cannot degrade 
the dipeptides sufficiently rapidly to avoid their use as substrate by VanA, thus result-
ing in low levels of wild-type lipid II. As a result, a small proportion of wild-type PG is 
produced, giving enhanced vancomycin sensitivity. In the absence of vanX the ad-
dition of even very small amounts of D-Ala (10-50 µM instead of 10-50 mM) already 
led to strong accumulation of wild-type precursors and a drop in the MIC of vanco-
mycin to values as low as 1 µg/ml. This is well within the range of clinical sensitivity. 
 How can the concepts developed in this work be implemented into approaches 
to counteract vancomycin resistant Gram-positive pathogens like VRE and VRSA? 
The high sensitivity of vanX null mutants to the combination of vancomycin and 
D-Ala strongly suggests that the combined treatment with vancomycin and D-Ala 
will be particularly effective in combination with molecules that perturb the bioactivity 
of VanX. VanX inhibitors have been described in the literature, but their effect was 
limited (Muthyala et al., 2014, Chang et al., 2006, Aráoz et al., 2000, Yang et al., 
2011b, Wu et al., 1995). Based on the data presented here, this is likely explained 
by the fact that the effect of a vanX deletion without additional D-Ala is very limited, 
only decreasing the MIC by two-fold in this work. Similarly, the data also point out 
that VanX inhibitors that have been or will be developed in the future should be 
(re)tested in the presence of added D-Ala, as this largely augments their efficacy. 
Strains that depend on the vancomycin resistance cluster for growth thereby candi-
date as screening hosts for a high-throughput screen of small molecules that target 
vancomycin resistance. This may prove an important asset in the hunt for drugs that 
counteract vancomycin-resistant pathogens such as VRE and VRSA.
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Figure 4. Model of how D-Ala influences the activity of VanA in the presence or absence 
of VanX. All drawings show the situation where VanA is constitutively expressed and in the 
absence of Ddl. (A) Normal situation. VanA produces both D-Ala-D-Ala and D-Ala-D-Lac, 
whereby D-Ala-D-Ala is broken down by VanX (resulting in a strong bias for D-Ala-D-Lac). (B) 
situation in the presence of excess D-Ala, which is then preferentially used as substrate by 
VanA to favor the formation of the D-Ala-D-Ala dipeptide, which is however still broken down 
by VanX. (C) situation in the absence of vanX. Because of the lack of VanX activity, D-Ala-D-
Ala accumulates and the pool of D-Ala-D-Ala is dramatically increased when access D-Ala 
is added. This then enhances the percentage of wild-type cell-wall precursors and strongly 
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ABSTRACT
The conversion of L-alanine (L-Ala) into D-alanine (D-Ala) in bacteria is performed 
by pyridoxal phosphate-dependent enzymes called alanine racemases. D-Ala is an 
essential component of the bacterial peptidoglycan and hence required for surviv-
al. The Gram-positive bacterium Streptomyces coelicolor has at least one alanine 
racemase encoded by the putative gene alr. Here, we describe an alr deletion mu-
tant of S. coelicolor which is completely dependent on D-Ala for growth and shows 
an increased sensitivity to the antibiotic D-cycloserine. The crystal structure of the 
alanine racemase (Alr) was solved with and without the inhibitors D-cycloserine and 
propionate. The crystal structures revealed that Alr is a homodimer with residues 
from both monomers contributing to the active site. The dimeric state of the enzyme 
in solution was confirmed by gel filtration chromatography, with and without L-Ala 
or D-cycloserine. Specificity of the enzyme was 66±3 U mg-1 for the racemization of 
L- to D-Ala, and 104±7 U mg-1 for the opposite direction. Comparison of Alr from S. 
coelicolor with orthologous enzymes from other bacteria, including the closely relat-
ed D-cycloserine-resistant Alr from S. lavendulae, strongly suggests that structural 
features such as the hinge angle or the surface area between the monomers do not 





All canonical, proteinogenic amino acids, with the exception of glycine, have a 
stereocenter at the Cα and can exist either as the L- or D-enantiomer. While in the 
past it was generally accepted that only L-amino acids had a role in living organisms, 
studies revealed a variety of roles for free D-amino acids, for example in the regula-
tion of bacterial spore germination and peptidoglycan structure (Cava et al., 2011). 
Peptidoglycan is essential for cell shape and osmotic regulation and its biosynthesis 
is dependent on the availability of the less naturally abundant D-alanine (Lam et 
al., 2009, Steen et al., 2005, Vollmer et al., 2008a). D-alanine (D-Ala) is generated 
through racemization of the abundant L-enantiomer (L-Ala) by the enzyme alanine 
racemase (Walsh, 1989).
 Alanine racemases (Alr; E.C. 5.1.1.1) are conserved bacterial enzymes 
that belong to the Fold Type III of pyridoxal phosphate (PLP)-dependent enzymes. 
Crystallographic studies of Alr’s from different bacterial species revealed a shared, 
conserved fold consisting of an eight-stranded α/β barrel at the N-terminal domain 
and a second, C-terminal domain mainly consisting of β-sheets. The PLP cofactor is 
bound to a very conserved lysine residue at the N-terminal side of the last helix of the 
barrel. In all studies, Alr’s crystals consist of homo-dimers, with residues from both 
monomers participating in the formation of the active site. Nevertheless, in-solution 
studies indicated an equilibrium between monomeric and homo-dimeric states in 
solution, with the homo-dimer being the catalytically active form (Ju et al., 2011, 
Strych et al., 2007).
 Streptomyces coelicolor is the most widely studied member of the Strepto-
mycetes, which are Gram-positive bacteria with a multicellular mycelial life style that 
reproduce via sporulation (Claessen et al., 2014). They are of great importance for 
medicine and biotechnology, accounting for over half of all antibiotics, as well as for 
many anticancer agents and immunosuppressants available on the market (Hop-
wood, 2007, Barka et al., 2016). Here we describe the heterologous expression, 
purification and crystal structure of S. coelicolor Alr, encoded by alr (SCO4745). An 
alr null mutant of S. coelicolor depends on exogenous D-Ala for growth. The purified 
enzyme catalyzed the racemization of L-Ala to D-Ala in vitro and was shown to be a 
dimer from gel filtration, both in the absence and presence of L-Ala or the inhibitor 
D-cycloserine (DCS). Furthermore, the crystal structure of the enzyme has been 
solved both in the absence and in the presence of the inhibitors DCS and propio-
nate. The comparison of the Alr enzymes from S. coelicolor and its close relative the 
DCS-resistant Streptomyces lavendulae (Noda et al., 2004b) questions the structur-
al role of Alr in DCS resistance.
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MATERIALS AND METHODS
Streptomyces coelicolor knock-out mutant and genetic complementation-
Streptomyces coelicolor (A3(2) M145 was obtained from the John Innes Centre 
strain collection and cultured as described (Kieser et al., 2000). S. coelicolor alr 
deletion mutants were constructed according to a previously described method (Swi-
atek et al., 2012). The -1238/-3 and +1167/+2378 regions relative to the start of alr 
were amplified by PCR using primer alr_LF and alr_LR, and alr_RF and alr_RR 
(Table S2) as described (Colson et al., 2007). The left and right flanks were cloned 
into the unstable, multi-copy vector pWHM3 (Table S1) (Vara et al., 1989), to al-
low for efficient gene disruption (van Wezel et al., 2005). The apramycin resistance 
cassette aac(3)IV flanked by loxP sites was cloned into the engineered XbaI site to 
create knock-out construct pGWS1151. Media were supplemented with 1 mM D-Ala 
to allow growth of alr mutants. The correct recombination event in the mutant was 
confirmed by PCR. For genetic complementation, the -575/+1197 region (numbering 
relative to the alr translational start codon) encompassing the promoter and coding 
region of SCO4745 was amplified from the S. coelicolor M145 chromosome using 
primer 4745FW-575 and 4745RV+1197 (Table S2) and cloned into pHJL401 (van 
Wezel et al., 2000a). pHJL401 is a low-copy number shuttle vector that is very well 
suited for genetic complementation experiments (van Wezel et al., 2000b).
Cloning, protein expression and purification
The alr gene (SCO4745) was PCR-amplified from genomic DNA of Streptomyces 
coelicolor using primers alr-FW and alr-RV (Table S2), and cloned into pET-15b 
with a N-terminal His6 tag. The construct was transformed into E. coli BL21 Star 
(DE3)pLysS electrocompetent cells (Novagen). E. coli cultures were incubated in LB 
medium at 37°C until an OD600 of 0.6 and gene expression induced by adding 0.5 
mM isopropyl β-D-1-thiogalactopyranoside (IPTG) followed by overnight incubation 
at 16°C. His6-tagged Alr was purified using a pre-packed HisTrap FF column (GE 
Healthcare) as described (Mahr et al., 2000). Briefly, after binding of the protein, the 
column was washed with ten column volumes of 20 mM sodium phosphate buffer, 
pH 7.0, 500 mM NaCl and 50 mM imidazole and N-terminally His6-tagged Alr eluted 
with the same buffer but containing 250 mM imidazole. Fractions containing the Alr 
were deslated using a PD-10 column (GE Healthcare) to remove the imidazole and 
Alr purified further by gel-filtration using a Superose-12 column (GE Healthcare). 
The collected fractions were analyzed by SDS-PAGE and those containing pure Alr 
were pooled, concentrated using a Centriprep centrifugal filter unit (10 kDa cut-off, 
Millipore), and flash-frozen in liquid nitrogen. 
Crystallization conditions and data collection
Purified Alr was concentrated to 20 mg mL-1 and crystallization conditions were 
screened by sitting-drop vapor-diffusion using the JCSG+ and PACT premier (Mo-
lecular Dimensions) screens at 20°C with 500-nL drops. The reservoir (75 μL) was 
pipetted by a Genesis RS200 robot (Tecan). Drops were made by an Oryx6 robot 
(Douglas Instruments). After 1 day, crystals grew in condition number 2-38 of PACT 
premier, which consisted of 0.1 M BIS-TRIS propane, pH 8.5, 0.2 M NaBr, 20% 
(w/v) PEG3350. Bigger crystals were grown in 1-μL drops. Prior to flash-cooling in 
liquid nitrogen, crystals were soaked in a cryosolution consisting of mother liquor, 




X-ray data collection was performed at the ESRF (Grenoble, France) on beamline 
ID23-1 (Kabsch, 2010) using a PIXEL, Pilatus_6M_F X-ray detector. A total of 1127 
frames were collected for the native Alr, with an oscillation of 0.15°, an exposure 
time of 0.378 s, total 426.006 s. The data set was processed by XDS (Kabsch, 
2010) and scaled by AIMLESS (Evans & Murshudov, 2013) to a resolution of 2.8 
Å. For the DCS-bound Alr 960 frames were collected, with an oscillation range of 
0.15°, an exposure time of 0.071 s per image and a total time of 68.16 s. For the 
propionate-bound structure, 1240 images were collected, with an oscillation degree 
of 0.1°, an exposure time per image of 0.037 s, and a total time of 45.88 s. Both in-
hibitor-bound data sets were auto-processed by the EDNA Autoprocessing package 
in the mxCuBE (Gabadinho et al., 2010) to a resolution of 1.64 Å and 1.51 Å for the 
DCS-bound and propionate-bound Alr, respectively. The structures were solved by 
molecular replacement with MOLREP (Vagin & Teplyakov, 1997) using 1VFH as a 
search model from the CCP4 suite (Winn et al., 2011) and iteratively refined with 
REFMAC (Murshudov et al., 2011). Manual model building was done using Coot 
(Emsley & Cowtan, 2004).
Enzyme kinetics
The racemization activity of Alr was determined by quantifying the derivatization 
product of L- and D-Ala by HPLC, as previously described (Hashimoto et al., 1992, 
Ju et al., 2005). The derivatization reagent consisted of a methanol solution of 10 
mg mL-1 o-phthalaldehyde (OPA, Sigma-Aldrich) and 10 mg mL-1 Boc-L-Cys (Sig-
ma-Aldrich). A 0.4 M boric acid solution was adjusted to pH 9.0 with sodium hydrox-
ide. The reaction mixture consisted of 20 µL of 20 mM sodium phosphate buffer, pH 
7.0 containing varying amounts of L- or D-Ala from 281 µM to 20 mM. The reaction 
was started by adding 100 nM of enzyme and stopped after 10 min at 25°C by add-
ing 20 µL of 2 N HCl. The reaction mixture was neutralized by NaOH. After adding 
350 µL of boric acid buffer and 100 µL of derivatization reagent, derivatization was 
conducted for 5 min at 25°C. The fluorescent products were separated on a Kinetex 
EVO C18 column (Phenomenex) by a gradient from 24% to 46.75% of acetonitrile 
in water in 30 min and detected by a Shimadzu RF-10AXL fluorescence detector.
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RESULTS AND DISCUSSION
Creation of an alr null mutant of S. coelicolor
To study the role of alr in amino acid metabolism and in morphogenesis of S. co-
elicolor, a deletion mutant was created by removal of the entire coding region (see 
Materials & Methods). In line with its expected role in biosynthesis of the essential 
D-amino acid D-Ala, alr null mutants depended on exogenously added D-Ala (50 µM) 
for growth (Fig 1a). Re-introducing a copy of the alr gene via plasmid pGWS1151 
complemented the mutant phenotype, allowing growth in the absence of added 
D-Ala (Fig 1a).
Figure 1.  SCO4547 encodes alanine racemase Alr. (A) A S. coelicolor alr null mutant fails 
to grow in the absence of added D-Ala. This phenotype is rescued by the introduction of plas-
mid pGWS1151 which expresses Alr. Strains were grown for 5 days on SFm agar plates. (B) 
Rescue of an S. coelicolor alr null mutant with D-Ala produced in vitro by Alr. Alr (0.2 nM) was 
incubated with 10 mM L-Ala for 0, 1, 5, 15, 30 or 60 min, followed by heat inactivation. The 
reaction mixture was then added to MM agar in 24 well plates and growth of the alr null mutant 
assessed. As a control, the same experiment was done with heat inactivated Alr (Alr*).Note 
the restoration of growth to the alr mutant after addition of the reaction mixture with active Alr, 
but not with heat-shocked Alr. The bottom rows show control experiments with added D-Ala 
or L-Ala (ranging from 0-1 mM). 
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Alr is the only alanine racemase in S. coelicolor
The Alr from S. coelicolor (AlrSco) shares 74.9% aa sequence identity with the Alr 
from the DCS-producing Streptomyces lavendulae (AlrSla) (Noda et al., 2004b) and 
37.9% with the well-studied Alr from Geobacillus stearothermophilus (AlrGst) (Shaw 
et al., 1997) (Fig. 2). To analyze the activity and kinetics of the enzyme, recombinant 
His6-tagged Alr was expressed in E. coli BL21 Star cells and purified to homogenity 
(Materials and Methods). Around 45 mg of pure Alr was obtained from 1 L of bacterial 
culture and Alr was identified using mass spectrometry (Table S4). 
To establish if AlrSco converts L-Ala into D-Ala, we designed a combined in vitro 
and in vivo assay, whereby 10 mM L-Ala was incubated with 0.2 nM purified Alr-His6 
for 10 sec to 60 min, after which the enzyme was heat-inactivated and the mixture 
was added to minimal media (MM) agar plates, followed by plating of 106 spores 
of the alr null mutant and incubation of 5 days at 30°C (Fig. 1b). If Alr converts 
L-Ala into D-Ala, the reaction should generate sufficient D-Ala to allow restoration 
of growth to alr null mutants. Indeed, sufficient D-Ala was produced to allow growth 
of the alr null mutant, whereby biomass accumulaiton was proportional to the incu-
bation time, while a control experiment with extracts from heat-inactivated Alr did 
not give any growth (Fig. 1b). Addition of D-Ala also restored growth of alr mutants, 
while no growth was seen for cultures grown in the presence of added L-Ala. Taken 
together, this shows that no Alr activity is present in S. coelicolor alr mutants, and 
that Alr actively converts L-Ala into D-Ala in vitro.
The kinetic parameters of recombinant AlrSco were determined using both L- and 
D-Ala as substrates. The enzyme shows a Km of 6.3 mM and 8.9 mM towards L- and 
D-Ala, respectively (Table S5). For comparison, kinetic parameters of AlrSla (Noda et 
al., 2004b)2004b and AlrGst are also shown in Table S5. To analyze possible multim-
erization of AlrSco, analytical gel filtration was used, which established an apparent 
molecular weight for the protein of 83 kDa in solution both in the absence and in the 
presence of L-Ala and DCS (Figure S1); this corresponds roughly to two Alr proteins 
(43.4 kDa per subunit). These data suggest that AlrSco forms a dimer in solution, both 
in the presence and in the absence of ligands.
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Figure 2. Multiple aminoacid sequence alignment of the Alr’s from S. coelicolor  (Sco), S. 
lavendulae (Sla; PDB 1VFT) and G. stearothermophilus (Gst; PDB 1XQK). The sequence 
alignment showing structural elements of AlrSco was generated with ESPript3.0. α-helices are 
shown as large coils labeled α, 310-helices are shown as small coils labeled η, β-strands are 
shown as arrows labeled β and β-turns are labeled TT. Identical residues are shown on a red 
background, conserved residues are shown in red and conserved regions are shown in boxes.
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Overall structure of Alr from Streptomyces coelicolor 
The crystal structure of ligand-free AlrSco was determined to a resolution of 2.8 Å 
(Table S6). The overall structure is similar to that of other prokaryotic Alr proteins 
(Noda et al., 2004b, Shaw et al., 1997). The asymmetric unit contains four protein 
molecules (A-D), which interact in a head-to-tail manner to form two dimers (dimer 
A-B and C-D, Fig. 3a). Each monomer has two structurally distinct domains. The 
N-terminal domain, comprising residues 1-259, has an eight-stranded α/β-barrel 
fold, typical of phosphate-binding proteins. The C-terminal domain, residues 260-
391, contains mostly β-strands (Fig. 3b). 96% of the amino acids are in the preferred 
regions of the Ramachandran plot, 4% are in the allowed regions and no residues 
are in the unfavored areas. After refinement, the r.m.s. deviation between Cα’s of the 
two interacting molecules A and B is 0.0794 Å, and between C and D is 0.1431 Å.
Figure 3. Ribbon representation of the Alr from S. coelicolor . (a) The asymmetric unit con-
tains two homo-dimers. The two chains within one dimer are colored in gold and dark cyan. 
(b) The N-terminal domain (1-259) is a α/β-barrel. The C-terminal domain (260-391) mostly 
comprises β-strands. The catalytic Tyr283 is highlighted in red.
There are two active sites per dimer, which are located at the interface between 
each α/β-barrel of one subunit and the C-terminal domain of the other. The catalytic 
core (Fig. 4a) consists of the PLP cofactor, a Lys, and a Tyr, which is contributed by 
the other subunit. The PLP is bound through an internal aldimine bond to the amino 
group of Lys46, located at the C-terminal side of the first β-strand of the α/β-bar-
rel. The side chain of the catalytic Lys46 points out of the α/β-barrel, towards the 
C-terminal domain of the interacting subunit, and in particular, towards Tyr283’. The 
phosphate group of the PLP is stabilized by hydrogen bonds with the side chains 
of Tyr50, Ser222 and Tyr374, and with the backbone of Gly239, Ser222 and Ile240. 
The pyridine ring of the PLP is stabilized by a hydrogen bond between the N-1 of 
the cofactor and Nε of Arg237. The C2A of the PLP also interacts with oxygen Q1 
of the carboxylated Lys141. All residues stabilizing the PLP cofactor (Tyr50, Ser222, 
Gly239, Ile240, Arg237, Tyr374) are conserved among Alr’s (Shaw et al., 1997). 
However, the AlrSco lacks one important hydrogen bond between Arg148 and the 
phenolic oxygen of the PLP molecule, as already observed for the AlrSla (Noda et 
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al., 2004a) (Noda et al., 2004b). Among the residues involved in PLP-stabilization, 
Tyr374, which corresponds to Tyr354 in the well-studied AlrGst, is particularly inter-
esting. In fact, while always regarded as a PLP-stabilizer, Tyr354 was shown to be 
actually anchored by the hydrogen bond with the PLP so to ensure substrate speci-
ficity of the Alr (Patrick et al., 2002).
Figure 4. Active site of the Alr without ligands (a) and in complex with propionate (b) and 
D-cycloserine (c). The electron density 2F0-Fc map is shown for the PLP and the two inhibitors. 
The residues in the active site which are contributed from the monomer not bound to the PLP 
are indicated as primed numbers. Dotted lines indicate interatomic distances shorter than 3 Å.
Alr crystal structures bound to propionate and DCS
The structure of AlrSco was solved in the presence of the two inhibitors propionate 
(Morollo et al., 1999) and DCS  (Noda et al., 2004b) to a resolution of 1.51 Å and 
1.64 Å, respectively. In AlrSco, the carboxylic group of propionate binds in the same 
orientation in all four active sites present in the crystal unit. One of the carboxylic 
oxygens of propionate forms hydrogen bonds with the amino group of Met331’, the 
phenolic oxygen and CE2 of Tyr283’ and a water molecule, which bridges the sub-
strate to several other water molecules in the active site. The second carboxylic 
oxygen of propionate interacts with Nz of Lys46, C4A of PLP, the phenolic oxygen of 
Tyr283’ and a water molecule. The electron density around C3 of propionate shows 
that this atom can have several orientations in the active site. In fact, it can either 
interact with O4 of the phosphate of PLP, the phenolic oxygen of Tyr283’ and a water 
molecule, or with the phenolic oxygen of Tyr50, the CE of Met331’, Nz of Lys46 and 
C4A of PLP (Fig. 4b). Both in AlrSco and AlrGst the hydrogen-bonding network stabi-
lizing the propionate is very conserved. As argued by (Morollo et al., 1999), the pro-
pionate-bound form of the Alr can be considered a mimic of the Michaelis complex 
formed between the enzyme and its natural substrate L-Ala.
DCS is an antibiotic produced by S. lavendulae and Streptomyces garyphalus, 
which covalently inhibits Alr (Noda et al., 2004b, Fenn et al., 2003, Asojo et al., 2014, 
Priyadarshi et al., 2009, Wu et al., 2008, Lambert & Neuhaus, 1972). The structure of 
the AlrSco in complex with DCS shows that the amino group of the inhibitor replaces 
the Lys46 in forming a covalent bond with the PLP C4 (Fig. 4c). The nitrogen and 
oxygen atoms in the isoxazole ring form hydrogen bonds with Tyr302’, Met331’ and a 
water molecule. The hydroxyl group of the DCS ring also interacts with Met331’ and 
Arg148 (Fig. 4c). The catalytic Tyr283’ is at hydrogen-bond distance from the amino 
group of DCS. DCS molecules superpose well in three of the active sites of the crys-
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tal (A, B and C). However, the DCS-PMP adduct in the fourth site showed a shift of 
the DCS compared to the other sites, while PLP still superposed well. Comparison 
of the hydrogen bonds in the proximity of the active site in the free and in the DCS-
bound form of Alr, revealed a role for Arg148 in substrate stabilization. In fact, while 
the side chain of Arg148 is hydrogen-bonded to Gln333 in free Alr, it shifted towards 
the hydroxyl moiety of the DCS upon binding of the inhibitor. Gln333 was stabilized 
by interaction with carboxylated Lys141. The rearrangement of the hydrogen bonds 
involving Arg148, Gln333 and Lys141 does not occur in the propionate-bound struc-
ture, suggesting that Arg148 is involved in stabilization of the carboxylic group of the 
substrate.
Alr and DCS resistance
AlrSco shows high sequence and structural similarity to AlrSla. Based on crystallo-
graphic studies, AlrSla was proposed as one determinant of DCS resistance in the 
producer strain (Noda et al., 2004b). However, detailed structural comparison of 
different Alr proteins based on interatomic distances between active site residues, 
dimerization areas and hinge angles (SI), failed to establish a clear correlation be-
tween structural features and DCS resistance. It therefore remains unclear what the 
role of Alr is in DCS resistance in the producer strain.
In conclusion, we showed that SCO4745 encodes the only Alr in S. coelicolor 
A3(2) and that it is essential for growth. Our structural studies on AlrSco and compari-
son to AlrSla suggest that Alr is not the only factor that contributes to DCS resistance, 
and further investigation is required, in line with recent studies on DCS-producing 
Streptomycetes (Matsuo et al., 2003) and DCS-resistant strains of M. tuberculosis 








The bacterial cell wall is an extremely dynamic macromolecule subject to constant 
construction and deconstruction depending on the requirements that are imposed 
by cell growth. New cell wall material is incorporated in a manner which still sup-
ports cell structure and survives the turgor pressure – there is no room for weak 
spots. Correct regulation of cell wall synthesis is essential for several processes in 
Streptomyces. After dormancy, spores need to germinate in a favorable environ-
ment, a process tightly regulated by the cAMP receptor protein CRP and Resus-
citation Promoting Factors (RPFs) (Piette et al., 2005, Sexton et al., 2015). After 
germination, DivIVA driven apical growth drives the formation of a large vegetative 
mycelial structure (Flärdh et al., 2012). During vegetative growth, cross-membranes 
and vegetative septa are formed to compartmentalize the vegetative mycelium, an 
SsgB-independent but FtsZ-dependent process (Celler et al., 2016, Yague et al., 
2016). Later, spores are formed by a process where SsgB recruits FtsZ, resulting in 
Z-rings that are spaced by approximately 1 µM, followed by septation and eventu-
ally spores (Willemse et al., 2011). After spore dispersal, the life cycle starts anew. 
This complexity and the necessity for regulation is expressed in the 7-11 SsgA-like 
proteins in streptomycetes that serve to control processes relating to cell wall remod-
eling, including germination, branching and sporulation (Traag & van Wezel, 2008), 
in the in the nine penicillin binding proteins (PBPs) and seven putative L,D-transpep-
tidases (LDTs) which together serve to cross-link the peptidoglycan, and in the 50-
60 genes predicted to be involved in peptidoglycan hydrolysis (Haiser et al., 2009). 
This regulation and modification is visible in the diverse muropeptide pattern, which 
shows more than 60 separate muropeptides, as shown in this thesis. As one of 
the most well-conserved cellular entities, the bacterial cell wall is a major target for 
antibiotics, and many of these are produced by actinobacteria (Barka et al., 2016). 
To protect themselves against their own antibiotics, Streptomyces carry antibiotic 
resistance mechanisms that vary from modifying the function of a single protein, like 
D-cycloserine resistance, to a complete cluster of genes that modifies a part of the 
cell wall, as seen in vancomycin resistance (Schaberle et al., 2011). Not surprisingly, 
there are many aspects of Streptomyces biology that have not been resolved. In this 
thesis, I investigated how the actinobacterial cell wall contributes to species differen-
tiation, cell growth and antibiotic resistance.
Cell wall research in actinobacteria finds its origins in the taxonomic separation 
of different species. Beginning with the pioneering work by Lechevalier and Leche-
valier, the composition of the cell wall has served as a useful tool for actinomycete 
classification (Lechevalier et al., 1971, Cummins, 1962). They showed that all acti-
nomycete cell walls contain N-acetyl-glucosamine, N-acetyl-muramic acid, alanine 
and glutamic acid. Diagnostic differences between different actinomycetes species 
can be found in the presence of glycine, lysine and either LL- or LD(meso)-diamino-
pimelic acid, together with a set of diagnostic sugars: arabinose, galactose, xylose 
and madurose. In their analysis, the authors also detected the sugars arabinose and 
galactose, which form the arabinogalactan layer of Mycobacterium and Nocardia 
species. 
Chapter 2 shows a polyphasic taxonomic approach to the characterization of 
Streptomyces roseifaciens, a novel species of Streptomyces originally isolated from 
the QinLing mountains in China (Zhu et al., 2014a, Zhu et al., 2014b). This Strep-
tomyces species is a morphological outlier of the Streptomyces, as this does not 
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make long spore chains, but verticillate spores which branch out of the side of aerial 
hyphae (Hatano et al., 2003). On analyzing the distribution of the SsgA-like pro-
teins (SALPS), it became apparent that verticillate Streptomyces typically lack SsgE. 
In Streptomyces coelicolor, ssgE deletion mutants predominately produce single 
spores, rather than spore chains, suggesting a role in spore chain morphology. This 
correlates well with the fact that verticillate streptomycetes have an entirely different 
way of producing spore chains, namely many short chains at the lateral side of the 
aerial hyphae instead of conversion of the aerial hyphae in a single long spore chain.
Whereas cell wall research has started as a taxonomic indicator, current cell wall 
research is performed to generate insight in bacterial cell growth and development. 
In Chapter 3 the cell wall composition of S. coelicolor was analyzed in growing 
vegetative hyphae and of spores to look for trends and changes in peptidoglycan 
composition, and more importantly, to get a hint on the mechanisms of tip growth. 
Therefore, the muropeptide profile was analyzed by LC-MS, which allows direct 
detection of the masses associated with different muropeptides, even with over-
lapping retention times. This study identified over 60 different muropeptides over 
the course of growth and development. Especially interesting was the high amount 
of 3-3 cross-links, produced by L, D-transpeptidases (LDTs). LDTs are recognized 
as transpeptidases that function similarly to Penicillin Binding Proteins (PBPs), al-
though cross-linking at a different point. Importantly, PBPs require the presence of 
pentapeptides to form a 3-4 cross-link, whereas LDTs require tetrapeptides to form a 
3-3 cross-link. The abundance of 3-3 cross-links is especially high in actinobacteria 
(which grow at the tip) and LDTs are suggested to remodel the cell wall in the post-tip 
area (Baranowski et al., 2018). The work described in Chapter 3 also revealed that 
the amount of 3-3 cross-links increases as vegetative mycelium ages, and hyphae 
grow longer. Cell wall hydrolysis was clearly visible in our data, especially vegetative 
mycelium showed a high amount of dimers lacking a set of glycans, indicating con-
stant cell wall hydrolysis. In addition, we show that a single muropeptide increases 
in abundance over the course of development, namely a MurN-tri peptide, which 
lacks GlcNAc and carries a de-acetylated MurNAc. Possibly, this muropeptide has 
no function itself but is the result of hydrolysis or spore separation. 
The muropeptide profile of S. coelicolor showed that the most apparent difference 
between the cell wall composition of vegetative mycelium and spores relates to the 
abundance of certain muropeptides, while no muropeptides were uniquely associat-
ed with either vegetative mycelium or spores. To investigate this further, we looked 
back at the taxonomy of streptomycetes. The presence of either LL-DAP, meso-DAP 
or both is indicative of the genus. This proves invaluable to distinguish Streptomyces 
from Kitasatosporae, which are very similar in respect to morphology and 16S rRNA 
and resulted in the inclusion of Kitasatospora within the genus Streptomycetes (Kim 
et al., 2004). However, Kitasatosporae have different SsgA-like proteins, and lack 
orthologues of mbl, bldB and whiJ, suggesting that development is regulated in a 
different manner (Girard et al., 2014). The main diagnostic difference between the 
cell walls of the two genera within the Streptomycetaceae is that Streptomyces cell 
walls contain LL-DAP, whereas Kitasatospora cell walls carry meso-DAP in the veg-
etative mycelium and LL-DAP in the spores (Takahashi, 2017, Girard et al., 2014). 
DAP is a key component of the peptidoglycan, as this amino acid is at the connecting 
part of cross-links between peptide chains, either a 3-3 or a 3-4 cross-link. We sus-
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pected that the difference in stereochemistry could be related to a difference in the 
peptidoglycan household. Indeed, the work in Chapter 4 shows that two species of 
Kitasatospora, K. setae and K. viridifaciens, heavily remodel the peptidoglycan be-
tween vegetative growth and reproductive growth. It is almost  as if the muropeptide 
profiles from vegetative mycelium and spores had been obtained from different or-
ganisms. This shows that not only the DAP isometry is different between two stages 
of development, but the entire PG architecture changes radically. The regulation of 
incorporation of either meso- or LL-DAP is unclear, as is the function of this chemical 
difference between vegetative mycelium and spores. 
As mentioned above, the bacterial cell wall is a very important target for antimicro-
bial compounds. Vancomycin is a glycopeptide antibiotic, mostly used as a last-re-
sort compound, when infections of Gram-positive bacteria are unresponsive to other 
antibiotics. Chapter 5 discusses the vancomycin resistance cluster of S. coelicolor, 
which largely resembles resistance clusters as found in vancomycin resistant En-
terococci (Hong et al., 2004). Vancomycin targets the D-Ala-D-Ala terminus of Lipid 
II, before this is incorporated into the mature peptidoglycan. Resistance against van-
comycin is gained by replacing the D-Ala-D-Ala terminus by D-Ala-D-Lac, performed 
by a combination of seven genes. A two-component regulatory system, VanR and 
VanS recognize vancomycin in the environment, VanH produces D-Lactic acid, VanA 
ligates D-Alanine and D-Lactic acid and VanX is a dipeptidase that cleaves D-Ala-D-
Ala. We show that the addition of D-Alanine increases the sensitivity of bacteria to 
vancomycin due to the bifunctional activity of the D-Alanine-D-Lactate ligase VanA. 
VanA is in essence a modified version of the D-Alanine-D-Alanine ligase Ddl and 
VanA is able to ligate D-Ala and D-Ala when this is available in the environment. 
This effect becomes especially clear in a knock-out mutant of vanX with the addition 
of exogenous D-Ala. When the amount of D-Ala in the environment is high, VanA 
produces D-Ala-D-Ala and when this is not broken down by VanX, the strain regains 
sensitivity to vancomycin. This emphasizes that antibiotic resistance mechanisms 
do not function perfectly, but serve to function good enough as to secure survival. 
A small molecule screen should facilitate the discovery of drugs that target VanX. If 
such a drug is found, it may be an efficient enhancer of the bioactivity of vancomycin. 
The pentapeptide chain in the peptidoglycan consists of interchanging L- and 
D-amino acids, of the MurNAc-bound D-Lac, L-Ala, D-Glu, LL-DAP and D-Ala-D-Ala 
(Vollmer et al., 2008a). This interchange serves to deter unspecific peptidases as 
regular peptidases only target L-amino acids, and a relatively simple mirror image of 
a peptidase could target a chain of D-amino acids (Radkov & Moe, 2014). A chain of 
interchanging L- and D- amino acids requires highly specific endopeptidases, such a 
phenomenon is also found in lantibiotics (Knerr & van der Donk, 2013). In Chapter 6 
we have explored the role of the alanine racemase Alr, which is essential for growth, 
and mutants can only be produced in the presence of D-Ala. This feature was used to 
show the in vitro bioactivity of the enzyme; alr null mutants cannot grow when media 
are supplemented with L-Ala, but if the amino acid is preincubated with Alr enzyme, 
the mixtures contained sufficient D-Ala to support growth. This clearly showed the in 
vitro racemase bioactivity of the enzyme, and this enzyme prep was subsequently 
used to determine its crystal structure. The Alr protein is pyridoxal phosphate-depen-
dent and forms a heterodimer. The crystal structure of the protein is solved both with 
and without its inhibitor D-cycloserine (DCS), a D-Ala analogue that acts as a sui-
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cide substrate for Alr. We expected that the DCS producer Streptomyces lavendulae 
might have significant changes in its Alr homologue, but comparison of the crystal 
structures of the Alr orthologues of S. coelicolor and S. lavendulae did not reveal any 
changes that could directly be related to obvious differences in substrate specificity. 
We therefore suspect that the D-alanine-D-alanine ligase (Ddl) plays an additional 
role in DCS resistance, and this idea needs to be worked out further.
OUTLOOK
The work presented in this thesis features different approaches to characterize 
actinomycetes and their cell wall, from the small scale of protein isolation and char-
acterization, peptidoglycan architecture analysis, to taxonomy and antibiotic resis-
tance mechanisms. Each of the research directions in this thesis leaves questions 
unanswered. In the case of the verticillate Streptomyces, we have identified a differ-
ent set of SALPS from Streptomyces with canonical spores, but we do not know how 
sporulation along the lateral wall is regulated. If this is resolved, it will deliver import-
ant cues as to how sporulation-specific cell division is controlled in time and space. 
The cell wall analysis of Streptomyces showed which muropeptides are available in 
a complete culture at different moments in time, but a muropeptide analysis requires 
an entire culture so we do not yet have spatial knowledge of different PG modifica-
tions. Analysis of Kitasatospora PG showed that vegetative PG had meso-DAP and 
spore PG LL-DAP. We can only wonder whether the difference in stereochemistry 
acts as a signal, or whether the stereochemistry is functional at all. The work on 
vancomycin resistance showed how a deletion of vanX increased sensitivity in Van-
comycin-resistant strains by a thousand fold, showing major potential for a solution 
to the high amount of vancomycin resistant infections. Here, the missing component 
is a chemical inhibitor of the VanX protein. This thesis describes a working fluores-
cence-based assay to screen for VanX-inhibitors, perhaps this can inspire future 
scientists to continue the research. 
We are currently at a time where genome sequencing becomes commonplace, 
among others due to ever-decreasing cost, and chemical toolboxes are expanding 
with new high-throughput methods for cell wall analysis. Imaging is becoming more 
informative and broadly applicable with fluorescent dyes such as the fluorescent 
D-amino acid HADA, that binds to PG at the position of D-Ala and allows scientists 
to localize sites of cell wall remodeling (Kuru et al., 2015). This combination of ge-
nomics, biochemical tools and biological insights provides scientists with the perfect 
opportunity to work with understudied organisms and to investigate how the different 
modes of growth are executed and controlled. Future work might show why Kita-
satosporae have different stereoisomers of DAP at different developmental stages, 
how sporulation is regulated in verticillate Streptomyces, or how Streptomyces know 
where septal sites in aerial mycelia need to be in order to produce a long chain of 




De bacteriële celwand is een dynamisch molecuul dat constant wordt afge-
broken en wederopgebouwd om celgroei en celdeling te faciliteren. Nieuw 
celwandmateriaal wordt ingebouwd terwijl de cel onder constante turgor-
druk staat; er is geen ruimte voor zwakke plekken. De juiste organisatie van 
celwandsynthese is essentieel voor meerdere processen in het leven van 
Streptomyceten. Als Streptomyces sporen een gunstige omgeving hebben 
gevonden zullen ze ontkiemen, een proces dat strak gereguleerd wordt door 
het cAMP receptor eiwit CRP en Resuscitation Promoting Factors (RPFs) 
(Piette et al., 2005, Sexton et al., 2015). Na ontkieming groeien vegetati-
eve hyfen verder vanuit de top, ondersteund door eiwit DivIVA, waarna de 
hyfen uitgroeien tot een meercellig mycelium (Flärdh et al., 2012). Tijdens 
de vegetatieve groei van deze lange hyfen ontstaan er compartimenten bin-
nen de hyfen zelf door cross-membranen en vegetatieve septa, een proces 
waarvoor het eiwit FtsZ essentieel is, maar wat onafhankelijk is van SsgB 
(Celler et al., 2016, Yague et al., 2016). Sporen worden later gevormd door 
de lange luchthyfen in kleine compartimenten te delen, waarvoor SsgB het 
celdelingseiwit FtsZ rekruteert. FtsZ vormt later FtsZ-ringen op precies 1 µM 
afstand van elkaar. Hierop vernauwen de ringen om een septum te vormen, 
en uiteindelijk de sporen zelf (Willemse et al., 2011). Na het verspreiden van 
sporen begint deze levenscyclus weer van begin af aan. De complexiteit 
en de noodzaak voor de regulatie van de groei wordt uitgedrukt in de 7-11 
SsgA-like proteins (SALPS) in Streptomyceten. Deze eiwitten reguleren pro-
cessen gerelateerd aan de celwand, waaronder de ontkieming, vertakking 
en sporenvorming (Traag & van Wezel, 2008). Behalve de celwand regulatie 
via SALPS, codeert het DNA van Streptomyces ook voor negen penicillin 
binding proteins (PBPs), en zeven L,D-transpeptidases (LDTs), die samen 
het peptidoglycaan cross-linken. De noodzaak voor regulatie zien we terug 
in de 50-60 genen waarvan verondersteld wordt dat zij verantwoordelijk zijn 
voor het afbreken van het peptidoglycaan (Haiser et al., 2009). Als een van 
de best geconserveerde onderdelen van de cel is de bacteriële celwand ook 
een geliefd doelwit voor antibiotica, waarvan er veel geproduceerd worden 
door actinobacteriën zelf (Barka et al., 2016). Om zichzelf te beschermen 
tegen hun eigen geproduceerde antibiotica dragen Streptomyces antibiotica-
resistentie mechanismen. Deze mechanismen variëren: van het modificeren 
van de functie van een enkel gen, zoals we zien in D-cycloserine resistentie, 
tot een compleet cluster van genen dat een onderdeel van de celwand ve-
randert, zoals we zien in vancomycine resistentie (Schaberle et al., 2011). 
Het komt niet als een verrassing dat er veel aspecten zijn van de Streptomy-
ces biologie nog onbekend zijn. In dit proefschrift heb ik onderzocht hoe de 
actinobacteriële celwand bijdraagt aan soortvorming, celgroei en antibiotica 
resistentie. 
Celwandonderzoek in actinobacteriën vindt zijn origine in de taxonomische 
scheiding van verschillende nauw verwante bacteriële soorten. Het pion-
ierende werk van Lechevalier en Lechevalier heeft als eerst de precieze 
samenstelling van de celwand bepaald van alle destijds bekende actinomy-
ceten, om zo een basis te leggen voor de chemische classificatie van deze 
soorten (Lechevalier et al., 1971, Cummins, 1962). Zij hebben aangetoond 
dat de celwanden van alle actinomyceten N-acetyl-glucosamine, N-acetyl 
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muraminezuur, alanine en glutaminezuur bevatten. De verschillen tussen 
de verschillende soorten actinomyceten zit in de aanwezigheid van glycine, 
lysine en ofwel de celwand LL- of LD (meso)-diaminopimelic acid, evenals 
de aanwezigheid van een set diagnostische suikers: arabinose, galactose, 
xylose en madurose. In dit onderzoek werden de suikers arabinose en ga-
lactose, de onderdelen van de arabinogalactanlaag van Mycobacterien en 
Nocardia, al aangetoond. 
Hoofdstuk 2 bevat een taxonomische benadering tot de karakterisatie van 
Streptomyces roseifaciens, een nieuwe soort binnen de streptomyceten die 
origineel geïsoleerd is in de QinLing bergen in China (Zhu et al., 2014a, Zhu 
et al., 2014b). Deze soort is een morfologische vreemde eend binnen de 
Streptomyces: S. roseifaciens maakt geen lange sporenketen, maar maakt 
sporen in een krans rond luchthyfen (Hatano et al., 2003). Wanneer we naar 
de SsgA-like proteins (SALPS) keken bleek dat streptomyceten met krans-
vormige sporenketens typisch SsgE missen. In Streptomyces coelicolor 
heeft een ssgE-gedeleteerde mutant voornamelijk enkele sporen in plaats 
van lange sporenketens, wat een rol in sporenketenuiterlijk suggereert. Dit 
past in de lijn dat kranssporulerende streptomyceten een andere sporenket-
enmorfologie hebben, namelijk met korte sporenketens aan de zijkant van 
luchthyfen in plaats van een lange luchthyfe dat wordt opgedeeld in kleine 
compartimenten om sporen te maken. 
Waar celwandonderzoek begonnen is als taxonomisch hulpmiddel, wordt de 
celwand tegenwoordig voornamelijk onderzocht om inzicht te krijgen in de 
groei en ontwikkeling van bacteriën. In hoofdstuk 3 is de celwandsamen-
stelling van Streptomyces coelicolor geanalyseerd in groeiende vegetative 
mycelia en in sporen om zo te zoeken naar trends en veranderingen in pep-
tidoglycaancompositie. Het doel hiervan is om inzicht te verkrijgen in de 
mechanismen achter topgroei. Het muropeptide profiel was geanalyseerd 
met behulp van LC-MS, deze techniek staat toe dat de massa’s direct geme-
ten wordt na de chromatografie, ook als de retentietijden overlappen. Deze 
studie identificeerde meer dan 60 verschillende muropeptiden gedurende 
de groei en ontwikkeling. Vooral interessant was de hoge hoeveelheid 3-3 
cross-links, geproduceerd door L, D-transpeptidases (LDTs). LDTs zijn tran-
speptidasen die een werking hebben lijkend op die van penicilline bindende 
eiwitten (PBPs), maar een link vormen op een andere positie. Essentieel is 
dat PBPs pentapeptiden als substraat nodig hebben om 3-4 cross-links te 
kunnen vormen, terwijl LDTs tetrapeptiden nodig hebben om 3-3 cross-links 
te kunnen vormen. De hoeveelheid van 3-3 cross-links is bijzonder hoog in 
actinobacterien, die allemaal van de top groeien en het is gesuggereerd dat 
LDTs de celwand veranderen in het gebied na de groeiende top (Baranowski 
et al., 2018). Het werk beschreven in hoofdstuk 3 toont dat de hoeveelheid 
3-3 cross-links toeneemt terwijl het mycelium groeit en ouder wordt. Celwand 
afbraak was duidelijk zichtbaar in onze data, wat laat zien dat er constante 
peptidoglycaanhydrolyse plaats vindt. Hierbij tonen we aan dat er een en-
kele muropeptide in hoeveelheid toeneemt bij sporenvorming. Deze MurN-tri 
peptide mist GlcNAc en heeft een gede-acetyleerde MurNAc. Mogelijkerwijs 




Het muropeptideprofiel van S. coelicolor laat zien dat het grootste verschil in 
celwandprofiel tussen vegetatief mycelium en sporen in de relatieve hoev-
eelheid van de muropeptiden zit, niet zozeer in de aan- of afwezigheid. Verd-
er onderzoek naar de celwand begon door opnieuw te kijken naar de taxon-
omische achtergrond van de familie streptomyceten. De aanwezigheid van 
ofwel LL-DAP of meso-DAP is een indicatie van het genus; op deze wijze 
kunnen Streptomyces en Kitasatospora van elkaar worden onderscheiden, 
ondanks dat deze twee soorten wat betreft morfologie en 16S rRNA enorm 
veel op elkaar lijken. (Kim et al., 2004). Een ander verschil in Kitasatosporae 
is de huishouding in SALPs en het ontbreken van orthologen van de genen 
mbl, bldB en whiH. Dit suggereert dat de ontwikkeling anders gereguleerd 
wordt in Kitasatospora dan in Streptomyces (Girard et al., 2014). Het verschil 
tussen deze twee genera is dat de Streptomyces celwand LL-DAP bevat, 
terwijl de Kitasatospora celwand meso-DAP in het vegetative mycelium heeft 
en LL-DAP in de celwand van de sporen (Takahashi, 2017, Girard et al., 
2014). DAP is een sleutelcomponent van het peptidoglycaan: dit aminozuur 
vormt het verbindende gedeelte van een cross-link tussen peptide ketens, 
als ofwel een 4-3 dan wel een 3-3 cross-link. We verwachten dat het verschil 
in stereochemie gerelateerd kan zijn aan de peptidoglycaanhuishouding. 
Het werk in hoofdstuk 4 betreft twee soorten Kitasatosporae, K. setae en K. 
viridifaciens. Deze twee soorten herstructureren het peptidoglycaan tussen 
vegetative groei en het vormen van sporen, waardoor er bij de analyse van 
deze twee groeistadia de indruk wordt gewekt dat het peptidoglycaanprof-
iel van andere organismen afkomstig zijn. Dit toont aan dat niet alleen de 
DAP isometrie anders is tussen deze twee stadia, maar de hele peptidogly-
caan architectuur verandert. De genetische regulatie van het aanmaken van 
meso- of LL-DAP is onduidelijk, net als de functie achter dit verschil tussen 
vegetatief mycelium en sporen. 
Zoals eerder genoemd is de bacteriële celwand een geliefd aanhechting-
spunt voor antimicrobiële compounds. Vancomycine is een glycopeptide 
antibioticum dat wordt gebruikt bij het behandelen van complexe infecties 
met Gram positieve bacteriën die niet meer op andere antibiotica reageren. 
Hoofdstuk 5 betreft het vancomycine resistentie cluster van S. coelicolor, 
die grotendeels overeenkomt met resistentie clusters van infectieuze stam-
men zoals de vancomycine-resistente Enterokok(Hong et al., 2004). Vanco-
mycine werkt op het ‘D-Ala-D-Ala’ uiteinde van Lipid II, voordat deze wordt 
ingebouwd in het peptidoglycaan. Resistentie tegen vancomycine wordt 
verkregen door de ‘D-Ala-D-Ala’ terminus te vervangen door een ‘D-Ala-D-
Lac’ uiteinde, een proces dat wordt uitgevoerd door een set van 7 genen in 
S. coelicolor. Dit proces start met een twee-component regulatie systeem, 
VanR en VanS, die de aanwezigheid van vancomycine in de omgeving kan 
herkennen.  VanH produceert D-lactaat, waarop VanA dit koppelt aan D-al-
anine om ‘D-Ala-D-Lac’ te vormen. VanX is een dipeptidase die de overige 
‘D-Ala-D-Ala’ afbreekt. Wij laten zien dat de toevoeging van D-Alanine de 
stam gevoeliger maakt voor vancomycine dankzij de tweeledigeactiviteit 
van de ‘D-Alanine-D-Lactaat’ ligase VanA. VanA is in essentie een gemod-
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ificeerde versie van de ‘D-Alanine-D-Alanine’ ligase Ddl en VanA is in staat 
deze zelfde functie te vervullen als D-Alanine in overvloed aanwezig is in de 
omgeving. Dit effect is overduidelijk als zowelhet gen vanX is uitgeschakeld 
en er extra D-Alanine wordt toegevoegd aan het groeimedium. Wanneer de 
hoeveelheid D-alanine in het medium hoog is, dan produceert VanA een 
D-Ala-D-Ala verbinding die niet wordt afgebroken door VanX, waardoor de 
stam gevoelig wordt voor vancomycine. Dit effect benadrukt dat antibioti-
caresistenties niet perfect zijn maar in essentie goed genoeg om de stam 
te helpen overleven. Een small-molecule screening zou het ontdekken van 
VanX-bindende moleculen kunnen faciliteren; een dergelijk molecuul zou de 
bioactiviteit van vancomycine verder kunnen versterken. 
De pentapeptideketen in het peptidoglycaan bestaat uit een afwisseling 
van L- en D-aminozuren, beginnend bij de MurNAc-gebonden D-Lac, L-Ala, 
D-Glu, LL-DAP en ‘D-Ala-D-Ala’ (Vollmer et al., 2008). Deze afwisseling 
zorgt voor een minder efficiënte binding van aspecifieke peptidasen, gezien 
reguliere peptidasen alleen ketens van L-aminozuren of simpele spiegel-
beeldisomerie ketens van D-aminozurenkunnen afbreken (Radkov & Moe, 
2014). Om een keten van afwisselend L- en D-aminozuren af te breken heb 
je hoog specifieke endopeptidasen nodig; antibiotica maken gebruik van dit 
fenomeen om de stabiliteit te verhogen (Knerr & van der Donk, 2013). In 
hoofdstuk 6 hebben we de rol van de alanine racemase Alr onderzocht, een 
eiwit essentieel voor groei van S. coelicolor en waarvan mutanten alleen 
kunnen worden gemaakt in aanwezigheid van D-Alanine. Deze eigenschap 
kan gebruikt worden om de in vitro bioactiviteit van het eiwit aan te tonen. Bij 
mutanten met een alr deletie is er geen sprake van groei wanneer L-alanine 
toegevoegd is aan het medium. Indien L-Ala eerst samen met Alr geincu-
beerd is heeft het reagens wel genoeg D-Ala, waardoor de cultuur toch kan 
groeien. Dit toont duidelijk aan dat Alr in vitro actief is. Dit preparaat is geb-
ruikt om de kristalstructuur te bepalen. Het Alr eiwit is pyridoxal phosphate 
afhankelijk en vormt een heterodimeer. De kristalstructuur van het eiwit is 
bepaald met en zonder de inhibitor D-cycloserine (DCS), een D-alanine an-
aloog die aan Alr hecht en vervolgens niet loslaat. We hadden verwacht dat 
de producent van DCS, Streptomyces lavendulae, wellicht veranderingen 
had in zijn Alr homoloog, maar een vergelijking van de kristalstructuren van 
de Alr orthologen van S. coelicolor en S. lavendulae toonde geen veranderin-
gen die gekoppeld zijn aan de duidelijke verschillen in substraat specificiteit. 
Hierom denken we dat de D-alanine-D-Alanine ligase (Ddl) een belangrijke 
rol speelt in DCS resistentie, wat verder uitgewerkt zou kunnen worden. 
Vooruitblik: 
Het werk in dit proefschrift toont verschillende benaderingen om de celwand 
van actinomyceten te karakteriseren en analyseren: van eiwit isolatie, pep-
tidoglycaan architectuuranalysen, tot taxonomie en antibiotica resistenti-
emechanismen. Ieder van deze onderzoeksrichtingen heeft vragen beant-
woord, maar ook een aantal nieuwe vragen opgebracht. In het geval van 
de kranssporulerende Streptomyces hebben we een andere set SALPS 
geïdentificeerd dan we vinden bij Streptomyces met normale sporenketens, 
127
Chapter 7
echterweten we nog niet hoe sporulatie langs de wand gereguleerd is. Verd-
er onderzoek zou ons kunnen vertellen hoe sporulatie langs de laterale wand 
georganiseerd is over ruimte en tijd. De celwandanalyse van Streptomyces 
coelicolor toonde welke muropeptiden aanwezig waren in een volledige cul-
tuur op verschillende momenten over tijd, echter weten we nog niet welke 
muropeptiden aanwezig zijn op specifieke plekken in de celwand. Een anal-
yse van Kitasatospora peptidoglycaan toonde dat vegetatief peptidoglycaan 
meso-DAP en sporen peptidoglycaan LL-DAP bevat. De functie van dit ver-
schil in stereo isomerie is nog onduidelijk. Het werk aan vancomycine resis-
tentie toonde aan dat een deletie van vanX de gevoeligheid voor vancomy-
cine in duizendvoud verhoogt in vancomycine-resistente stammen. Dit toont 
veelpotentie als oplossing voor het groeiende probleem van vancomycine 
resistente infecties. Voor deze oplossing moet nog een chemische inhibitor 
van het VanX eiwit worden gevonden. Dit proefschrift beschrijft een assay 
waarmee de functie van VanX gevolgd kan worden met een fluorescent sig-
naal, wat in de toekomst zou kunnen helpen om een inhibitor te vinden. 
Wij bevinden ons in een tijd waar genoomsequenties algemeen worden, 
waarbij scheikundige hulpmiddelen steeds uitgebreider worden en we meer 
methoden ontwikkelen om snelle celwandanalysen te doen. Microscopie ook 
wordt steeds informatiever en breder toepasbaar. Een voorbeeld hiervan is 
het gebruik van fluorescente kleurstoffen zoals het fluorescente D-amino zuur 
HADA, die aan het peptidoglycaan bindt op de positie van D-Ala, waarmee 
onderzoekers kunnen zien waar nieuw celwandmateriaal wordt ingebouwd 
(Kuru et al., 2015). Deze combinatie van genetica, biochemie en biologisch 
inzicht geeft wetenschappers de perfecte gelegenheid om met onderbe-
studeerde organismen te werken en om te onderzoeken hoe verschillende 
manieren van groei worden uitgevoerd en gecontroleerd. Toekomstig werk 
zou kunnen laten zien waarom Kitasatosporae verschillende stereoisomeren 
van DAP hebben, hoe sporulatie gereguleerd is in kranssporulerende Strep-
tomyces of hoe Streptomyces weten waar de tussenschotten tussen hon-
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